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„6every experiment destroys some of the knowledge of the system 
which was obtained by previous experiments.“ 
 
Werner Heisenberg 
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Summary 
Biopharmaceuticals, such as monoclonal antibodies (mAb), have recently become 
increasingly important in the treatment of many different diseases. Usually these molecules 
have complex molecular structures which poses great challenges for their characterization. 
However, full characterization is essential for FDA and EMA drug approval. Nowadays, 
antibodies are usually analyzed by high-resolution mass spectrometry (HR-MS). One 
approach is the middle-down analysis, where enzymes such as pepsin are used to digest the 
antibodies into specific fragments which are in a more suitable size-range and can be more 
easily analyzed. However, mAb characterization usually starts with top-down analysis of 
intact antibodies using HR-MS or liquid chromatography (LC) hyphenated to HR-MS (LC-MS) 
for determining the molecular mass to charge (m/z) of the protein. 
In this work new methods for sample preparation in protein analytics of biopharmaceuticals 
have been developed. In particular, the main approach discussed herein describes the 
sample preparation of therapeutic proteins with heterogeneous nanobiocatalysts based on 
gold nanoparticles (GNPs) with coated or immobilized enzymes such as pepsin. The different 
synthesis steps of the nanoparticulate carriers were investigated and compared in size and 
function using classical methods, such as Vis-spectroscopy, dynamic light scattering (DLS), 
Lowry assay and Michaelis-Menten kinetic analysis. Newer methods such as Resonant Mass 
Measurement and Taylor Dispersion Analysis were also used for this purpose. In order to 
extend the toolbox of methods in this regard, the results of these modern characterization 
methods were compared with those of the classical ones. For functional studies of the gold 
nanoparticle-conjugated enzyme, the comparison of enzyme activities with free, unbound 
enzymes (e.g. pepsin) is an important aspect for the performance evaluation of the new 
nanobiocatalysts. The immobilization of enzymes to nanoparticulate carriers has some 
advantageous. Since the gold nanoparticles have a high density, separation of the nano 
biocatalysts from the sample is easily possible with simple benchtop centrifuges, as they are 
present in almost every modern laboratory. Thus, the enzyme can be easily removed after 
reaction and does not contaminate the sample with another protein (enzyme) which might 
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give interferences in subsequent MS analysis. However, it has to be ascertained that 
immobilization does not reduce the enzyme activity. In this work it is documented that pepsin 
immobilized on gold nanoparticles has even higher enzymatic efficiencies than pepsin in free 
solution. 
The aim of the present work is to provide an overview of the synthesis and characterization 
of GNPs as a nano framework for enzymes used for protein and antibody analysis. Also, the 
current state of technology in methods for the use of GNPs should be pointed out here. 
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Zusammenfassung der Dissertation 
Biopharmazeutika, wie zum Beispiel monoklonale Antikörper (mAb), haben unlängst bei der 
Behandlung vieler verschiedener Krankheiten an Bedeutung gewonnen. In der Regel haben 
diese Moleküle komplexe molekulare Strukturen, die ihre Charakterisierung vor große 
Herausforderungen stellt. Eine vollständige Charakterisierung ist jedoch für die Zulassung 
von FDA und EMA-Arzneimitteln unerlässlich. Heutzutage werden Antikörper gewöhnlich 
durch hochauflösende Massenspektrometrie (HR-MS) analysiert. Ein Ansatz ist die Middle-
Down Analyse, bei der Enzyme wie Pepsin verwendet werden, um die Antikörper in 
spezifische Fragmente zu verdauen, die sich in einem geeigneteren Größenbereich befinden 
und so leichter analysiert werden können. Die mAb-Charakterisierung beginnt jedoch in der 
Regel mit der Top-Down Analyse von intakten Antikörpern mittels HR-MS oder 
Flüssigkeitschromatographie (LC) gekoppelt mit HR-MS (LC-MS), welche auch die übliche 
Methode darstellt, um das Verhältnis Masse zu Ladung (m/z) der Proteine zu bestimmen. 
In dieser Arbeit wurden neue Methoden zur Probenvorbereitung in der Proteinanalytik von 
Biopharmazeutika entwickelt. Der hier diskutierte Hauptansatz beschreibt insbesondere die 
Probenaufarbeitung von therapeutischen Proteinen mit heterogenen Nanobiokatalysatoren 
auf der Basis von Goldnanopartikeln, die mit Enzymen wie Pepsin beschichtet oder diese auf 
ihnen immobilisiert sind. Die verschiedenen Syntheseschritte der nanopartikulären Träger 
wurden unter Verwendung klassischer Methoden, wie Vis-Spektroskopie, Dynamische 
Lichtstreuung (DLS), Lowry-Assay und Michaelis-Menten-Kinetik, in Größe und Funktion 
untersucht und verglichen. Neuere Methoden, wie die Resonanzmassenmessung und die 
Taylor-Dispersion, wurden ebenfalls für die Studie verwendet. Um den Werkzeugkasten an 
Methoden in dieser Hinsicht zu erweitern, wurden die Ergebnisse dieser modernen 
Charakterisierungsmethoden, mit denen der klassischen Modelle verglichen. Für funktionelle 
Untersuchungen der Enzymaktivität von auf Goldnanopartikel konjugierten Proteinen, ist der 
Vergleich der Enzymaktivitäten von freien und ungebundenen Enzymen (z. B. Pepsin) ein 
wichtiger Gesichtspunkt für die Bewertung der Leistung der neuen Nanobiokatalysatoren. 
Die Immobilisierung von Enzymen an nanopartikuläre Träger hat einige Vorteile. Da die 
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Goldnanopartikel eine hohe Dichte aufweisen, ist die Trennung der Nanobiokatalysatoren 
von der Probe mit einfachen Tischzentrifugen, wie sie in fast jedem modernen Labor 
vorhanden sind, möglich. Somit kann das Enzym nach der Reaktion leicht entfernt werden 
und kontaminiert die Probe nicht mit einem anderen Protein (Enzym), das Interferenzen bei 
der nachfolgenden MS-Analyse verursachen kann. Es muss jedoch sichergestellt werden, 
dass die Immobilisierung die Enzymaktivität nicht verringert. In dieser Arbeit wird 
dokumentiert, dass auf Goldnanopartikeln immobilisiertes Pepsin, sogar eine höhere 
enzymatische Effizienz aufweist, als Pepsin in freier Lösung. 
Ziel der vorliegenden Arbeit ist es, einen Überblick über die Synthese und Charakterisierung 
von GNPs zu geben, welche als Nano-Grundgerüst für Enzyme dienen, die für die Protein- 
und Antikörperanalyse verwendet werden. An dieser Stelle soll auch der aktuelle Stand der 
Technik an Methoden, welche GNPs verwenden, erörtert werden.  
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1. General Introduction 
 
1.1. Biopharmaceuticals 
Biopharmaceuticals are medicinal products, i.e. drugs that are produced under the aid of 
biotechnological processes. Active pharmaceutical ingredients (APIs) gained from these 
kinds of biological sources are usually complex in molecule structure. The analytical 
claim of such complex molecules, such as proteins and antibodies (Abs), in terms of 
production and quality is different from those of conventionally synthesized 
pharmaceutical molecules [1] as the commercial importance of these molecules has 
increased in recent years. Since the first commercially available therapeutic monoclonal 
antibody (mAb) Muromonab-CD3 (https://www.drugbank.ca/drugs/DB00075, 01.06.2018) 
with the trade name Orthoclone OKT3 (1986, Janssen-Cilag) [2], FDA (Food and Drug 
Administration) approved for the prevention of renal transplant rejection, there are 
already over 40 monoclonal antibodies (mAbs) available for cancer treatment, orphan 
drugs and blockbusters for treatment of asthma and rheumatism [3]. Noteworthy here are 
monoclonal antibodies, such as CD-20 antibody Rituximab [4], which is considered a 
pioneer of targeted cancer therapy (FDA approval 1997, EMA (European Medicines 
Agency) approval 1998) and approved for the treatment of rheumatoid arthritis [5]. Also, 
worth mentioning, are the mAbs for the treatment of asthma like the immunoglobulin E/ 
IgE Omalizumab (Xolair® market by Novartis and Roche) [6] and interleukin-5/ IL5 
antibodies such as Reslizumab (FDA and EMA approval in 2016) [7] and Mepolizumab 
(FDA and EMA approval in 2015) [8]. 
All information regarding FDA and EMA approvals, trade names and companies were 
taken from the URL of Animal Cell Technology Industrial Platform (ACTIP) “Monoclonal 
Antibodies Approved by the EMA and FDA for Therapeutic Use (status 2017)” 
(http://www.actip.org/products/monoclonal-antibodies-approved-by-the-ema-and-fda-for-
therapeutic-use/). 
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Figure 1: The therapeutic monoclonal antibody market from Dawn M Ecker et al. 2015 [3]. Annual approvals of 
mAbs products from 1982 to 2014 (Reprinted with permission). 
 
Figure 1 gives an overview of the development of the markets for therapeutic antibodies 
from 1982 to 2014. A clear increase from the beginning of the 2000s can be clearly seen. 
In 2016, the global market for mAbs was $ 85.4 billion. A forecast for 2024 published at 
Grand View Research in 2016 assumes an annual growth rate of approximately 5.7% 
and around $ 140 billion for 2024 [9]. 
This growth also poses challenges to the quality and speed of analytical quality control. 
 
1.1.1. Methods for Quality Control of mAbs 
To monitor the development and production of therapeutic antibodies, a variety of 
different analysis tools have been developed in recent years. For this purpose, 
various electrophoresis methods, but also liquid chromatography, mass spectrometry 
and their hyphenations are used, to obtain information e.g. about the complete 
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structural characterization and the glycoprofile [10]. Figure 2 gives a brief overview 
about possible characterization tools. 
 
 
Figure 2: Overview of characterization tools for mAbs (adapted from Beck et al. 2013 [10]) 
 
All these methods are mandatory for quality control during research and 
development, for formulation and scale-up, pre-clinical phases and for the 
identification of possible optimization parameters, to obtain new therapeutical 
mAbs [10]. 
 
1.1.2. Sample Preparation Protocols 
In the case of sample processing for convenient analysis of biopharmaceuticals the 
typical workflow involves enzymatic digestion or chemical fragmentation prior to LC-
MS/MS analysis [10,11]. For classical bottom-up protein analysis at peptide level 
trypsin is mostly used for proteolytic cleavage [12]. In cases of therapeutic proteins, 
such as antibodies [11], pepsin, papain, IdeS and/ or a combination of these three 
biocatalysts along with reducing agents (to cleave disulfide bonds) is usually used to 
Primary Structure Analysis
Higher Order Structure Analysis
Quantification
ELISA
Immunofluorescence
Isotope dilution LC-MS
Charge variants
Middle-up LC-MS
Peptide mapping LC-MS/MS
Top-down MS/MS
AA Sequence variants
Intact mass ESI-MS
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Glycovariants
Released glycans (PNGase F)
MALDI-TOF and ESI-MS/MS
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Higher order
X-ray diffraction
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Ion mobility MS
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Aggregates
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SPR
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(see higher order)
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cut the large intact antibody molecule (about 150 kDa) by specific cleavage into 
smaller defined fragments [10]. 
 
 
Figure 3: Top-down, middle-down and bottom-up characterization of antibodies. Redrawn in modified form 
according to “Result part “FabRICATOR® - treated Therapeutic Antibody” was taken from Biofiles Volume 8 
No 02, Sigma-Aldrich, 2013” [13]. 
 
Pepsin, with a molecular weight (MW) of around 36 kDa and an isoelectric point (pI) 
of about 3.2 [14,15], cleaves antibodies near the hinge region as a digestive protease. 
This cleavage leads in particular to F(ab')2 (MW of around 100 kDa) and two 25 kDa 
Fc fragments (see Figure 3) [10]. In the cleavage of peptide bonds in proteins, pepsin 
preferentially attaches to the C-terminal side of phenylalanine and leucine [16,17]. 
 
Comparable results to pepsin can be also provided by “Immunoglobulin G-degrading 
enzyme of Streptococcus pyogenes or IdeS. This highly specific enzyme can only use 
immunoglobulin G (IgG) as a substrate and a full digestion can be done in rapid 30 to 
120 minutes [18]. The cleavage near the hinge region results in on 100 kDa F(ab’)2 
fragment and two 25 kDa Fc fragments. [19-21]. IdeS, recombinantly modified from 
Streptococcus pyogenes, is being marketed by Genovis under the brand name 
FabRICATOR®. 
(https://www.genovis.com/products/igg-proteases/fabricator/, 10.06.2018) 
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The cysteine protease papain cleaves antibodies specifically above the hinge region. 
This middle-down approach results in two Fab fragments and one Fc fragment with 
around 50 kDa each (see Figure 3) [10]. Papain naturally occurs in Carica papaya. 
The protein structure analysis was carried out in 1968 by Derenth et al [22]. Papain 
consists of 212 amino acids, has a MW of about 24 kDa and a pI of approximately 8.8 
[23,24]. 
 
Dithiothreitol (DTT) is a reducing agent which is used in SDS-PAGE for cleaving 
disulfide bonds (R1-S-S-R2) to sulfhydryl groups (-SH). Due to this fact is also used 
to improve the long-term stability of proteins. Here, the oxidation of sulfhydryl groups 
to disulfide bonds by atmospheric oxygen is prevented [25,26]. The chemical 
fragmentation of antibodies with DTT leads to two heavy chains (HC) each with about 
50 kDa molecular mass, and two light chains (LC) with 25 kDa each (see Figure 3) 
[10]. Besides DTT, TCEP (tris-(carboxyethyl)phosphine), is nowadays frequently used 
for the same purpose, the cleavage of disulfide bonds of antibodies. 
 
The most popular protocol now established makes use of IdeS and subsequently 
reduces the disulfides of the resultant Fc and F(ab')2 to end up with 25 kDa fragments 
which are advantageous from viewpoint of MS detection than the larger 50kDa or 
100 kDa fragments [10,11]. 
 
In addition to the middle- and top-down analysis, there is also the possibility of the 
bottom-up approach. This technique is also referred as peptide level analysis [10,11], 
since as sample preparation a complete enzymatic digestion is carried out with 
trypsin or endoproteinase Lys-C, Asp-N, Glu-C. Trypsin as the gold standard cleaves 
the protein on the carboxyl side of arginine (Arg) and lysine (Lys), protocols are well 
established and it is easily available. To result in a purified sample, pre-cleaning of 
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the proteins before digestion by gel electrophoresis or in-gel digestion can be 
performed [11]. 
 
The protein digest mixtures are separated by liquid chromatography and 
subsequently sequenced by tandem mass spectrometry (e.g. MALDI-MS or ESI-MS). 
The determined peptide masses are used for protein identification by means of 
peptide mapping/ peptide mass fingerprint using peptide databases such as Mascot. 
This requires a well-established protocol to avoid miscleavages and to achieve high 
sequence coverage in order to obtain a valid result [10,11]. 
 
All these are possibilities for the sample preparation of antibodies to make them more 
amenable for subsequent structure characterization by MS. Techniques of 
immobilization of such enzymes on nanoparticles, full characterization of all 
nanoparticle synthesis steps and applications were in the focus of this work and are 
discussed on the following pages. 
 
1.2. Nanoscience 
Nanotechnology and Nanoscience deal with the phenomena of materials according to the 
IUPAC (International Union of Pure and Applied Chemistry) definition for nano dimension 
(vide infra) [27]. This concerns materials in the atomic, molecular and macromolecular 
range, where the physical properties are different to them of the corresponding bulk 
materials [28]. The study of this, for example, optical, electrical or mechanical properties 
gained more and more scientific interest for comparing different techniques and to 
complete the impression with new measuring techniques [29]. 
 
1.2.1. Definition 
In general, according to IUPAC, nanomaterials have minimum one dimension in the 
range of approximately 1 nm to 100 nm in at least one dimension [27]. This definition 
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was established at the ICSU-CODATA workshop (23–24 February 2012, Paris) and 
published in Chemistry International Vol. 34 No. 6, November – December 2012. 
These materials can only be visualized by microscopic techniques, except nano foils, 
because here the thickness and not the area is scaled in nanometer range. 
 
 
Figure 4: Illustration of the size dimensions on a typical functionalized nanoparticle Explanation of used 
abbreviations: gold nanoparticle (GNP), pegylated gold nanoparticle with bifunctional crosslinker SH-PEG7-COOH 
(GNP-PEG7), attached pepsin onto pegylated gold nanoparticle (GNP-PEG7-Pepsin). 
 
1.3. Gold -Bulk Material and Nanoparticles 
Gold is a rare precious metal with the elemental symbol Au, the atomic number of 79 and 
an atomic mass of 196.9666 u. It has a bright and shiny yellowish to reddish appearance, 
a relative low melting point of 1064.18 °C and it is highly ductile. Due to its density of 
19.320 g mL-1 gold has a high specific weight [30]. These facts and the relatively simple 
handling make gold the most precious material for jewelry and valuables for centuries. 
Also, gold will not lose its shiny appearance by wearing it, like silver jewelry for example 
does. The reason for this resistance of corrosion is one of the least reactive behaviors of 
all chemical elements. Gold is only soluble with strongly oxidizing acids. With aqua regia 
(king`s water or royal water) chloroauric acid will be formed. 
Today, gold is not only being important for jewelries and investments, also electronical 
devises and medicinal products contain gold. Currently, the best estimates suggest a 
34 
 
total mined amount of 190,040 t of gold was mined all over history (end-2017). Around 50 
% of the new mined gold will be used for jewelry, 40 % for investments and around 10 % 
will be used for technology (http://www.gold.org, 21.05.2018). 
 
Gold nanoparticles (GNPs) differ in appearance strongly from the bulk products. Based 
on the size of the particles, the color spectrum ranges from blood-red for smaller particles 
to pale violet for larger particles (see Figure 5 below) [31]. This phenomenon is based on 
the so-called localized surface plasmon resonance (LSPR) which is the light induced 
resonant oscillation of the electron collective of delocalized electrons which is caused by 
an external electric field [32,33]. 
 
 
Figure 5: Colloidal gold suspensions of various particle sizes. Photograph courtesy of Dr. Irawati Kandela, 
University of Wisconsin, BBPIC laboratory [31] (Reprinted with permission). 
 
Size, shape, concentration, aggregation of the nanoparticles, environment and surface-
adsorbed species influence the corresponding absorption spectrum when using this 
technique for the characterization of nanoparticles (SPR spectroscopy) [34,35]. Due to 
the different density of colloidal gold suspensions compared to solid gold, induced dipole 
interactions occur, which make the colloids appear more colorful. Here the relative 
absorption size is influenced by the shape/ geometry of the nanoparticles. Quantification 
is achieved by optical cross sections whose relative contributions are calculated 
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according to the Mie theory. The Mie theory offers as a model a correct solution of the 
Maxwell equations for compact spheres [36,37]. As the size of the particles increases, 
the plasmon band shifts toward a higher wavelength. This correlates with the Mie theory 
[38]. If the wavelength of the light becomes much larger in comparison to the size of the 
nanoparticles, standing resonance conditions are to be expected. The free electrons in 
the metal structures oscillate excited by the light, which is in resonance with surface 
plasmon oscillation. Absorption and scattering phenomena determine the resonance 
condition. This also depends on the shape, size and dielectric constant of the metal 
nanostructures, as well as on the surrounding material [33]. 
 
1.3.1. Historical Background 
Metallic nanoparticles have been used since ancient times, especially as a dye in the 
glass and ceramic industries. A well-known example is the Lycurgus Cup, a Roman 
glass cup manufactured in the 4th century AD, which appears green in reflected light 
and ruby red when illuminated from the inside. This effect is caused by the presence 
of traces of gold and silver colloids in the range of about 40 ppm for gold and about 
300 ppm for silver [39,40]. 
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The Lycurgus Cup illuminated from outside (left) and from inside (middle) © of the British Museum. 
At the right side the Mille Fleurs vase, as an example of the Family Rose porcelain © The Guimet 
Museum in Paris - Réunion des Musées Nationaux [39]. 
Figure 6: Examples for the use of metallic nanoparticles in ancient times [39] (Reprinted with permission). 
 
The use of gold nanoparticles as a red colorant has also been used for the 
manufacturing of porcelain goods. During the early seventeen century the secret of 
the Purple of Cassius described by Andreas Cassius of Leyden in 1685 reached 
China and was used, e.g. for the manufacturing of the beautiful Family Rose 
porcelain [41]. 
 
1.3.2. Theranostic Properties and Risks 
The unique optical properties, such as localized surface plasmon resonance [32] and 
Mie scattering [42], make gold nanoparticles also interesting for theranostic 
(theranostic = therapy + diagnostic) approaches in the field of nanobiotechnology. As 
discussed by Khlebtsov et. al. [43] here, the therapeutic and diagnostic properties are 
combined with sensing properties of gold nanoparticles. 
GNPs can be used as contrast imaging agents in cancer therapy for real-time 
monitoring as well as for controlled drug release. Therefore, GNPs can be used as a 
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carrier attached with drugs, peptides, proteins, such as antibodies, DNA and RNA to 
transport them to their place of use and for maximizing the individual and 
personalized aspects. However, studies are also known where GNPs are described 
as toxic when interacting with biological systems. Shape, size, surface and charge of 
the nanoparticles can have a decisive influence here [44]. 
 
 
Gold nanoparticles as theranostic platform, e.g. as targeted vehicles for controlled drug release, 
laser-mediated photothermal therapy and gene therapy, as well as contrast imaging agents to allow 
for real-time monitoring of both disease and therapeutic progression [44]. 
Figure 7: GNPs as theranostic platform for several approaches [44] (Reprinted with permission). 
 
Due to their small size, the nanoparticles can penetrate organic membranes such as 
cell walls. In experiments 2 nm GNPs with cationic ligands were able to penetrate and 
destabilize lipid membranes and, if the concentration was increased, destroy them. 
GNPs with anionic ligands did not show these effects. They even had a stabilizing 
effect on the lipid membrane when the pH was increased [45]. 
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The positive theranostic properties of modified GNPs make them unique tools, but 
long-term studies should thoroughly test the effects of nanoparticles on living systems 
to exclude any toxicological side effects. 
 
1.4. Current Technologies 
While nanoparticles have been used as dyes in the past, the breakthrough in 
nanotechnology was initiated by Turkevich and Frens et al. [46-49] and Schmid and Brust 
et al. [50-52] by developing and describing methods for size-controlled syntheses of gold 
nanoparticles. Until today there are various methods for synthesis and characterization 
described, but also various practical applications of gold nanoparticles. A brief review of 
these utilizations is given in this chapter. Gold nanoparticle synthesis methods, surface 
modification and characterization are described in the following chapters. 
 
1.4.1. Enzyme-Linked Immunosorbent Assay 
The Enzyme-Linked Immunosorbent Assay (ELISA) was developed in parallel by 2 
different working groups and published in 1971. The group around Eva Engvall and 
Peter Perlmann from the University of Stockholm had submitted their work in 
December 1970, Bauke van Weemen and Anton Schuurs from the Research 
Laboratories of NV Organon, Oss, The Netherlands, submitted their work in April 
1971 [53,54]. This antibody-based assay is based on an enzymatic color reaction, 
wherein the antigen of interest is attached adsorptively onto a surface (today 
commonly a microtiter plate is used). An antibody bound to an enzyme is coupled to 
the antigen, and in the last step, an enzyme reaction with the corresponding 
substrate-color-complex results in a detectable color change. 
These tests can also be modified with gold nanoparticles to achieve an amplification 
of the optical signal [55] or to modify the color reaction itself [56]. 
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1.4.2. Pregnancy Test by Lateral Flow Immunoassay 
Pregnancy tests can be based on a so-called lateral flow immunoassay (LFIA) which 
is an easy to handle and cheap test that generates results in minutes [57]. This 
qualitative immunochromatographic technique is based on a combination of thin-layer 
chromatography (TLC) and immunostaining with proper labeled antibodies. The 
antibodies are immobilized, bind and enrich human chorionic gonadotropin (hCG) 
from the urine sample and the result is displayed as a colored area [58,59]. The 
immobilized antibodies can be labeled with gold nanoparticles which can give a red to 
pink band at the detection line [59] and in addition amplify the signal [58]. GNPs also 
allow a different colored negative control (gray to blue) based on an aggregation of 
nanoparticles [59,60]. 
 
1.4.3. Lateral Flow Assay for the Monitoring of Digoxigenin 
Apart from the pregnancy test, the lateral flow (immuno)assay (LFA) can also be used 
for other applications, as shown in a recent publication. The cardiac glycoside 
digoxigenin, which is used for the treatment of tachycardia, has a small therapeutic 
window. Minor increases in concentration can already lead to toxic effects. Easy-to-
use techniques for examining the blood concentration level, especially for so-called 
home monitoring, can be essential. For the detection of digoxin and its derivative for 
the antibody coupling digoxigenin, a common gold nanoparticle lateral flow assay is 
used, which can be evaluated by means of a smartphone. For this purpose, a so-
called dark box made of black cardboard was developed for home monitoring of the 
blood concentration level. For the visual evaluation of the LFA an app is used. The 
results of the app were compared with those of a high resolution bioimager and thus 
the function of the new system for quantitative determination could be confirmed [60]. 
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1.4.4. Drug Test MAVAND Solutions GmbH Rapid STAT® 
Drug tests can also be based on the lateral flow test using colloidal gold [61]. These 
on-site tests are easy to use, robust and deliver fast results for multiple drugs at the 
same time by analysis of oral fluid [62]. Worth mentioning here is the kit Rapid 
STAT® from Mavand Solution GmbH, Mössingen, Germany, with which up to 7 
analytes can be detected simultaneously. These include amphetamine, 
benzodiazepine, cocaine, methadone, methamphetamine, ecstasy, opiate and THC 
(http://www.mavand.de/de/produkte/drogenschnelltests/rapid-statr.html, 06.08.2018). 
The kit has already been compared for several times with other on-site tests and 
chromatographic methods for checking the test kit results, and is used, for example, 
by the German police [62-64]. 
 
1.5. Materials and Shapes 
In the synthesis of colloidal gold processed by a reduction of tetra chloroauric acid and 
stabilization of the particles by citrate (see Chapter 1.7 Synthesis of GNPs), typical 
spherical nanoparticles are formed [65]. Further variants of GNP preparation by changing 
the synthesis have been already discussed in literature. Thus, by switching from an 
aqueous system to N,N-dimethylformamide (DMF), which contains polyvinylpyrrolidone 
(PVP, commonly called povidone) and by a slight addition of salt (NaCl), forms such as 
cubes, tetrahedrons and octahedrons be synthesized. By increasing the concentration of 
tetra chloroauric acid in aqueous solution hexagonal nano sheets with a thickness of 
about 60 nm and a size of approximately 900 nm can be synthesized [66]. 
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SEM images of the as-prepared truncated tetrahedral (a), cube (b), cubic (c), octahedral (d) gold 
nanoparticles. Insets in the figures show the enlarged SEM image (top-right), the TEM image of an 
individual typical nanoparticle (left) and its corresponding SAED (selected area electron diffraction) 
pattern (right) [66]. 
Figure 8: SEM images of differently shaped gold nanoparticles [66] (Reprinted with permission). 
 
In addition to the spheres, various other forms of gold nanoparticles, such as Au rods 
[67], Au stars, Au-Ag cages [43] and silica-gold nanoparticle-clusters [68] are described 
in literature. 
 
1.6. Why Gold as Starting Material for the Synthesis of Heterogeneous 
Nanobiocatalysts? 
It was decided to start with GNPs as a core for further preparation of the heterogeneous 
nanobiocatalysts. This decision is based on several interesting properties of these kind of 
nanoparticles. The handling of colloidal gold suspension is comparable to a liquid. So, it 
is possible to use classical pipettes for transferring the suspension. This easily enables to 
accurately and precisely handle miniaturized sample volumes of 1 mL and less down to 1 
µL scale or so with appropriate pipettes. A big advantage therefore is to reduce the 
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volume of valuable samples, such as monoclonal antibodies. These small sample 
volumes are quite sufficient for analysis by liquid chromatography coupled with mass 
spectrometry. Due to the materials’ specific density of the gold core it is easily possible to 
remove the nano biocatalysts from the sample by simple centrifugation steps with a 
bench-top centrifuge/mini spin. Therefore, 12,000 until 13,500 rounds per minute (rpm) 
have been proven sufficient. These materials’ specific advantages make them a useful 
tool for the analysis of different kind of samples like therapeutic peptides and proteins, 
including monoclonal antibodies [69]. Additionally, faster reaction kinetics for similar 
approaches are described in literature due to the immobilization of the enzymes [70]. The 
reason for this effect is not fully understood yet, however, it seems that locally higher 
concentrations of substrates can be achieved. 
 
1.7. Synthesis of GNPs 
Figure 9 displays the synthesis of spherical GNPs according to the method of Turkevich-
Frens [46,49,71]. This classical and straightforward approach is suitable for the synthesis 
of around 10 to 30 nm particles. It is also possible to prepare larger particles, but this will 
influence the monodispersity and particle shape negatively.  
 
 
Figure 9: Synthesis method for GNPs described by Turkevich-Frens 
 
The preparation is based on the reduction of gold (III) chloride trihydrate with trisodium 
citrate and simultaneous stabilization of GNPs by citrate due to attachment on the GNP 
surface providing them a negative surface charge. Therefore, citrate is a reducing and 
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stabilization agent for the size-controlled synthesis of gold nanoparticles. With an 
increasing amount of citrate, the particle size will decrease. This phenomenon was 
described by the nucleation-growth process (Figure 10) by Polte et al.[72]. 
 
 
Figure 10: Nucleation-growth process (adapted from Polte et al. [72]) 
 
In the first nucleation step, initial cores will be formed. They will grow by fast and slow 
aggregation steps and will at last reach their final size. 
 
A smaller particle size from 1-3 nm with a surface coating of thiols can be achieved with 
the Brust method from 1994 [73]. This approach is based on a reduction of AuCl4– by 
sodium borohydride in the presence of an alkanethiol in a two-phasic water–toluene 
mixture. 
 
A more actual approach is the biological synthesis of gold nanocubes by bacillus 
licheniformis after a 48 hours’ incubation at room temperature in aqueous solution [74]. 
The gained polydisperse nanocubes are ranged in the size from 10 to 100 nm. 
 
1.8. Surface Modification of GNPs 
The synthesized GNPs are an interesting starting material for various functionalization’s. 
Functionalization by coating of polymers or polyelectrolytes, via bifunctional crosslinkers 
based on polyethylene glycol (PEG), as well as adsorptive binding of proteins should be 
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~ 6 nm
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mentioned at this point. The gold particles are here used as a solid core which can be 
modified with a hydrophilic biocompatible shell. 
 
 
Figure 11: Immobilization of bifunctional crosslinker with SH-PEG7-COOH 
 
For example, by using O-(2-carboxyethyl)-O`-(2-mercaptoethyl)-heptaethylene glycol 
(SH-PEG7-COOH) a self-assembled monolayer (SAM) obtained by dative Au-S covalent 
bonding can be formed as a first layer of the gold core. 
 
 
Figure 12: Self-assembled monolayer (SAM) 
 
For building a second layer a crosslinking reaction can be performed with the functional 
molecule of interest, e.g. an enzyme, affinity ligand, or antibody. Crosslinking can be 
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described as the building of covalent bonding between two or more molecules. Between 
the carboxylic acid groups of the attached bifunctional HS-PEG7-COOH linker and the 
amino groups of the enzyme NHS-EDC coupling is obvious. Here, NHS (N-
Hydroxysuccinimide) can convert carboxylic acids to NHS esters under neutral to slightly 
basic conditions if activation reagents like EDC (1-ethyl-3- (3-dimethylaminopropyl) 
carbodiimide) or EDAC (N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide) are present. 
EDC is forming active ester intermediates with carboxylic acids. These intermediates 
react readily with primary amino functions, such as of peptides or proteins, which are 
significantly more nucleophilic than alcohols, to form amide crosslinks. NHS is not 
mandatory for carbodiimide reactions, but the use greatly increases the coupling 
efficiency by forming NHS ester intermediates [75]. 
If pepsin is to be crosslinked to the carboxylic acid groups of the attached bifunctional 
HS-PEG7-COOH linker, a “one-pot reaction” with EDC under weakly acidic conditions can 
be performed. Since pepsin is irreversibly inactivated from a pH of about 6 [76], the 
coupling reaction in slightly acidic conditions is preferable to NHS-EDC coupling at 
neutral to slightly basic conditions. Remaining EDC-activated carboxylic groups can be 
end-capped with Tris moieties (tris(hydroxymethyl)-aminomethane). In this final synthesis 
step, pepsin-functionalized GNPs with residual carboxylic acid groups are obtained, 
which improve the colloidal stability and storage stability of the nanobiocatalysts [69,77]. 
 
 
Figure 13: Activation of HS-PEG7-COOH by EDC and immobilization of Pepsin 
 
46 
 
A direct adsorptive binding of enzymes by ionic and hydrophobic interactions on gold 
nanoparticles should also be mentioned here as an easy and suitable possibility [69]. 
 
1.9. GNP Characterization 
An important topic in the synthesis and functionalization of gold nanoparticles is their 
characterization. Here, techniques are interesting that can give an idea of particle shape 
and size, but also information about the molecular structure and surface properties are 
important parameters. Such methods include various techniques, including spectroscopic 
and microscopic methods. For the characterization of nanobiocatalysts, useful 
microbiological and biophysical techniques can also be used. Due to the large number of 
characterization techniques, however, only a brief introduction of some popular 
techniques is given below, which were also used in the present work. 
 
1.9.1. Electron Microscopy Technique 
The crystal structures and surface of the nanoparticles influence their chemical and 
physical properties. Transmission electron microscopy (TEM) is for the visualization 
and characterization of nanoparticles a well described technique. Here, an electron 
beam is focused and transmitted through a sample to form an image. The electron 
beam is interacting with the sample atoms by elastic and inelastic scattering. A TEM 
image can be generated since the electron intensity distribution behind the sample 
can be recorded onto a fluorescent screen. To generate differences in electron 
densities between sample and matrix, the nanoparticles are placed on a copper grid, 
dried and coated with a thin carbon layer [78,79] 
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Figure 14: TEM analysis of colloidal gold suspension and histogram of statistical size analysis [70], redrawn in 
modified form (Reprinted with permission). 
 
A statistical evaluation of the particle size distribution is also possible with TEM 
analysis. Therefore, the particle size of a defined number of particles can be analyzed 
and compared [70,80]. 
 
1.9.2. Vis-Spectroscopy 
UV-Vis spectroscopy is a cost-effective and an easy-to-use characterization 
technique that can be performed with standard laboratory equipment in almost every 
laboratory. Colloidal gold has a characteristic UV-Vis absorbance spectrum which can 
be attributed to the presence of localized surface plasmon resonance in the visible 
part of the spectra [81]. The size of the gold nanoparticles can be evaluated by a shift 
in the absorbance maximum of the spectra. Also the peak width of smaller particles is 
more narrow than that of bigger, e.g. functionalized, particles (see Figure 15) [82]. 
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UV-Vis study with different citrate/HAuCl4 (C/H) ratio. With a higher citrate ratio particles and peak width 
get smaller [82]. 
Figure 15: Vis-Spectroscopy study of citrate stabilized gold nanoparticles with different particle sizes [82] 
(Reprinted with permission). 
 
In addition to size, UV-Vis spectroscopy can also be used to determine the 
concentration of colloidal gold. If the molar concentration and volume of HAuCl4 used 
is known, and also the number of gold atoms per nanoparticle depends on the particle 
diameter, the gold atoms in solution can be calculated. With the number of gold 
atoms in solution, the concentration of GNPs can then be calculated using the known 
volume of the solution and the Avogadro number [82]. Other approaches for the 
determination of the GNP concentration by using UV-Vis spectroscopy have already 
been described in the literature [80]. 
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Vis-spectra of Pepsin@GNP (pepsin-modified GNPs with PEG7 spacer) and adsorptively bound 
pepsin on GNPs. Because of a high colloidal stability, the peak of Pepsin@GNP shows a good 
shape. The undefined peak shape of adsorptively bound pepsin is due to particle aggregation [69]. 
As an addition this figure shows a picture of aggregated functionalized GNPs (own data). 
Figure 16: Vis-Spectroscopy study of Pepsin@GNP and GNP-Pepsin adsorptive [69] (Supplementary Material, 
Reprinted with permission). 
 
The colloidal stability can also be determined by the shape of the Vis spectra. An 
undefined peak shape, e.g. shoulders or similar, is due to particle aggregation. Good 
colloidal stability of the nanoparticles can be deduced from nice and narrow peaks in 
the UV-Vis spectra. 
 
1.9.3. Shelf Life and Stability Studies 
For the determination of the shelf life stability of nanoparticles the UV-Vis 
spectroscopy could be an interesting tool. Based on one batch, measurements can 
be carried out at defined time points to study the long-term colloidal stability. Different 
synthesis stages can be checked to complete the results. 
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Colloidal stability and shelf life of functionalized nanoparticles. (a) Citrate-stabilized GNPs, (b) GNPs 
coated with bifunctional PEG spacer having carboxy-terminated surface and (c) immobilized pepsin-
GNP conjugate. (d) Absorption maxima of the SPR band of all nanoparticle stages measured over 
35 days. All samples were diluted 1:5 in ddH2O. Samples were stored at 4 °C [69]. 
Figure 17: Shelf Life and Stability Studies of all nanoparticle stages [69] (Supplementary Material, Reprinted with 
permission). 
 
Based on the quality of the UV-Vis spectra, the colloidal stability of the gold 
nanoparticles can be deduced and the stability within a defined period can be 
determined. 
 
1.9.4. Dynamic Light Scattering (DLS) 
The determination of the dynamic light scattering (DLS) is a very important tool for the 
characterization of particle sizes for dissolved analytes, such as dispersions and 
colloids, in the range from nanometers to micrometers. In polydisperse systems, the 
particle size of a sample varies. Here, not the particle size but the particle size 
distribution (PSD) of a sample is determined. Due to the strong light-scattering 
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properties of colloidal gold, the DLS is particularly well suited for their characterization 
[83,84]. 
For the determination of the hydrodynamic radius monochromatic and coherent laser 
light is used for illumination of the particles. The Rayleigh scattering is analyzed by a 
photon detector. The scattering intensity fluctuates due to the Brownian motion of the 
particles and can be analyzed over the time on a microsecond timescale. The 
measured fluctuations, which reflect the diffusion rate of the particles, are determined 
via autocorrelation which allows a calculation of the diffusion rate. The diffusion 
coefficient D can also be seen as a measure of the movement of the particles [85]. 
 
     Stokes-Einstein equation (1) 
D  diffusion coefficient (in liquids) 
kB  Boltzmann constant 
T  absolute temperature 
η  dynamic viscosity 
r  hydrodynamic radius for spherical particles 
 
With the Stokes-Einstein equation the hydrodynamic radius Rh can be related to the 
diffusion coefficient D (replace D by Rh in Stokes-Einstein equation). The rate of 
diffusion is represented by the term Rr, the diameter of a rigid sphere, their diffusion is 
comparable to that of the analyte [85]. 
 
A sample of synthesized nanoparticles differs normally in particle sizes. They are not 
homogeneous and therefore not monodisperse but varies in size and shape. This 
polydispersity is also referred to as size distribution and denotes the degree of 
particle to particle size variability. This measure of the heterogeneity of molecule and 
 
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particle sizes is called dispersity and the polydispersity index (PDI) indicates the 
variance of the distribution [86,87]. 
 
 
Figure 18: DLS study of citrate stabilized colloidal gold with an average particle size distribution of 31.4 ± 0.9 nm 
(own data) 
 
For nanoparticles with the diameter d, the intensity of the scattered light is 
proportional to the square of the molecular mass or to the sixth power of d (d6). DLS 
is therefore more sensitive to larger particles than smaller particles, and consequently 
the relative quantities of multimodal particle distributions are distorted. The average 
particle size in this situation is usually overestimated. Larger particles generally show 
much greater scattering than smaller particles. In addition, some aggregates can 
interfere the analysis of smaller particles, resulting in a less accurate result. A 
quantification of size distribution is not possible by DLS [85,84]. 
 
1.9.5. Nanoparticle Tracking Analysis (NTA) 
Nanoparticle tracking analysis (NTA) is a direct real-time analysis. The method is 
similar in principle to DLS. The Brownian motion of particles is detected and is related 
to the size. Since the light scattered by the nanoparticles, unlike to DLS, is detected 
here with a high-resolution CCD camera and thus every particle size can be detected 
independently of one another, so NTA overcomes the disadvantages of DLS. The 
result of the size distribution is therefore more accurate and independent of the 
polydispersity of the analytes. A disadvantage of the NTA, in comparison to DLS, is 
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the lower working dynamic range and that particles smaller than 20 nm cannot be 
sufficiently detected [84,88]. 
 
 
Figure 19: NTA measurement of particle size and concentration. Result of 100 nm and 300 nm polystyrene beads 
mixture (ratio 5:1) [88] (Reprinted with permission). 
 
1.9.6. Zeta (ζ) Potential by Electrophoretic Light Scattering (ELS) 
Colloidal stability, electrophoretic mobility, and the influence of electrolyte solutions 
can be described using the Derjaguin-Landau-Verwey-Overbeek (DLVO) theory. 
Traditional forces of particle-particle interactions, such as Van der Waals attraction 
and electrostatic repulsion, are crucial for the theoretical description. Thereafter, the 
total potential energy of action is the sum of attractive Van der Waals interactions and 
electrostatic repulsion or in general, the sum of adsorptive and dissociative processes 
at the interface. Other structural contributions to the interaction potential can be 
considered (hydration and osmotic power) if the particles are suspended in a suitable 
medium (liquid or gaseous) [89,90]. Charge carriers of both phases interact with each 
other. If charged particles are in suspension, the charge state at the particle surface 
can be affected by dissociation of adsorbed charged molecules. According to the 
principle of the electrical double layer of counter ions, which is formed near the 
surface of a charged particle, the surface charge of the suspended particles is 
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generally compensated by diffuse distributed counterions for charge neutrality of the 
overall system (potential tends towards zero and at infinite distance to the particle). 
This involves the repulsion of co-ions from the solvent, but also the attraction of 
counterions (see Figure 20). 
 
 
Figure 20: The electrical double layer (adapted from Malvern Instruments Ltd. [90]) 
 
The electrical double layer can be divided into a compact layer around the particle 
and a more diffuse distributed layer beyond. This compact layer is also called Stern 
layer and is provided by DLS measurement as the hydrodynamic size (particle plus 
fixed layer of solvent ions, see chapter 1.9.4). Ions within the stern layer are strongly 
bond on the particle surface, means the counterions in this layer are immobile due to 
the strong electrostatic attraction. This achieves a linear decrease in the electrostatic 
potential. The Stern layer followed by the diffuse layer in which the electrostatic 
potential decreases exponentially with the distance from the particle surface. This 
layer consists of loosely connected counterions. Solid particles and liquid phase are 
constantly in motion. In this case ions are sheared off in the diffuse layer. As a result, 
a measurable potential difference is formed at this shear plane or slipping plane, 
which is characterized as zeta (ζ) potential, or the electrical potential between the 
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double layer at the slipping plane and the surrounding solvent [91,90,92].The ζ-
potential provides information on colloidal stability by means of the potential 
difference between the dispersion media and the fixed layer of fluid ions around the 
particle. The electrophoretic mobility µE is the analytically determined value and the ζ-
potential will be calculated with the Smoluchowski equation [91]. 
 
      Smoluchowski equation (2) 
µE electrophoretic mobility 
ε dielectric coefficient 
ζ zeta potential 
η dynamic viscosity 
 
For the experimental determination of the zeta potential, various methods based on 
the electrokinetic effects, such as electrophoresis, electroosmosis and flow potential, 
can be used [91]. Electrophoresis refers to the movement of particles in an applied 
electric field. This principle is also used in electrophoretic light scattering (ELS) for 
sample testing. In an applied electric field, a laser beam is divided into a respective 
reference and scattering beams. The scattering beam is passed through the sample, 
while the reference beam is passed around the measuring cell. The electrophoretic 
drift velocity can be indicated by the recombination of the scattering and reference 
beam, since this generates a difference frequency. Finally, the electrophoretic 
mobility µE is mathematically accessible via the electrophoretic drift velocity [93]. 
 
μ 
ε  ζ
πη
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Figure 21: ζ-potential study of citrate stabilized colloidal gold with an average ζ-potential of -31.7 ± 1.7 mV 
(own data) 
 
By measuring the electrophoretic drift velocity with ELS in disperse systems, the ζ-
potential can be determined by electrophoretic mobility. In accordance to the DLVO 
theory the ζ-potential can be used for the qualitative prediction of colloidal stability. 
Sufficient colloidal stability is also confirmed by ζ-potentials higher than values of ± 25 
to 30 mV, depending on the literature while values of ± 10 mV are considered 
approximately neutral [94,69]. If the disperse nanoparticle systems are not sufficiently 
balanced by electrostatic repulsion, these high electrostatic potentials are required to 
overcome the electrostatic attraction of the Van der Waals interactions, which are 
considered to be the main cause of aggregation of nanoparticles [69,94]. 
 
1.9.7. Resonant Mass Measurement 
While the surface coverage of the nanoparticles by proteins can be determined 
indirectly with microbiological methods such as the Lowry assay (see chapter 6.8), 
the mass of the nanoparticles in the femtogram to attogram region can be determined 
directly with the Resonant Mass Measurement (RMM) [95]. With this technique, the 
particles are detected and counted by micro-electromechanical systems (MEMS). As 
the resonant frequency of the suspended microchannel resonator (SMR) is very 
sensitive, particles with a different density compared to the surrounding solvent can 
be detected. Due to the buoyant mass (MB) of the particle a frequency shift at the 
suspended microchannel resonator embedded in a microfluidic channel can be 
analyzed when a particle passes through. If the resonator is passed by a particle with 
57 
 
a higher density than that of the solvent, this leads to a decrease in the resonance 
frequency of the microchannel. The decrease of the frequency is proportional to the 
buoyant mass of the particle [95,29]. When the density of the solvent (e.g. water) and 
the gold nanoparticles is known the dry mass of the particle can be calculated with 
the buoyant mass. 
 
     (Dry) mass calculation (3) 
M dry mass 
MB buoyant mass 
ρ density of the fluid and the particle 
 
If also the corresponding data for the coating molecules is available (ρcoating), the mass 
of them can be calculated by comparing the RMM data of uncoated and coated 
particles (mass balance ∆MB) according to equation (3) [29]. 
 
 
Histograms of buoyant mass measurement by RMM of citrate-capped GNPs and pepsin-coated GNPs 
(obtained from 1.04 mg mL−1 pepsin in reaction mixture). Samples were diluted 1:5 (v/v) with ultrapure 
water before measurement [29]. 
Figure 22: Resonant Mass Measurement of coated and uncoated gold nanoparticles [29] (Reprinted with 
permission). 
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1.9.8. Taylor Dispersion Analysis 
Taylor dispersion analysis (TDA) is a suitable method for the determination of the 
diffusion coefficient and thus the hydrodynamic radius of biopharmaceuticals [96] [29]. 
It was described by G. I. Taylor in 1953 [97] and it was enhanced in 1956 by Aris with 
respect to the longitudinal diffusion of molecules [98]. The Taylor dispersion is an 
effect in fluid mechanics where shear flow increases the effective diffusivity of a 
species and thus facilitates the balancing of a concentration gradient. In the case of 
pressure-driven fluids in cylindrical capillaries, the flow velocity to the channel edge 
decreases due to the viscosity of the fluid and friction at the tube wall (known as 
convection). Here the fluid flows under laminar conditions according to Poiseuille and 
a parabolic flow profile is formed as displayed in Figure 23. This implies that the 
velocity of the liquid decreases radially from a maximum in the center of the tube to a 
minimum at the tube walls. The combination of radial diffusion and convection causes 
a symmetric concentration distribution of the injected sample molecules (see Figure 
23) [99]. 
 
  
The axial spreading of the solute along the direction of flow whereat the flow velocity decreases radially 
from the maximum umax in the center of the tube to a minimum umin at the tube walls according to fluid 
viscosity and friction. Due to the combination of radial diffusion and convection a symmetrical 
concentration distribution of the injected sample molecules occurs [99]. 
Figure 23: Axial spreading by convection and radial diffusion (adapted from Malvern Instruments Ltd. [99]) 
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Here, the peak broadening of the sample injected into an existing solvent flow of 
known viscosity is analyzed. The sample is moved through the capillary due to the 
hydrodynamic pressure. The peak broadening of the sample zone is monitored by 
absorbance measurement of a detector at two consecutive measuring windows in the 
capillary. From this and by using the time data of the two peak centers detected at the 
two capillary windows the hydrodynamic radius Rh can be deduced [96] [29]. As 
additional sample information the viscosity can be determined. 
 
    Rh calculation (4) 
Rh hydrodynamic radius 
kB Boltzmann constant 
T temperature 
τ standard deviation (peak broadening) 
η viscosity 
r radius for the capillary 
t peak center time 
 
 
Taylorgram for citrate and citrate stabilized GNPs a) and straylight corrected viscosity measurement of 
citrate stabilized GNPs b). Both results show the signal shifts of window 1 and 2 [29]. 
Figure 24: Taylor dispersion analysis of citrate and citrate stabilized GNP [29] (adapted from paper and 
Supplementary Material, Reprinted with permission). 
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1.9.9. Protein Determination by Lowry Assay 
Another important question in the characterization of protein-functionalized 
nanoparticles is the amount of protein that could be immobilized on the particles. 
Since in the present experiments free pepsin is bound onto the nanoparticles, it must 
be investigated whether such an immobilization has taken place and if yes, what is 
the amount of immobilized protein? With enzyme assays such as the Lowry assay 
[100,101], this parameter can be investigated but there are other determination 
techniques like the Bradford [102] and the bicinchoninic acid or Smith assay (BCA) 
[103] as displayed in Table 1 [104,105]. Details for the protein assays are described 
in the Protein assay technical handbook from Thermo Scientific published in 2017 
[105] 
 
This chapter gives a brief overview of different methods, but it mainly describes the 
Lowry assay. 
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Table 1: Protein determination techniques 
Overview of colorimetric protein assay techniques, such as Lowry, BCA and Bradford assay 
[104,105] 
Assay Lowry BCA (Smith) Bradford 
Method 
Biuret 
+ Folin & Ciocalteu's phenol reagent 
Coomassie 
(Brilliant Blue G-250) 
Detection [nm] 650 562 595 
Range [µg/mL] 
(Thermo Scientific Assay Kit) 
1 - 1500 
0.5 – 20 
(Micro BCA) 
1 - 1500 
Peptides 
tyrosine, 
tryptophan 
cysteine, cystine, 
tryptophan, tyrosine 
and peptide bond 
lysine, 
arginine 
 
Lowry assay is based on two separate reactions. In the biuret reaction, a blue-violet 
complex is formed in alkaline solution between the peptide bonds and Cu(II) ions. In 
the second step, Cu(II) is reduced to Cu(I) due to the peptide bond. Furthermore, 
Cu(I) reduces the yellow Folin & Ciocalteu's phenol reagent (a solution of 
molybdophosphoric acid and phosphotungstic acid) to molybdenum blue. Detection is 
performed with a spectrophotometer at 650 but related to the protein of interest a 
wavelength modification of 600 or 750 nm is suitable [104,106]. The results can be 
quantified by using a calibration function. Protein levels in the lowest range of 0.01 to 
1 mg/mL can be determined [101]. With assay kits provided by Thermo Scientific a 
range from 1 to 1500 µg/mL is possible [105]. 
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Figure 25: Lowry assay in 96 well plate (own data) and Cu(II)-protein-Biuret complex (adapted from Matissek et 
al. [107]) 
 
To investigate the enzyme immobilization a stock solution of known concentration of 
pepsin was produced. This solution was added to the gold nanoparticles and 
separated again from the nanoparticles by centrifugation after defined reaction 
conditions. The initial concentration of the stock solution and the separated pepsin 
solution was analyzed by Lowry assay. The amount of immobilized pepsin could then 
be calculated back by using mass balance equation. 
 
 
The behavior of citrate stabilized GNPs in the presence of Lowry reagent A and 1 % CuSO4 [69]. 
Figure 26: Trouble-shooting Lowry assay by vis-spectroscopy [69] (Supplementary Material, Reprinted with 
permission). 
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Investigation of the amount of immobilized protein directly on the gold nanoparticles 
could also be very interesting. Studies show this is not possible because the 
nanoparticles aggregate in the presence of Lowry reagent A and 1% CuSO4, among 
other things which could not be clarified. This behavior could be confirmed by UV-Vis 
spectroscopy [69]. 
 
1.9.10. Bioactivity Test by Michaelis-Menten Kinetic Studies 
While the amount of immobilized protein could be determined by using Lowry assay, 
further studies are needed for the determination of the bioactivity of the bound 
enzymes. This can be done by means of Michaelis-Menten kinetic [108,109], but a 
suitable method to determine the conversion of a test protein (e.g. CYC) with the 
functionalized nanoparticles at defined times is required [69]. HPLC analysis can help 
here. The test protein must be detectable with the appropriate method. The protein 
peak must be baseline separated from the signals of the degradation products. Thus, 
a precise quantification of the test protein amount is guaranteed, and the Michaelis-
Menten parameters can be calculated according to the Lineweaver-Burk model [110]. 
 
 
Figure 27: Bioactivity test by Michaelis-Menten Kinetic studies. Chromatogram taken from [69] (Supplementary 
Material, Reprinted with permission). 
 
The enzyme-substrate reaction can be described by the equation below (see Figure 
27). As biocatalysts enzymes E form a reversible complex [ES] with their substrate S. 
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Both result the enzyme-substrate complex [ES], where the substrate is converted to 
the product P by the intermediate step of the substrate-product complex [EP]. 
 
 
Figure 28: Reaction equation for enzymatic digestion 
 
The velocity constants k1 to k3 describe the forward rate and the constant k`1 to k`3 the 
reverse rate of the enzymatic reaction. The reverse reaction to the substrate is 
negligible under the conditions of enzyme kinetics with low product concentration. 
Also, k´2 is usually much smaller than k3, so the simplification of the formation of E + 
P without the intermediate step [EP] is justified. 
In general, enzymes are able to balance fluctuating substrate concentrations very 
quickly by adjusting their activity to the substrate amount. This means that the 
concentration of the enzyme-substrate complex remains constant on the slower time 
scale which is valid for the process of product formation [111]. For the description 
according to Michaelis-Menten also the assumption of a steady state applies. 
 
The Michaelis-Menten kinetics derived from the reaction equation can generally be 
represented as follows: 
 
     Michaelis-Menten Equation (4) 
 
Here, v0 indicates the initial reaction rate at a specific substrate concentration [S]. vmax 
describes the saturation of the reaction. This is attained when all enzyme is bound to 
E + S [ES]
k1
k`1
k2
k`2
[EP]
k3
k`3
E + P
%0 
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substrate. Km measures the substrate-enzyme-affinity (a small Km indicates high 
affinity). 
Another important variable is the turnover number kcat, also described as molecular 
activity. This constant describes the maximal number of substrate molecules 
converted by one enzyme molecule into the product. It is also referred to as a 
constant of the rate-determining step of the reaction, namely the dissociation of the 
enzyme-product complex into product and enzyme. 
The Michaelis-Menten parameters can provide information about the activity of 
enzymes. Given the requirement, namely the activity determination of pepsin 
immobilized on gold nanoparticles, a comparison with free pepsin is indispensable in 
order to be able to compare and classify the results. 
 
1.10. Mass Spectrometry in Protein Analysis 
Mass spectrometry is a technique that determines the mass-to-charge ratio (m/z) of 
ionized analyte molecules. In general, the analytes are ionized in the ion source, 
transferred into the gas phase and subsequently separated in a mass analyzer in 
accordance to their mass-to-charge ratio. Finally, the number of ionized analyte 
molecules at each m/z value is determined with a detector [112]. 
In protein analysis (proteomics) typical used ion sources are electrospray ionization (ESI) 
and matrix-assisted laser desorption/ionization (MALDI). Typical instrument 
configurations are displayed in Figure 29. A much higher diversity is given in mass 
spectrometry but to convey a good overview, only the most common instruments are 
described below. 
 
For liquid chromatography coupled with mass spectrometry ESI is widespread and 
suitable for protein samples. Here, a spray needle with applied voltage is used to ionize 
the analyte molecules [113]. For protein analysis, ESI is usually coupled with time-of-
flight (TOF and TOF-TOF, orbitrap and quadrupole instruments. 
66 
 
In general, TOF instruments use a flight tube in which the ions get accelerated and 
separated due to their different velocities related to their different masses. A reflector can 
be used here (reflector time-of-flight instruments, see Figure 29 a) for turning the ions 
around. This process compensates for slight differences in kinetic energy of the ions 
before they hit a detector which counts their number of arriving. 
TOF instruments can also be coupled via a collision cell (TOF-TOF, see Figure 29 b). In 
the collision cell after the first TOF section, ions of a particular mass-to-charge ratio can 
be selected and fragmented. Subsequently the different masses of the individual 
fragments can be separated in the second TOF section.  
Quadrupole instruments are not commonly used for intact protein analysis but 
widespread for the analysis of proteins at the peptide level in targeted proteomics. An 
electric quadrupole consists of two oppositely alternating positively and negatively 
charged rods arranged at the corners of a square. As a component of a mass 
spectrometer a quadrupole is made up of four metal rods, which generate a time-varying 
electric field. Only ions with a certain m/z can pass on a stable trajectory. All other ions 
get distracted. Quadrupoles can also be combined to a triple quadrupole (Q1-Q3). In Q1 
ions with specific m/z are selected, fragmented in Q2 and the fragments get separated in 
Q3 (see Figure 29 c). 
The linear ion trap does also use quadrupole sets for capturing ions (see dot in Q3, 
Figure 29 c). The ions in the trap are in a calm and orderly state. When applying a 
resonant electric field, ions get excited and fragmented. These fragments leave the trap 
and can be detected (tandem mass spectrum). The applied electric field determines the 
ions or fragments that are excited, which are characterized by a defined mass. A multiple 
repetition of excitation and mass selection is possible. 
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The left and right upper panels depict the ionization and sample introduction process in electrospray 
ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI). The different instrumental 
configurations (a–f) are shown with their typical ion source [112]. 
Figure 29: Mass spectrometers used in protein analysis [112] (Reprinted with permission). 
 
The MALDI method relies on co-crystallized analyte and matrix with a high excess of 
matrix ionized by pulsed laser beam. It uses small matrix molecules, such as α-cyano-4-
hydroxycinnamic acid (HCCA) and 2,5-dihydroxybenzoic acid (DHB), which absorb a lot 
of energy at the wavelength of the nitrogen laser used [114]. MALDI is usually coupled 
with a combination of triple quadrupole and reflector TOF instrument (see Figure 29 d), 
ion trap and FT-MS. 
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Figure 30: Co-crystalized transferrin and DHB for MALDI analysis (own data) 
 
In a three-dimensional ion trap, ions are captured in a calm and orderly state (see 
Figure 29 e). Excitation and fragmentation of ions with a certain m/z is similar to the linear 
ion trap. 
In Fourier transform ion cyclotron mass spectrometry (FT-ICR-MS) ions got trapped with 
strong magnetic fields. Typically, a combination with a linear trap is used (see 
Figure 29 f). This ensures an efficient isolation, fragmentation and detection of the 
ionized analytes. 
 
One of the most important new developments in the field of mass spectrometry in recent 
years is the Orbitrap mass analyzer. In 2000, Alexander Makarov published his work on 
his functional prototype. Orbital Trapping is a further development of the classic ion trap. 
Ions get trapped in an electrostatic field by orbiting around an axial electrode in harmonic 
oscillations with frequency proportional to (m/z)-1/2 [115]. The stability of the ions is 
achieved solely by orbiting around the electrode. The frequency of the oscillations is 
converted into mass spectra similarly to FT-ICR-MS, but since no magnetic field is 
required, the costly cooling with liquid helium is eliminated. Due to the high mass 
resolution, mass accuracy, resolving power, and dynamic range [116,117], mass 
spectrometry analysis with the Orbitrap mass analyzer is now an important pillar for the 
research of biopharmaceuticals [18]. 
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1.10.1. Protein Identification by Mascot Database 
Protein analysis, carried out with a classical proteolytic sample digestion and peptide 
separation by liquid chromatography, is not completed by mass spectrometry 
detection. The final information, namely which proteins are contained in the original 
sample, has not yet been clarified. This information can be obtained by software 
support, for example with the Mascot database (http://www.matrixscience.com/, 
08.08.2018). Thousands of proteins in complex matrix can be identified with this 
software [118]. However, how can conclusions be drawn from the results of LC-
MS/MS analysis on the proteins? For this, the results must be converted into a 
corresponding file format (e.g. mzML) to be able to evaluate the peak lists with 
Mascot scan. A clear identification of all proteins with a high score and good 
sequence coverage is the goal here. In order to be able to specify the search, 
different parameters can be defined in advance. Since different proteolytic enzymes 
digest proteins differently (e.g. trypsin vs. pepsin), a correct selection is essential. In 
addition, parameters such as the state of charge of the peptides (e.g. +1, +2, +3), 
precursors and ion fragment mass tolerances (e.g. ±0.2 Da) can be set. Mascot 
database search uses probability scoring to judge whether a result is significant and 
not a random event. Scores, greater than 67 are considered significant (p <0.05) 
[119,120]. Another interesting information that can be deduced from the results of 
Mascot is a possible autodigestion of the proteolytic enzyme. This phenomenon 
occurs, for example, during a tryptic digestion and can be eliminated by immobilizing 
the enzyme on colloidal gold [70]. 
All this information is ultimately essential to be able to classify the results correctly. 
Computer-aided protein identification tools have greatly simplified and accelerated the 
evaluation of LC-MS/MS results and enabled the analysis of complex samples. 
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1.11. Intact Protein Determination of Genotropin (additional project, not 
published) 
In this chapter, the method described in Höldrich et al. [69] for the characterization of 
intact proteins, the growth hormone genotropin was analyzed. This study has not been 
published yet, but it is a vivid example for intact protein determination using on-line SPE 
LC-MS/MS. 
 
1.11.1. Preliminary 
Genotropin or somatropin/ somatotropin is a human growth hormone for growth 
control by stimulating the liver. It is used as drug for Growth Hormone (GH) treatment, 
e.g. for treating conditions which can result in short stature and can stimulate an 
amino acid uptake and protein synthesis in muscles. 
 
Figure 31: Molecule structure of genotropin (http://www.drugbank.ca) 
 
Somatropin uses zinc as ligand at the positions 44 and 200. It has 191 amino acids 
(217 amino acids in total with 26 amino acids as signal peptide at the position 1-26), a 
molecular weight (MW) of approximately 22.129 kDa and a theoretical isoelectric 
point (pI) of 5.27. The molecular weight and the pI were calculated with the pI/MW 
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calculator from ExPASy (forwarded from www.uniprot.org). Somatropin has two 
disulfide bonds at the positions 79↔191 and 208↔215. 
 
1.11.2. Method for Intact Protein Determination by On-line SPE 
Genotropin® MiniQuick 0.2 mg powder and resolvent for the preparation of a solution 
for injection was used for research. Therefore, 1 µL of the ready-to-use drug solution 
was taken for the mass determination. The detection was carried out with a Triple 
TOF 5600+ quadrupole time-of-flight mass spectrometer from Sciex (Concord, 
Ontario, Canada) equipped with a DuoSpray source operated in positive mode using 
a 50 µm ID microelectrospray ionization (µESI) needle from Sciex. For the on-line 
SPE (solid phase extraction) installation a Phenomenex® security guard system with 
a C4/Butyl 300 Å wide pore column as a trapping material for protein enrichment and 
desalting steps was used (see picture for installation below). 
 
 
Figure 32: Installation on-line SPE; photographed by A. Sievers-Engler, method published by Höldrich et al., 2016 
[69] (Source: Adrian Sievers-Engler, photograph printed with permission) 
 
The analytes were detected in reversed flow direction (back flow mode). As mobile 
phase, double deionized water with 0.1 % formic acid was used in channel A for 
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loading the sample on the column and flush out buffers, salts and all other molecules 
which did not interact with the column into the waste. Acetonitrile with 0.1 % formic 
acid in channel B was used for flushing the sample into the ion source of the mass 
spectrometer. For the chromatographic conditions see the table below. 
 
Table 2: Parameters on-line SPE 
Time   
[min] 
Flow Rate 
[µL min-1] 
ddH2O    
[%] 
Acetonitrile 
[%] 
0 250 100 0 
2 250 100 0 
2.01 500 5 95 
3 500 5 95 
4 500 0 100 
5 500 100 0 
    
 
The measurement had to be performed in intact protein mode. Therefore, the 
CEM/MCP voltage was reduced by 100 V. All relevant settings for the mass 
spectrometer are displayed in the table below. 
 
Table 3: Parameters mass spectrometer 
Parameter Setpoint 
Curtain gas [psi] 35 
Nebulizing gas [psi] 60 
Drying gas [psi] 50 
Source Temperature [°C] 550 
Ion spray voltage [V] 5500 
Start mass [Da] 500 
End mass [Da] 4000 
Declustering potential [V] 230 
Collision energy [eV] 30 
Transmission 100 % @ 1250 
Time bins to sum 60 
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1.11.3. Results of Intact Protein Determination for Genotropin 
The protein mass was determined by manual calculation and with the Bio Tool Kit for 
Analyst® from Sciex. 
 
1.11.3.1. Definition of Mass in Mass Spectrometry 
In the following, various common scientific terms are used for "mass" and these 
are briefly described here because of their differences [121]. 
 
The molecular mass of a substance (e.g. a protein) represents the mass of a 
molecule which is equal to the sum of the masses of all atoms contained in that 
molecule. It is often referred to as molecular weight, which is not entirely correct, 
as no weight or force is measured in mass spectrometry. 
 
The values of nominal mass, monoisotopic mass and average mass differ by the 
isotope weights used for the calculation. The consideration of the mass defect 
also contributes to the determination and definition. Thus, the nominal mass of a 
molecule is composed of its most common naturally occurring stable isotopes. 
Here, however, the mass defect is not considered. The difference between the 
nominal mass and the monoisotopic mass in mass spectrometry is the mass 
defect. For its determination the exact mass of the most abundant isotopes is 
used. The average mass of a molecule is determined from the average masses of 
the constituent elements. Monoisotopic mass and average mass differ more with 
increasing molecular mass. This is especially true for peptides and proteins, as 
they have a high content of hydrogen, which in turn has a high mass defect. The 
mass of carbon serves as a reference of the atomic mass unit and its mass defect 
of carbon is negligible. 
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The accurate mass or the analytically determined accurate mass is an 
experimentally determined value. For the identification of proteins by mass 
spectrometry the accurate mass is determined on proteolytic fragments (bottom 
up approach) or in intact protein mode (bottom down). 
 
The exact mass is a calculated value summing up all atomic masses of the most 
abundant isotopic species of the molecule.  
 
1.11.3.2. Intact Mass Determination by Manual Calculation 
The intact genotropin sample was analyzed with a Triple TOF 5600+ quadrupole 
time-of-flight mass spectrometer from Sciex. Below the TIC (Total Ion Current) 
chromatogram of the sample is shown. 
 
 
Figure 33: TIC chromatogram of the intact genotropin sample 
 
The TIC represents the whole intensity of the ion current of a determined mass 
range. In the case of an intact protein determination with ESI-MS a typical charge 
envelope of the protein will be found (see below). ESI produces distinct multiply 
charged protein species with varying charge numbers (protein charge envelope). 
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Figure 34:Charge envelope of the intact genotropin sample 
 
By using the different mass-to-charge ratios of the protein charge envelope it is 
possible to calculate the charge states and the exact mass of the molecule. 
 
The calculation of the molecular mass of the intact protein was performed with the 
equations 5 - 8 listed below [121]. Here, the accurate mass was determined by 
the equations 5 and 6. For the exact molecular mass 22129.0497 Da calculated 
with the pI/MW calculator from ExPASy was taken. The results are displayed in 
Table 3. The m/z ratios for the manual calculation were taken from the mass list of 
the analyzed genotropin sample. 
 
      Equation (5) 
 
Here, b is the m/z value of the first ion, z is the charge number of the first ion, a is 
the m/z value of the second (adjacent) ion of lower m/z, and 1.0072 is the mass of 
one proton. 
 
     Equation (6) 
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By knowing the correct charge (z) the calculation of the exact mass can be 
performed. 
 
 Equation (7) 
 
With the determined exact mass and the accurate mass of the molecule the mass 
error in Da can be calculated. 
 
   Equation (8) 
 
With the calculated mass error in Da finally the mass error in ppm for the exact 
mass can be determined. 
 
Table 4: Mass calculation with equations 1 - 4 
  
m/z z M [Da] 
a 1476.3240 14 22134.0201 
b 1581.6820 13 22128.2253 
 1703.2796 12 22129.0852 
 1845.1388 11 22127.0781 
 2012.8078 10 22128.2527 
 2214.0034   
    
 Accurate Mass  22129.3323 
 Exact Mass 
(calculated with ExPASy) 
 22129.0497 
 Mass error [Da]  0.2826 
 Mass error [ppm]  12.7694 
 
For the manual calculations the same mass to charge ratios were taken as the 
Bio Tool Kit from Sciex used (see Figure 35). As shown in Table 4 the accurate 
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mass could be determined as 22129.3 Da with a calculated mass error of 0.3 Da 
(0.2826 Da) and 12.8 ppm. 
 
1.11.3.3. Intact Mass Determination by Bio Tool Kit from Sciex 
The intact mass of the same genotropin sample was determined by the Bio Tool 
Kit from Sciex for comparing the results. In Figure 35 below the MS spectrum of 
genotropin processed by the Bio Tool kit is shown; the charge state as calculated 
by the algorithm of eq. 1 within the protein envelope is displayed in red. 
 
 
Figure 35: Protein charge envelope of the intact genotropin sample with the Bio Tool Kit from Sciex 
 
A mass range for performing the mass determination has to be chosen (in this 
case 21000 Da to 23000 Da). 
 
 
Figure 36: Reconstituted MS spectrum of the intact protein: Calculated intact protein mass of the genotropin 
sample with the Bio Tool Kit from Sciex marked in red 
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The intact mass was determined as 22129.2 Da with a mass error of 0.2 Da and 
9.0 ppm. An overview of the calculated and determined results of the protein 
mass for genotropin is displayed in the table below. 
 
Table 5: Overview results of the calculated and determined genotropin protein mass 
Protein Mass [Da] from ExPASy 
22129.05     
Results Manual Integration 
Protein Mass [Da] Mass Error [Da] Mass Error [ppm] 
22129.3 0.3 12.8 
Results Bio Tool Kit 
Protein Mass [Da] Mass Error [Da] Mass Error [ppm] 
22129.2 0.2 9.0 
 
1.11.4. Conclusion of Intact Protein Determination of Genotropin 
The intact protein mass of the same genotropin sample was determined by manual 
calculation and with the Bio Tool Kit from Sciex after the analysis with a Triple TOF 
5600+ quadrupole time-of-flight mass spectrometer from Sciex. The result for the 
manual integration was determined as 22129.3 Da with a calculated mass error of 
0.3 Da and 12.8 ppm. For this calculation the same mass to charge ratios were taken 
as the Bio Tool Kit from Sciex used, which determined the protein mass for 
genotropin as 22129.2 Da with a mass error of 0.2 Da and 9.0 ppm. For both 
calculations the results are highly comparable. As discussed by K. Strupat [121] a 
manual determination of a typical protein envelope leads to correct results. However, 
current kits/ add-ins, such as the Bio Tool Kit from Sciex, lead to correct results and 
facilitate the calculation and presentation of the results due to their logical and easy 
handling. 
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2. Aim of the Work 
The aim of the present work was to explore new and further possibilities for sample 
preparation in protein and antibody analysis. There are several published and well 
established enzymatic and chemical methods for bioprocess and quality control strategies in 
biopharmaceutical production. So, what had to be developed new and what advantages 
could be expected here? 
 
First at all gold was used as a basic carrier for the development of new heterogeneous 
nanobiocatalysts. Advantages, such as the simple transfer of the colloidal suspension by 
pipetting, but also the possibility of complete separation of the catalysts from the sample 
solution by standard bench top centrifuges due to the high specific density of gold, led to the 
choice of this nanomaterial. Other characteristics, such as simple methods for the synthesis 
of GNPs, various well-established analytical methods for characterization, and the ability to 
work in small volumes down to 1 µL can be positively mentioned here. Especially in the 
analysis of biopharmaceuticals such as monoclonal antibodies, working with small sample 
volumes from a financial point of view, but also due to the amount of sample material 
available, is essential. In addition, the handling of small sample volumes is sufficient for 
analysis by liquid chromatography and high-resolution mass spectrometry. 
Gold nanoparticles are available for various immobilization strategies for peptides, proteins, 
carbohydrates, DNA, RNA and many more. Many conjugation strategies can be readily 
adapted due to the straightforward surface modification of gold e.g. by self-assembled 
monolayer formation with thiolated ligands. 
 
The full-particle separation of the catalysts is an important point in the analysis of protein 
samples, for example when working with enzymes. They can show auto digestion and are 
thus present in the final protein analysis with characteristic peptides in the sample. Whether 
these enzymes have been added to the sample as a catalyst or whether they were part of 
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the sample cannot be easily clarified in the final discussion. However, if these enzymes as 
catalysts are immobilized, they can be completely separated from the sample.  
 
These material-specific advantages make them a useful tool for analyzing various types of 
biopharmaceutical samples, such as therapeutic peptides and proteins, including monoclonal 
antibodies. Durability and reusability of catalysts should be important issues in development. 
 
The present work deals with the synthesis of heterogenous nanobiocatalysts and the 
complete characterization of all synthesis steps with well-established methods such as Vis-
spectroscopy, DLS, zeta potential measurements and protein assays. In addition, further 
characterization methods should be discussed and, if possible, compared with above 
methods. In addition, methods will be investigated and developed for the determination of 
functional parameters regarding enzyme activity. Methods for the investigation of 
biopharmaceuticals are to be examined and newly developed in order to finally ensure a 
practical applicability of the heterogeneous nanobiocatalysts. 
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Abstract 
Immobilization of enzymes on mesoporous microparticulate carriers has traditionally 
been accompanied by reduction in enzyme activity. Herein, we document that 
immobilization of pepsin via amide coupling on gold nanoparticles (GNPs) with carboxy-
terminated hydrophilic PEG7-shell resulted in a heterogeneous nanobiocatalyst with 
essentially equivalent turnover rates kcat (90 %) and enhanced catalytic efficiencies 
kcat/KM (107 %) compared to homogeneous catalysis with pepsin in free solution for 
cytochrome C as model substrate. This heterogeneous catalyst showed further at least 
equivalent bioactivity in a digestion reaction of a protein mixture consisting of 
cytochrome C, bovine serum albumin and myoglobin. UHPLC-ESI-QTOF-MS/MS 
analysis of the digests with subsequent Mascot database search allowed unequivocal 
identification of all proteins with high score and good sequence coverage. The 
functionalized nanoparticles were further characterized by Vis spectroscopy in terms of 
the surface plasmon resonance (SPR) band, by dynamic light scattering (DLS) with 
regard to hydrodynamic diameters, and in view of their ζ-potentials at each step of 
synthesis and surface modification, respectively. These measurements have also 
revealed that the pepsin-functionalized GNPs are sufficiently stable over at least 1 month 
providing satisfactory shelf life to the heterogeneous catalyst. Advantageously, the 
pepsin-GNP bioconjugate can be conveniently removed after reaction by simple 
centrifugation steps which makes them a useful tool for analysis of therapeutic peptides 
and proteins, including monoclonal antibodies. The practical utility of the nanobiocatalyst 
was documented by digestion of a monoclonal antibody which yielded the F(ab’)2 
fragment with a mass of 97,619.4 Da. 
 
 
Keywords 
Gold nanoparticle, bioconjugate, heterogeneous nanobiocatalyst, quadrupole time-of-
flight mass spectrometry, enzyme kinetics, monoclonal antibody fragment F(ab’)2 
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Introduction 
Workflows in protein analytics, e.g. in proteomics and analysis of protein therapeutics, 
commonly involve enzymatic digestion protocols prior to their LC-MS/MS analysis [1]. 
Thereby, most popular for proteolytic cleavage into peptide fragments is trypsin which is 
very efficient and yields short peptides with Arg or Lys at the C terminal end. Due to very 
short peptide fragments MS identification often fails leading to incomplete sequence 
information. Alternative enzymes are also often utilized, in proteomics primarily Lys-C, 
Glu-C, chymotrypsin and pepsin [1] and in therapeutic protein (i.e. monocolonal antibody) 
analysis pepsin, papain, IdeS [2] or ideally a combination of these biocatalysts [1]. These 
enzymes can also be very helpful for stereochemical configuration-dependent sequence 
elucidations of therapeutic peptides and peptidic natural products [3]. To avoid 
detrimental interferences from enzyme and confusing results in such applications, 
immobilization of these biocatalysts to solid surfaces, e.g. beaded agarose or monolithic 
supports, has been suggested as viable option to enable straightforward removal of the 
enzyme after the proteolytic reaction [4]. There are a number of other advantages 
associated with such heterogeneous catalysts, amongst which ameliorated enzyme 
stability, reusability are prominent ones [5,6]. Often, however, bonding to solid supports 
results in reduction of bioactivity of immobilized enzymes mainly because of hindered 
substrate access to the active site or unfavorably altered conformation of immobilized 
enzyme [5,6]. In an attempt to overcome such limitations of heterogeneous catalysts, 
researchers have evaluated nanomaterials as carriers for enzyme immobilization [7,8]. In 
fact, a number of studies reported increased activities and enhanced reaction rates as 
well as improved stabilities when enzymes were immobilized on nanocarriers [9,10]. 
In general, according to IUPAC nanomaterials have a length scale of less than 100 nm in 
at least one dimension [11]. This gives them peculiar properties of which their large 
surface-to-volume ratio is perhaps the most significant one in terms of heterogeneous 
bionanocatalysis for providing a large surface for functionalization with enzyme and a 
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large interface for enzyme-substrate reactions [12-14]. Frequently utilized nanoscaled 
supports for nanobiocatalysts comprise magnetic nanoparticles [8], silica nanoparticles, 
polymeric nanomaterials, metal oxides, nanofibers and metallic nanoparticles onto which 
enzymes have been immobilized by adsorption, covalent bonding, ionic interactions, via 
affinity tags, by crosslinking, or physical entrapment (entanglement) in a polymeric 
network [7,8]. Amongst the latter gold nanoparticles (GNPs) received particular attention 
and belong to one of the most intensely studied nanomaterials [15]. They can be 
prepared by a straightforward and low-cost size-controlled synthesis by reduction and 
stabilization of gold(III) chloride with citrate according to Turkevich-Frens [16,17]. 
Through a nucleation and growth-controlled mechanism [15,18,19] GNPs can be 
obtained in the size range between 1 and 50 nm. Furthermore, convenient quality control 
by Vis-spectroscopy due to the surface plasmon resonance (SPR) band with absorbance 
maximum around 520 nm makes this material attractive as carrier for biofunctionalized 
nanomaterials [20,21]. Besides adsorptive bonding of enzymes by ionic and hydrophobic 
interactions, enzymes can be conveniently immobilized via bifunctional ligands containing 
a terminal thiol group for direct attachment to the GNP surface and dative Au-S bond 
through self-assembled monolayer (SAM) formation [22] and subsequent conjugation of 
enzyme [12,23]. For this reason it is not further surprising that GNPs have become 
popular enzyme carriers for sample preparation in protein analysis, e.g. with trypsin 
[12,24,25], for enzyme-based sensor devices [26], for immunoassays [27,28], for 
theranostic applications e.g. in vivo tumor targeting and detection by surface-enhanced 
Raman scattering [29].  
In this work, we report on the synthesis and characterization of pepsin-modified 
heterogeneous nanobiocatalysts based on a gold core with a hydrophilic PEG7 shell onto 
which pepsin was covalently attached and their proteolytic performance for sample 
preparation in protein analytics. Pepsin is a digestive protease with a molecular weight 
around 36 kDa and an isoelectric point (pI) at approximately 3.2 [30][31]. Pepsin cleaves 
peptide bonds of proteins preferentially at the C-terminal side of phenylalanine and 
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leucine residues [32,33]. It is sometimes used in proteomics as alternative to trypsin 
(roughly estimated in about 0.4% of proteomic studies [1]), but also for antibody digestion 
near the hinge region to produce specifically F(ab')2 and Fc fragments [2]. For this 
reason, it was also a popular enzyme target for its immobilization to various supports 
such as microparticles [34,35], magnetic beads [36], monoliths  [37,38], nanospray 
emitter [39], planar surfaces low-density polyethylene (PE) films, or on polycarbonate 
(PC) plates, on microscope glass slides [40]dextran-modified fused-silica capillaries [41] 
and on fibers [42]. In a few studies, pepsin was immobilized on nanoparticulate carriers 
such as alumina nanoparticles ([43]), anisotropic gold nanoclusters [44] and colloidal gold 
[45]. However, the weak physical binding in these studies with non-covalent 
immobilization is regarded suboptimal in terms of chemical stability of these 
nanobiocatalysts as they have a tendency for enzyme leaching from the surface. To 
alleviate such limitations we propose herein covalently linked pepsin-GNP conjugates 
with an optimized surface chemistry that provides both chemical as well as colloidal 
stability and does not compromise bioactivity 
 
 
Materials and Methods 
 
Materials 
Pepsin (from hog stomach, E.C.3.4.23.1, 3651 U mg-1) was received from Fluka 
(Steinheim, Germany). Albumin, from bovine serum (BSA, EC Number 232-936-2, MW 
66 kDa) was obtained from Sigma-Aldrich (Munich, Germany). Cytochrome C 
(CYC_HORSE, from horse heart, EC Number 232-700-9, MW 12,270 Da) and myoglobin 
(MYG_HORSE, from horse skeletal muscle, EC Number 309-705-0, MW 16,900 Da) 
were supplied by Calbiochem (Darmstadt, Germany). 
Gold (III) chloride trihydrate (HAuCl4·3H2O), trisodium citrate, tris(hydroxymethyl)-
aminomethane (Tris), N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide (EDC), O-(2-
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carboxyethyl)-O’-(2-mercaptoethyl)heptaethylene glycol (HS-PEG7−COOH), Folin & 
Ciocalteu’s phenol reagent glycerol, a silver staining kit and monoclonal anti-HSA 
antibody for ELISA were obtained from Sigma-Aldrich (Munich, Germany). 
 
Preparation of GNPs and Immobilization of pepsin 
The preparation of GNPs was based on the reduction and simultaneous stabilization of 
gold (III) chloride trihydrate with trisodium citrate in accordance to the Turkevich-Frens 
method [16,17,12,46]. For the synthesis of 10 mL solution of GNPs, 5.05 mg HAuCl4 
(1.28 mmol in 11.25 mL double deionized water corresponding to a final concentration of 
1.14 mM) was used and heated up to the boiling point and kept under reflux under 
constant stirring. Afterwards 1.25 mL of 20.5 mM trisodium citrate solution 
(6.03 mg mL-1) was added (final concentration of 2.28 mM in a total volume of 11.25 mL) 
and heated for further 10 minutes, while the color turned red. The GNP solution was 
allowed to cool down and stirred at room temperature for another 60 minutes. The GNP 
solution was finally stored at + 4°C until usage [47]. 
To obtain covalently immobilized pepsin, first 1 µL of HS-PEG7−COOH solution was 
added to 1 mL of above prepared GNP solution and the bifunctional linker immobilized 
overnight under constant stirring at room temperature. Afterwards the solution was 
centrifuged at 12,000 rpm and resuspended in 20 mM MES buffer pH 4.5. This washing 
step was repeated twice. 50 µL of EDC (12 mM in MeOH) to activate carboxylic acids 
and 250 µL pepsin (6 mg mL-1 in 20 mM MES buffer pH 4.5) were added and stirred for 
two hours at room temperature. The nanoparticles were washed in 20 mM Tris-HCl buffer 
pH 7.5 twice to cap residual activated carboxylic groups. The supernatant of the first 
washing step was used for protein quantification by Lowry assay (see below) [12]. 
The resultant nanoparticles were washed twice and resuspended in in double deionized 
water and characterized after each step of surface functionalization by Vis spectroscopy, 
DLS and ζ-potential measurements (see Fig. 1 and Electronic Supplementary Material 
Fig. S1). 
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In an additional study, in one synthesis batch nanoparticles of each step of surface 
functionalization were tested for their stability over 35 days. For this purpose, all samples 
were diluted 1:5 with double deionized water (ddH2O) and characterized by Vis 
spectroscopy (see Electronic Supplementary Material Fig. S2). 
 
Vis Spectroscopic Characterization of Nanoparticles as well as Size and Zeta 
Potential Measurements 
The SPR band was measured by Vis-spectroscopy after each step of surface 
modification acquiring spectra in the wavelength range between 350 and 800 nm. All 
measurements were performed with a VWR UV-1600PC Spectrophotometer. The 
differently functionalized nanoparticles were further characterized by DLS and their 
ζ-potentials, derived from electrophoretic mobility measurements, before and after each 
step of chemical modification using a Zetasizer Nano ZS instrument (Malvern 
Instruments, Herrenberg, Germany). The Zetasizer was equipped with a He-Ne laser and 
the detection was performed at 173° backscatter detection mode. Samples were diluted 
in double deionized water (1:5; v/v) and measured as triplicates. Each value was the 
mean of 15 sub-runs. 
 
Chromatographic Characterization of Pepsin Activity 
A kinetic study was performed with pepsin in solution and with functionalized 
heterogeneous nanobiocatalysts with immobilized pepsin to determine the Michaelis-
Menten parameters. Thus, several concentrations of CYC were digested in 20 mM 
sodium acetate pH 4.5 for 10 minutes at 37 °C. The digestion was stopped by adding 
0.2 mL of 0.1 M NaOH to 0.8 mL reaction mixture (0.6 mL reaction buffer + 0.1 mL 
pepsin + 0.1 mL CYC stock solutions with different concentrations) to achieve neutral pH. 
For the study of pepsin in homogeneous solution as control reaction, 100 µL enzyme 
solution (2.5 mg mL-1 stock solution, 0.25 mg mL-1 final concentration) in above buffer 
was used for the digestion. The approach with the immobilized pepsin was performed in 
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1 mL total volume of the nanoparticle solution (0.7 mL nanoparticle solution in reaction 
buffer + 0.1 mL CYC stock solutions with different concentrations). Therefore 
Pepsin@GNP was centrifuged at 12,000 rpm for 10 minutes and resuspended in 0.7 mL 
20 mM sodium acetate pH 4.5. The supernatant after the centrifugation step was 
discarded. After stopping the digestion by adding 0.2 mL 0.1 M NaOH (total volume 
reaction mixture 1 mL) the nanoparticles were centrifuged and the supernatant was 
analyzed by LC-UV for quantification of undigested CYC.  
Michaelis-Menten parameters KM and vmax were calculated by linear and bilinear 
equations according to Lineweaver-Burk diagrams [48]. A calibration function was 
established and used to quantify undigested CYC in the reaction mixture. All samples 
were measured as triplicates. For the LC analysis method of undigested CYC, an Agilent 
1100 series HPLC instrument with a binary gradient pump, vacuum degasser, 
autosampler, column oven and a variable wavelength detector was used. The separation 
was performed with a 10 minutes gradient on a monolithic poly(styrene-co-
divinylbenzene) ProswiftTM RP-1S 4.6 x 50 x 4.6 mm ID column from Dionex 
(ThermoFisher Scientific) with 50 mM ammonium formate pH 3.5 containing 5 % ACN in 
channel A and ACN + 5 % 50 mM ammonium formate pH 3.5 in channel B (0-2 minutes 
20 % B, 2-6 minutes 60 % B, 6.01-10 minutes 20 % B). The flow rate of the mobile phase 
was 1 mL/min and the column temperature was set to 40 °C. The injection volume was 
5 µL and detection was performed at 280 nm. 
The method was validated considering the ICH Guidelines. Linearity, precision and 
accuracy were evaluated. The LOD and LOQ were determined as the concentrations with 
a signal-to-noise ratio of 3:1 and 9:1, respectively (see Electronic Supplementary Material 
Fig. S3 and Fig. S4 as well as Table S1).  
 
Protein Determination by Lowry Assay 
The amount of immobilized pepsin was determined by Lowry assay [49]. Briefly, the 
supernatant collected after the enzyme immobilization step was used for the 
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quantification of non-immobilized pepsin. Applying the mass balance equation, the 
immobilized amount of enzyme could then be back calculated. A calibration function was 
set up with free pepsin in 20 mM MES buffer pH 4.5 in the range 0.05 to 1 mg/mL. 25 µL 
of the sample/standard/blank were mixed with 125 µL of Lowry A solution and reacted for 
20 minutes. Afterwards 12.5 µL Folin & Ciocalteu’s phenol reagent (Lowry reagent B) 
was added and reacted for further 30 minutes before measurement. Lowry reagent A was 
freshly prepared every day (2.45 mL 4% Na2CO3 anhydrous in ddH2O, 2.45 mL 0.1 M 
NaOH, 0.1 mL 2% Na-K-tartrate in ddH2O and 0.05 mL CuSO4·5H2O in ddH2O). Folin & 
Ciocalteu’s phenol reagent was commercially available from Sigma-Aldrich. 
For the photometric determinations a Versa max microplate reader from Molecular 
Devices was used and the wavelength was set to 650 nm. All measurements were 
carried out at room temperature. For more details see also Electronic Supplementary 
Material Fig. S5 and Fig. S6. 
 
Protein digestion with pepsin-conjugated GNPs 
BSA, CYC and MYG (0.2 mg mL-1 each of each protein) were utilized as model proteins 
to test the digestion efficiency of conjugated pepsin. For this purpose, 0.2 mL of the 
protein mixture was transferred to 1 mL of the nanoparticle suspension (Pepsin@GNP in 
1 mL 20 mM sodium acetate pH 4.5). The reaction with the nanoparticle approach was 
stopped by centrifugation (12,000 rpm for 10 minutes) resulting in a clear supernatant for 
LC-MS/MS analysis. For the digestion protocol with free pepsin 0.3 mg ml-1 pepsin was 
used (0.25 mg mL-1 final concentration in 1.2 mL total volume) and, to 0.8 mL pepsin in 
digestion buffer was given 0.2 mL of the protein mixture. 100 µL aliquots were taken and 
the reaction was stopped by adding 20 µL of 0.1 M NaOH before injecting the sample for 
LC-MS7MS analysis. 
The digestion of the protein mixture was performed in 20 mM sodium acetate buffer pH 
4.5 at 37 °C from 4 to 24 hours digestion time. As control a sample at 0 h digestion time 
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was also taken and analyzed. Blank samples as 20 mM sodium acetate pH 4.5 were 
prepared as well. 
Recyclability (see Electronic Supplementary Material Fig. S7) and pepsin leaching from 
Pepsin@GNP bioconjugate (see Electronic Supplementary Material Fig. S8) were also 
examined.  
 
LC-MS/MS Method 
All samples were injected via PAL HTC-xt autosampler (CTC Analytics, Zwingen, 
Switzerland). The separation was performed with an Agilent 1290 LC-system (Agilent 
Technologies, Waldbronn, Germany) on an Aeris Peptide C18 (3.6 µm 150 x 2.1 mm ID) 
column from Phenomenex (Torrance, CA, USA) with a 90 minutes gradient containing 
ddH2O with 0.1 % (v/v) formic acid in channel A and acetonitrile with 0.1 % (v/v) formic 
acid in channel B (0-5 minutes 5 % B, 5-60 minutes from 5 to 60 % B, 60-65 minutes 
from 60 to 95 % B, 65-70 minutes 95 % B, 70-72 minutes to 5 % B, 72-90 minutes 5 % 
B). The peptide masses were detected with the quadrupole time-of-flight mass 
spectrometer Triple TOF 5600+ from Sciex (Concord, Ontario, Canada) equipped with a 
DuoSpray source operated in ESI positive mode. The source temperature was set to 
350 °C and the ion spray voltage floating was 5500 V. The pressure of the ion source 
gases 1-3 was 50, 40 and 30 psi. Finally, the declustering potential was set to 100 V and 
the collision energy to 10 V. Ions were measured in information dependent data 
acquisition (IDA) mode for ions greater than 100 Da with an intensity threshold greater 
than 10 counts per second. Accumulation time for MS (survey scan) and MS/MS 
experiments were set to 250 ms. The dynamic background subtraction was activated and 
the collision energy for all MS/MS experiments was set to 25 V. 
A Mascot search was performed to detect the digested protein and to examine the 
occurrence of autodigestion of the immobilized pepsin. Mascot version 2.0.05 was used 
with the Swiss-Prot database. Pepsin-A was selected as the enzyme. Precursor and 
fragment ion mass (monoisotopic) tolerance was set to ±0.2 Da. Peptide charge state 
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was set to +1, +2, +3 and one missed cleavage was allowed. Taxonomy and 
Modifications were not specified. 
More detailed results on the UHPLC-ESI-QTOF-MS/MS analysis of the digested protein 
mix can be found in the Electronic Supplementary Material Fig. S9 to Fig. S12 as well as 
Table S2. 
 
Antibody digestion with Pepsin@GNP 
For this experiment the intact mass of monoclonal anti-HSA from an ELISA kit was 
determined before and after the digestion with immobilized pepsin by UHPLC-µESI-QTof-
MS. 
For the digestion 100 µL Pepsin@GNP in 20 mM sodium acetate pH 4.5 was mixed with 
100 µL anti-HSA (1:100 dilution in 20 mM sodium acetate pH 4.5). The digestion was 
performed at 37 °C for 4 hours. To obtain a clear supernatant for analysis the 
nanobiocatalysts were centrifuged (12,000 rpm for 10 minutes). 
 
LC-MS Method for the determination of intact protein masses 
A Zorbax column (SPE 300 Å C18 5 µm 35 x 0.3 mm ID) from Agilent (Santa Clara, CA, 
USA) was used for online SPE. Within the first two minutes the column was used for 
desalting and enrichment of the sample with a flow of 50 µL/min 100 % ddH2O with 
0.1 % (v/v) formic acid in channel A. From 2.01 to 8 minutes the adsorbed, desalted 
proteins were eluted from the SPE column and flushed into the mass spectrometer with 
50 µL/min 100 % acetonitrile containing 0.1 % (v/v) formic acid in channel B. A two 
minutes pre-equilibration step was performed to reach the starting conditions of the 
method. The protein masses were detected with the quadrupole time-of-flight mass 
spectrometer Triple TOF 5600+ from Sciex (Concord, Ontario, Canada) equipped with a 
DuoSpray source operated in µESI positive mode, using a 50 µm I.D. µESI-needle 
(Sciex). The source temperature was set to 400 °C and the ion spray floating voltage 
(ISFV) was 5100 V. Nebulizer gas (GS1) was set to 40 psi, drying gas (GS2) to 40 psi 
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and curtain gas to 30 psi. Finally, the declustering potential (DP) was set to 230 V and 
the collision energy (CE) to 30 V. TOF-MS scan ranged from 500 to 4000 Da.  For intact 
protein detection Sciex’s Intact-Protein script was activated, Q1 transmission was set to 
100 % at 1250 m/z and sensitivity was increased by summing 60 time bins. Data 
processing and identification of the intact protein mass was performed with the Bio Tool 
Kit from Sciex. 
 
 
Results and Discussion 
 
Synthesis and Characterization of Functionalized GNPs 
Citrate-capped GNPs were prepared according to the method by Turkevich-Frens 
[16,17]. This approach is based on the reduction of HAuCl4 by trisodium citrate and 
allows a straightforward size-controlled synthesis of GNPs in the range of 10 to 30 nm by 
variation of the molar citrate-to-gold tetrachloride ratio in the range between 6:1 and 2:1 
[47]. Citrate ions attached to the GNP surface after synthesis are responsible for the 
good colloidal stability of the resultant nanoparticle suspensions. A convenient strategy 
for enzyme immobilization on nanoparticulate carriers represents adsorptive bonding 
driven by attractive electrostatic interaction forces. This approach towards heterogeneous 
nanobiocatalysts was examined herein as well, yet found to be suboptimal in terms of 
stability of resultant nanocolloids. Therefore, immobilized pepsin, having pI between 2 
and 3 according to literature, may easily detach under reaction conditions (pH between 1-
4), contaminating the resultant reaction solution after removal of the nanoparticles with 
proteinogenic material which may interfere with final analytical determinations. Hence, a 
covalent attachment strategy of pepsin was adopted following the reaction scheme 
presented in Fig. 1. The bifunctional linker HS-PEG7-COOH was first self-assembled in a 
dense monolayer on the gold surface via stable dative thiol-gold bond. It was previously 
shown that this linker provides stable SAMs (self-assembled monolayers) with surface 
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coverages of 4.29 ± 0.45 ligands per nm2 [50]. The PEG linker supports colloidal stability 
and prevents non-specific binding of proteins. It was found that enzyme-GNP conjugates 
have better colloidal stability when the enzyme was bonded via a PEG linker as 
compared to corresponding alkyl linkers and compared to adsorptively bonded enzyme-
GNP conjugates as well [12]. Longer spacers turned out to be advantageous in terms of 
bioactivity, and therefore the bifunctional linker HS-PEG7-COOH was selected in the 
current work as first choice. The terminal carboxylic groups constitute reactive anchor 
functionalities for bonding of pepsin by direct amide coupling with EDC under weakly 
acidic conditions. As a last step in the synthesis, remaining EDC-activated carboxylic 
groups were capped with Tris moieties yielding the final pepsin-functionalized GNPs with 
residual carboxylic acid groups. The latter are supportive for the colloidal stability and 
shelf life of the resultant bionanocatalyst. 
All nanoparticles were characterized after each step of synthesis and surface 
modification, respectively, by Vis spectroscopy for measurement of changes of the SPR 
band, by DLS analysis for nanoparticle size (i.e. hydrodynamic diameter) characterization 
and by determination of the ζ-potential. The results are illustrated in Fig. 2. 
Citrate-stabilized GNPs obtained by synthesis with a 2:1 molar ratio of citrate/HAuCl4 
revealed a mean diameter of 31.4 ± 0.9 nm according to DLS measurements and a ζ–
potential of -34.7 ± 1.7 mV. Such nanoparticle sizes were recently found to be favorable 
over smaller ones for protein immobilization [12]and were therefore used as starting 
carrier for all batches of modified GNPs in this study. The final concentration of the GNP 
solution of 1.5 x 10-6 mM was calculated with the results of the DLS measurements and 
the Lambert-Beer law [47]. 
Vis spectroscopy represents the most straightforward and useful tool for quality control of 
surface modification. Alterations in size, size distribution and shape as well as chemical 
changes at the surface lead to shifts of the characteristic SPR band which is found as an 
absorption band with a maximum at around 525 nm according to the Mie theory [51,52]. 
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As displayed in Fig. 2a, the SPR band as monitored by Vis spectroscopy is slightly 
shifted to higher wavelength upon each step of surface modification 
(from λmax = 525 ±0.6 nm for citrate-capped GNPs to λmax = 528 ±1 nm after pegylation to 
λmax = 532 ±1.7 nm after bonding of pepsin) and confirms successful bonding of the 
respective ligand at each step. It becomes further evident that no significant aggregation 
occurs upon pegylation which yielded carboxy-terminated GNPs nor after enzyme 
immobilization which afforded the final pepsin-conjugated GNPs. Aggregation typically 
leads to broad absorption bands with λmax > 550 nm which are absent in the current Vis 
spectra (Fig. 2a) [46]. Narrow absorption bands are observed for all three studied particle 
types due to absence of aggregation. The slightly broader absorption band for the 
pepsin-modified GNPs may be due to asymmetrically-shaped particles and departure 
from strictly spherical shape after enzyme immobilization [47].  
Sufficient colloidal stability is also confirmed by the ζ–potentials of the modified particles. 
In any case, ζ–potentials were < -25 mV (Fig. 2b) which is indicative for sufficient 
electrostatic repulsion overcoming attractive van der Waals interactions that are the 
prime cause for aggregation of nanoparticles. 
Nanoparticle diameters were measured by DLS. As expected, with each layer of surface 
modification the size of the resultant nanoparticles increased confirming successful ligand 
attachment. The bifunctional PEG7 linker with terminal carboxylic group has a length of 
about 3.5 nm [50]. After its bonding to the GNP surface by SAM formation the diameter of 
the nanoparticle grew from 31 nm to 52 nm which is in good agreement with 
expectations. The slight difference between theoretical and experimental values may be 
due to strong solvation of pegylated GNPs. The sphere equivalent particle diameter 
further increased to 105 nm after coupling of pepsin to the carboxy-terminated GNPs 
(Fig. 2b). 
The surface coverage of pepsin on the GNPs was determined by protein quantification 
with Lowry assay measuring free pepsin in the supernatant after the reaction and 
applying mass balance considerations The pepsin concentration on the GNPs was 
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determined to 0.25 ± 0.03 mg mL-1 (7.24 ± 0.87 x 10-6 mol/L) For sake of comparison, 
also the data for nanoparticles with pepsin adsorptively bonded directly to citrate-capped 
GNPs are included in Fig. 2b. It can be seen that the diameter was significantly smaller 
(66 nm) as expected due to the missing PEG-shell. Most notably, the ζ-potential of this 
adsorptively bonded bioconjugate was much lower as compared to the covalently bonded 
pepsin-GNP conjugate. In fact, it turned out that such GNPs are less stable, may easily 
aggregate and show reduced shelf life making them less suitable for the intended 
analytical purpose. In contrast, covalent pepsin-modified GNPs with PEG-linker showed 
excellent stability over extended period (see also Electronic Supplementary Material 
Fig. S1). Hence, the covalent immobilization strategy proposed herein is favorable in 
particular also from viewpoint of shelf-life of the functionalized nanoparticles as well as 
with regards to bleeding of enzyme into the reaction mixture in the course of sample 
preparation giving rise to interferences in the subsequent analysis.  
 
Characterization of heterogeneous nanobiocatalyst by Michaelis-Menten enzyme 
kinetics 
As a simple test to characterize the functionality of the new nanoparticulate biocatalyst, 
cytochrome C (CYC) was digested with pepsin-GNP bioconjugate in comparison to 
homogeneous catalysis with free pepsin and the data were processed in accordance to 
the formalism of the Michaelis-Menten enzyme kinetics. Three replicate batches of 
incubations at each substrate concentration level (n = 3) were examined for both free and 
immobilized enzyme. In order to allow a representative comparison, the enzyme 
concentration was kept constant in reactions with free and immobilized pepsin 
(concentrations of pepsin were 7.24 x 10-6 for free and 7.24 ±0.87 x 10-6 mol/L incubation, 
respectively, for immobilized pepsin). For this purpose, an LC-UV method for the 
quantitative determination of non-digested CYC was developed and validated according 
to ICH guidelines (details about method validation and method performance are given in 
the Electronic Supplementary Material Fig. S3, Fig. S4 and Table S1). The assay, based 
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on separation of the intact CYC protein from digested peptides which elute more or less 
unretained in the established RPLC method with poly(styrene-co-divinylbenzene) 
monolithic column, allowed accurate and precise quantification of undigested CYC. For 
the quantitative evaluation of the enzyme kinetics the reaction rate was determined from 
the time-dependent decrease of educt (CYC). Incubations of variable concentrations of 
substrate (CYC) with free and immobilized pepsin were analyzed following the formalism 
of the Michaelis-Menten equation (see Fig. 3). Both, nonlinear and linear curve fitting to 
derive KM and vmax gave insufficient quality of fit for both, digestion with free and 
immobilized enzyme. From the linear representation in accordance to the Lineweaver-
Burk diagram in Fig. 2b, the nonlinear behavior is evident. Nevertheless, for a rough 
estimation of the kinetic parameters KM and vmax were calculated from the data plotted 
according to the Lineweaver-Burk-diagram. The results are summarized in Table 1. KM 
values of 29 (±3) µM and 21 (±2) µM for free and immobilized pepsin, respectively, have 
been calculated indicating that immobilization did not negatively affect affinity of the 
substrate to the enzyme. Apparently, access of CYC to the catalytic site is not hindered 
considerably by the linkage of pepsin to GNPs and the chemical bonding does not seem 
to induce major conformational changes in the enzyme with negative effects on 
bioactivity. At this point it is, however, also quite clear that due to the intrinsic structural 
heterogeneity of the heterogeneous nanobiocatalyst originating from polydispersity in 
size, shape, protein coverage and in particular orientation each individual microscopic 
state of the enzyme conjugate may possess distinctly unique kinetic properties. As a 
consequence, this characteristic kinetic parameter KM of the pepsin-GNP conjugate 
actually represents macroscopically a weighted average value of individual 
microscopically distinct nanobiocatalysts. Since the non-directed immobilization by the 
selected amide coupling leads to random protein orientation and hence presumably to 
hindered access of the active site in some orientations, the decrease of the macroscopic 
KM value by 27% relative to free pepsin is not further surprising. The maximal rates of 
enzymatic reaction vmax achieved by free pepsin and heterogeneous pepsin 
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nanobiocatalyst at maximum (saturating) substrate concentrations are also very similar 
(vmax = 4.4±0.3 and 3.5±0.2 x 10-8 M s-1, respectively). Furthermore, knowledge of the 
total enzyme concentration in the reaction allows calculation of the turnover number kcat 
which was 6.1 x 10-3 s-1 and 4.5 x 10-3 s-1 for free and immobilized pepsin. This 
corresponds to a catalytic constant for the heterogeneous nanobiocatalyst of 78 % of free 
pepsin which may be regarded as equivalent to homogeneous catalysis. Even more so 
the ratio kcat/KM, which is a characteristic parameter to describe the catalytic efficiency, is 
even higher for the immobilized pepsin. Consequently, it can be concluded that 
immobilization of pepsin to pegylated GNPs affords a nanobiocatalyst which can benefit 
from properties of heterogeneous catalysis (like easy removal) while still exhibiting kinetic 
properties like a homogeneous biocatalyst.  
As mentioned above, nonlinearity was found in Lineweaver-Burke diagrams for both free 
and immobilized pepsin. To more adequately characterize enzyme kinetics a biphasic 
behavior was assumed and bilinear Lineweaver-Burke diagrams exploited for deriving 
characteristic parameters. A summary of the results is given in Table 1. It can be seen 
that at higher CYC concentration levels the KM values (KM,2) increase by a factor of 
around 10 indicating lower affinity of the substrate to both free and immobilized enzyme. 
At the same time, theoretical vmax values increase by a factor of ca. 4 at high substrate 
concentrations. Overall, catalytic efficiencies are by a factor of ca. 2 lower in the high 
concentration regime. In any case this nonlinear behavior may indicate feedback 
inhibition or competitive binding of peptidic products. Such feedback inhibition has been 
reported previously for other pepsin-catalyzed reactions as well [53]. 
 
Protein digestion with free and GNP-conjugated pepsin 
To test on a wider scope the performance with a more complex sample, the 
functionalized heterogeneous nanobiocatalyst with immobilized pepsin was evaluated for 
its digestion capability of a protein mixture composed of bovine serum albumin (BSA), 
CYC and myoglobin (MYG) in comparison to its free analog. Again, for comparison the 
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pepsin content was adjusted to be similar for both incubations with free and immobilized 
pepsin. The resultant protein digests sampled at 0, 4, 12, and 24 h were analyzed by 
UHPLC-ESI-QTOF-MS/MS measurements in data-dependent IDA scan mode and the 
exported peak list subjected to Mascot search in order to elucidate the quality of digestion 
in a time-dependent manner by monitoring scores of protein identification and 
corresponding sequence coverages. Fig. 4a-4d show chromatograms of the pepsin 
digests resulting at different digestion times with pepsin-GNP conjugate and Fig. 4e-4h 
the corresponding chromatograms obtained with free pepsin.  
It can be seen in Fig. 4a that immediately after addition of pepsin-GNP conjugate to the 
protein mixture peptides appear in the chromatogram, while digested peptides are 
virtually absent in the free enzyme incubation (Fig. 4e) (see also Fig.5a). This could 
indicate accelerated reaction with the immobilized pepsin, maybe owing to a higher local 
pepsin concentration on the enzyme-GNP conjugate as compared to that in free solution 
despite the approximately equal overall presence of pepsin in the system. Another 
explanation might be continued digestion during workup while spinning down the pepsin-
modified GNPs. After 4 h, BSA and MYG are completely digested both with immobilized 
and free enzyme (Fig. 4b and 4f). 39 and 42 peptides were detected with immobilized 
and free pepsin, respectively (Fig. 5b). The number of detected peptides was not 
significantly altered after 12h (Fig. 4c and 4g as well as fig. 5c), and only slightly 
increased after 24 h digestion (Fig. 4d and 4h as well as fig. 5d). From the Venn 
diagrams [54] in Fig. 5 it is clearly evident that the heterogeneous pepsin-bionanocatalyst 
shows a larger, or at least similar, number of digested peptides as free pepsin. 
Mascot database search uses probability-based scoring to judge whether a result is 
significant and not a random event, and scores greater than 67 are deemed to be 
significant (p<0.05) [55,56]. Scores for the distinct digested samples are depicted in Fig. 
6a. It can be seen that the Mascot search enables identification of the proteins with high 
scores (>100) in all digests after 4 h digestion time or more, not only for pepsin in solution 
but also the pepsin-GNP conjugate. In fact, the scores of the Mascot search were on 
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average even higher for the immobilized pepsin. Moreover, sequence coverages > 20% 
in the digests with 4 and 12 h digestion times for the heterogeneous nanoparticle-based 
biocatalyst allows to conclude that its bioactivity and catalytic performance is at least of 
equal quality as compared to pepsin in free solution which cannot be conveniently 
removed by brief spinning (Fig. 6).  
 
A common problem of digestion using proteolytic enzymes in solution in sample 
preparation is autodigestion. This problem can be largely eliminated with immobilized 
enzymes. It was therefore carried out a dedicated search for signature peptides 
originating from pepsin in the protein digests. However, in the present case neither in 
solution nor in digests from immobilized pepsin, auto-digestion could be detected. 
However, this issue might get more important if reaction times need to be extended for 
proteins which are more resistant to digestion by pepsin. 
On the other hand, no pepsin contamination was present in the incubation in case of the 
immobilized pepsin nanobiocatalyst whereas the soluble enzyme might represent an 
impurity and interference in the analyzed protein sample in conventional reaction 
incubations. No pepsin was bleeding from the GNP-pepsin conjugate in the course of 
digestion of CYC (see Electronic Supplementary Material Fig. S18).  
Last but not least, the immobilized pepsin@GNP nanobiocatalyst can be re-used. 
Recyclability was tested and it was found that up to 3 cycles of re-use the digestion 
performance (sequence coverage) was largely maintained at the same level while after 3 
reuse cycles its digestion performance started to decline (see Electronic Supplementary 
Material Fig. S7). 
 
Comparative peptide mapping 
In order to gain insight into the proteolytic specificity of the conjugated pepsin and to 
compare its performance with free pepsin, also in terms of missed cleavages and peptide 
homology, a closer lock into the peptide fragments obtained by digestion of the protein 
110 
 
mix (CYC, MYG, BSA) for 4h with Pepsin@GNP and free pepsin in solution was 
undertaken. Fig. S9-S11 of the Electronic Supplementary Material show an overview of 
precursors generated by Pepsin@GNP, overlays of XICs of protein-specific peptides for 
each CYC, MYG and BSA, and an exemplary MS/MS spectrum of a model peptide. 
Figure 7 illustrates the protein sequences of CYC (Fig 7a) and MYG (Fig. 7b), and the 
peptides identified in corresponding digests of free and immobilized pepsin are indicated 
by arrows covering the respective sequence (corresponding map for BSA can be found in 
the Electronic Supplementary Material Fig. S10). Solid arrows show the fragments cut by 
pepsin in solution, dashed arrows the fragments cut by Pepsin@GNP. 100 % homology 
was found in the generated peptide fragments in case of CYC yielding a sequence 
coverage of 68 % for CYC both with free and gold-conjugated pepsin (Fig. 7a). Only two 
missed cleavages are found (F in position 11 and L in position 69). The former missed 
cleavage may be due to K in P3 while the latter could be a result of the negative effect on 
cleavage exerted by Pro at P3’. Moreover, the N-terminal tail was not identified by 
Mascot. To a large extent, good but slightly lower homology between heterogeneous and 
homogeneous catalysis was also found for MYG (Fig. 7b). While identified peptides were 
identical over large sequences at the N- and C-terminal tails, in the range between 
position 50 and 105 peptides and sequence coverage were different for the two 
approaches of digestion. Both missed to cleave at positions 3 (L), 44 (F), 47 (F), 73 (L) 
and 152 (F).  Sequence coverage was 72 % and 62 % for MYG by free pepsin and 
Pepsin@GNP, respectively. Overall, good homology in generated peptide fragments 
between immobilized and free pepsin was found also for BSA (see Electronic 
Supplementary Material Fig. S12). 
 
Determination of the antibody mass before and after digestion with Pepsin@GNP 
In addition to the characterization of the heterogeneous nanobiocatalysts by model 
proteins (BSA, CYC and MYG) a digestion of a real sample, a monoclonal antibody, in 
accordance with the intended purpose of use of the developed heterogeneous 
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nanobiocatalyst should demonstrate its functionality. Pepsin digestion of IgG under non-
denaturing conditions yields antibody fragments which are particularly useful for middle-
up mass measurement for characterization of therapeutic antibodies by high-resolution 
MS. Since pepsin cleaves IgG at the C-terminal side of the inter-heavy-chain disulfides in 
the hinge region, it produces a bivalent antigen binding fragment, F(ab’)2, with a 
molecular mass of about 100 kDa.  
HR-MS using a QTOF equipped with a µESI sprayer and a C18 online trap column for 
desalting of the protein sample was used for characterization of the intact monoclonal 
antibody and the fragment obtained by digestion with pepsin@GNP. In the established 
assay, the protein elutes at around 5 min from the trap column, well separated from the 
salt plug at around 2.5 min (Fig. 8a). The MS spectrum of the intact monoclonal antibody 
is shown in Fig. 8b. It shows the characteristic charge envelope in the range +50 to +100, 
as expected. The deconvoluted MS spectrum of the intact anti-HSA antibody revealed a 
mass of about 149 kDa with a number of isoforms (insert) (Fig. 8c). The same experiment 
with the antibody fragment obtained by digestion with Pepsin@GNP resulted in a single 
peak with a mass of 97,619.4 Da for (Fab')2.  These results clearly document the 
functionality of the immobilized pepsin nanobiocatalyst and evidence its practical utility for 
therapeutic protein characterization. 
 
 
Conclusions 
Pepsin A was successfully immobilized on gold nanoparticles via bifunctional PEG7-linker 
resulting in efficient functionalized heterogeneous nanobiocatalysts with good colloidal 
stability and shelf life over at least a month. Characterization of the enzyme kinetics of 
the pepsin-GNP bioconjugate in comparison to free pepsin by digestion of the model 
protein cytochrome C clearly revealed that the enzyme fully retained its catalytic 
efficiency after immobilization on this nanoparticulate carrier. Digestions of protein 
mixtures followed by UHPLC-ESI-QTOF-MS/MS analysis with subsequent protein 
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identification by Mascot database search documented the pertinent bioactivity of the 
pepsin-GNP bionanocatalyst and its utility for protein analysis and characterization, 
respectively. By measuring in intact protein mode it was possible to determine the (Fab')2 
fragment after digestion of anti-HSA with Pepsin@GNP. 
While the heterogeneous pepsin-GNP bionanocatalyst showed equivalent kinetic 
performance and catalytic efficiency, it offers significant additional benefits, thus 
combining favorable properties of homogeneous and heterogeneous catalysis. It can be 
pipetted like a solution due to the stable colloidal suspension which facilitates sample 
handling, automation, and miniaturization of sample preparation protocols, properties 
which are characteristic for homogeneous catalysis, Due to the high density of the 
metallic gold nanoparticle core, the heterogeneous bionanocatalyst can be easily spinned 
down on a minispin in a few minutes at low rpm, equipment which is available in virtually 
any lab and does not involve complicated procedures. In the current enzyme-GNP 
bioconjugate, the enzyme is freely accessible on the surface of the nonporous gold 
particle and not deeply buried inside a pore channel such as in more common 
heterogeneous catalysts in which enzymes are immobilized on mesoporous 
microparticles, such as (crosslinked) agarose. Due to this fact, diffusion limitations are 
thought to be less serious on enzyme-GNP bionanocatalysts. On contrary more common 
microparticulate heterogeneous catalysts may seriously suffer from diffusion limitations in 
intraparticulate pore spaces which may easily lead to substrate depletion as well as 
product accumulation at intraparticulate active enzyme centers. Overall, however, the 
removal of the functionalized heterogeneous nanobiocatalysts by centrifugation bevor the 
analytical determination is the striking advantage, both for single as well as coupled 
digestion or sample preparation protocols. This is of utmost importance in primarily 
intended application fields such as for therapeutic peptide and protein characterization as 
well as (sequence and stereoconfiguration) analysis of (lipo)peptides from natural pools 
where enzyme contaminations might easily interfere with the analysis and complicate the 
interpretation of results.  
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Figures and Figure Captions: 
 
 
Fig. 1 Reaction scheme for functionalization of GNPs with bifunctional crosslinker and 
pepsin. 
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Fig. 2 Characterization of nanoparticles after each step of synthesis and surface 
functionalization, respectively. (a) Vis spectra showing slight shifts of the SPR band upon 
surface modification, (b) size (hydrodynamic diameters) as measured by DLS and ζ-
potentials of all nanoparticle stages, along with adsorptively immobilized pepsin-modified 
nanoparticles as well as free pepsin. 
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Fig. 3 Characterization of bioactivity of free and GNP-conjugated pepsin by Michaelis 
Menten enzyme kinetics in nonlinear representation (a) and linearized form according to 
Lineweaver-Burk diagram. 
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Fig. 4 UHPLC-ESI-QTOF-MS/MS measurements (TIC) of a protein mix digested with 
GNP-conjugated pepsin (a-d) and free pepsin (e-h) for 0 h (a,e), 4 h (b,f), 12 h (c,g) and 
24 h (d,h).  
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Fig. 5 Venn diagrams comparing numbers of peptides detected in samples digested with 
GNP-conjugated pepsin (red circle), free pepsin (green circle) and both (intersection) a) 
immediately after admixing the enzyme to the incubation mixture i.e. 0 h, b) after 4h, c) 
after 12 h, and d) after 24 h of digestion time. 
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Fig. 6 Mascot search results for protein identification in digests of a protein test mixture 
composed of BSA, CYC and MYG obtained with GNP-PEG7-pepsin and pepsin in 
solution which shows the score (a) and the sequence coverage (b) after 0, 4, 12 and 24 h 
digestion time (for corresponding chromatograms see Fig. 4). The Mascot search using 
MS/MS data of the IDA scan mode was performed with the SwissProt database. 
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Fig. 7 Sequence of CYC (a) and MYG (b) with identified peptides found in digests with 
free pepsin in solution (solid arrows) and pepsin-modified GNPs with HS-PEG7−COOH 
spacer (dashed arrows). Peptides were determined by Mascot search and compared with 
reference to the protein sequences.  
  
MGDVEKGKKIFVQKCAQCHTVEKGGKHKTGPNLHGLFGRK 40
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Fig. 8 Digestion of monoclonal antibody with Pepsin@GNP. TIC (a) and TOF-MS 
spectrum (b) of intact anti-HSA as measured by online-SPE µESI-QTOF-MS. The TOF-
MS spectrum was taken at the indicated area between tR 4.5 and 5.5.min and shows the 
charge envelope of anti-HSA. The mass spectra (c) and (d) depict the intact protein mass 
of anti-HSA before (c) and after (d) digestion with Pepsin@GNP. 
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Supplementary Material 
 
Aggregation-induced shift of SPR band 
Aggregation in colloidal preparations of (functionalized) GNPs is detrimental for their 
functionality. For instance, aggregation of pepsin-conjugated GNPs may easily lead to 
loss of enzymatic activity because of precipitation of aggregates and preclusion of access 
of substrates to the active site of the immobilized enzyme. Thus, during synthesis and 
functionalization it is of importance to maintain stable colloidal suspension and monitor 
colloidal stability. A convenient and simple method to detect colloidal stability and 
aggregation, respectively, is monitoring the surface Plasmon resonance (SPR) band in 
the range between 400 and 800 nm of Vis spectra of the nanoparticle suspensions 
resulting after synthesis and surface modification, respectively. Upon aggregation, the 
intensity of the original SPR absorbance band at around 520 nm is reduced and a new 
red-shifted second absorbance band appears at higher wavelength (depending on size of 
aggregates and original particles e.g. 580 nm) indicating onset of aggregation. The 
conduction electrons near each particle surface become delocalized and are shared 
amongst neighboring particles in aggregates causing the surface Plasmon resonance 
shifting to lower energies which becomes evident as red-shifted SPR band. Fig. S1 
shows an example of aggregated GNPs versus stable colloidal suspension.  Eventually, 
aggregation can be observed even visually. The red nanoparticle solution turns to purple 
or dark, and finally a clear uncolored solution can be observed with black precipitate. 
Once aggregated, in nearly all cases it is difficult or even impossible to redisperse the 
aggregates into individual particles forming stable colloidal suspensions. During the 
current synthesis protocol, it was observed that activation of carboxy-terminated 
pegylated GNPs by OSu (N-hydroxysuccinimide) easily aggregate, but aggregates 
disappear upon protein binding. Nevertheless, a direct coupling without OSu activation 
was employed for this reason herein. 
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Fig. S1: Vis-spectra of Pepsin@GNP (pepsin-modified GNPs with PEG7 spacer) and 
adsorptively bound pepsin on GNPs. Because of a high colloidal stability the peak of 
Pepsin@GNP shows a good shape. The undefined peak shape of adsorptively bound 
pepsin is due to particle aggregation. 
 
Stability study of all nanoparticle stages for 35 days 
One synthesis batch of pepsin-modified GNPs was used to study the long-term colloidal 
stability. Thus, an aliquot of each citrate-capped GNPs, pegylated GNPs (GNP-PEG7-
COOH) and pepsin-modified GNPs with PEG7 spacer were stored in the refrigerator at 
4°C in the dark for 35 days. Changes of the nanoparticles, in particular aggregation, were 
then monitored by Vis spectroscopy measuring Vis spectra between 350 and 800 nm in 
the first 9 days daily and then once a week and every second week, respectively.  
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Fig. S2: Colloidal stability and shelf life of functionalized nanoparticles. (a) Citrate-
stabilized GNPs, (b) GNPs coated with bifunctional PEG spacer having carboxy-
terminated surface and (c) immobilized pepsin-GNP conjugate. (d) Absorption maxima of 
the SPR band of all nanoparticle stages measured over 35 days. All samples were 
diluted 1:5 in ddH2O. 
 
The results are illustrated in Fig. S2. As can be seen, essentially no changes in Vis 
spectra can be found for GNPs (Fig. S1a) and GNPs with PEG-spacer (Fig. S1b) over 
the entire period. For pepsin-modified GNPs wavelength shifts in absorbance maxima are 
virtually absent as well and colloidal stability over 35 days is confirmed. However, a slight 
decline in absorbance of the SPR band between day 16 and 35 may indicate that some 
nanoparticles have precipitated leading to a slightly reduced concentration in the 
heterogeneous enzyme suspension. Such slightly lower concentration might, however, 
be easily and conveniently compensated for by pipetting slightly larger volumes to 
reaction mixtures in order to keep the total enzyme concentration in reaction incubations 
130 
 
constant. This would guarantee satisfactory batch-to-batch reproducibility of enzymatic 
reactions when working with one pepsin-GNP conjugate batch over extended period.  
 
Chromatographic assay for the determination of CYC in enzyme kinetics study 
An accurate and precise validated HPLC-UV method was set up for the reliable 
quantitative analysis of undigested CYC in reaction batches of the enzyme kinetics study. 
For this chromatographic method a polystyrene-co-divinylbenzene monolith column with 
macropore diameter of 1 µm was selected. This type of columns has been shown to be 
favorable for fast protein analysis due to convective mass transfer. Due to a small mass 
transfer resistance term the column can be operated at high flow rates which allow fast 
analysis with high sample throughput. The mobile phase conditions and gradient profile 
were adjusted such that the protein was well retained while the digested peptides eluted 
at the front close to t0, thereby avoiding interferences with CYC quantification. A 
representative chromatogram is given in Fig. S3. 
 
 
Fig. S3: Representative chromatogram of HPLC determination of undigested CYC in 
reaction batches from enzyme kinetics study. Experimental conditions: Column, 
ProswiftTM RP-1S (4.6 x 50 mm, Dionex/ThermoFisher Scientific). Mobile phase, A: 50 
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mM ammonium formate pH 3.5 + 5 % ACN; B:  ACN + 5 % 50 mM ammonium formate 
pH 3.5; gradient profile see insert; flow rate, 1 mL min-1; column temperature, 40 °C. 
 
The method was validated according to ICH guidelines for method performance 
characterization in terms of detection limit (DL), quantitation limit (QL), intra-assay and 
inter-day precision as well as accuracy, and assay specificity. 
Thus a calibration function was established by diluting a CYC stock solution of 2 mg/mL 
in 20 mM sodium acetate buffer pH 4.5 in the range of 0.05, 0.1, 0.2, 0.5, 1 and 2 mg/mL 
and analyzing the solutions by above HPLC-UV method. The calibration function is 
shown in Fig. S4. It can be seen that good linearity in the given concentration range was 
obtained with a determination coefficient R2 of 0.9993. DL (S/N=3:1) and QL (S/N=10:1) 
were determined as 0.02 mg/mL and 0.08 mg/mL, respectively. 
 
 
Fig. S4: Calibration function for CYC analyzed in the course of the enzyme kinetics 
study. 
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Table S1: Validation parameters for CYC 
 
c(CYC) 0.05 mg/mL 0.1 mg/mL 1 mg/mL 2 mg/mL 
accuracy 130.00% 114.67% 102.40% 104.87% 
intraday 
precision 1.15% 0.79% 0.48% 0.31% 
interday 
precision 1.21% 1.08% 0.60% 0.63% 
 
For validating the assay performance intra-assay and inter-day precision and accuracy 
were validated across the relevant concentration range at three concentration levels 
(close to LOQ, intermediate and high concentration range) of quality control (QC) 
samples in three replicates. The results are given as %RSD for precision testing and as 
%-recovery for accuracy testing. As can be seen from Table S1, RSD values < 1 % in all 
cases as well as recoveries close to 100 % indicate excellent assay precision and 
accuracy. The assay was therefore suitable for measuring CYC concentrations in 
samples from enzyme kinetics study accurately and reliably. 
 
Determination of surface coverage of GNPs with pepsin by Lowry Assay 
For determination of surface coverage of GNPs with pepsin, common protein 
quantification assays were envisaged. Lowry assay was finally selected. In the Lowry 
assay, peptide bonds of the analyzed protein(s) are first complexed with Cu(II) ions in 
alkaline solution according to Biuret reaction. In a second step, Cu(II) is reduced to Cu(I) 
which in turn reduces the yellow Folin-Ciocalteu reagens 
(phosphomolybdate/phosphotungstic acid). The end product has a blue color. The protein 
quantity in the sample can be determined by absorbance measurements at 650 or 
750 nm against a standard protein curve. 
 
133 
 
 
Fig. S5: The behavior of citrate stabilized GNPs in the presence of Lowry reagent A and 
1 % CuSO4. 
 
Initially, on-bead protein quantitation using Lowry assay was intended. However, the 
citrate stabilized GNPs aggregated in the presence of Lowry reagent A (2.45 mL 4% 
Na2CO3 anhydrous in ddH2O, 2.45 mL 0.1 M NaOH, 0.1 mL 2% Na-K-tartrate in ddH2O 
and 0.05 mL CuSO4·5H2O in ddH2O). In an additional experiment was discovered that 
the CuSO4 has a considerable negative influence on the colloidal stability of the 
nanoparticles (Fig. S5). For this reason, the protein concentration of non-immobilized 
pepsin in the supernatant was finally determined and the immobilized protein calculated 
by mass balance. The total pepsin concentration in the reaction mixture was 1.2 mg/mL. 
Thus, a calibration function between 0.05 and 1.0 mg/mL pepsin in 20 mM MES buffer 
pH 4.5 (the reaction medium) was established (n=3) (Fig. S6). As can be seen, good 
linearity with a determination coefficient of R2 = 0.9947 was obtained. Precision of the 
Lowry assay was good with average RSD values of 7.3 % over the relevant concentration 
range. 
The mean pepsin content of three measured reaction mixtures in the supernatant after 
the immobilization by Lowry assay was determined to be 0.95 ± 0.11 mg/mL. 
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Accordingly, the surface coverage of GNPs with pepsin was 0.25 ± 0.03 mg ml-1 of 
pepsin-GNP conjugate solution.  
 
 
Fig. S6: Calibration function pepsin in 20 mM MES buffer pH 4.5 for Lowry assay. 
 
Recyclability of Pepsin@GNP 
CYC (1.2 mg mL-1 stock solution) was utilized as model protein to test the digestion 
efficiency of conjugated pepsin in the course of a re-usability study. For this purpose, 
0.2 mL of the protein sample was transferred to 0.8 mL of the nanoparticle suspension 
(Pepsin@GNP in 1 mL 20 mM sodium acetate pH 4.5). The digestion was performed at 
37 °C for 4 hours digestion time. 
The reaction with the nanoparticle incubation was stopped by adding 0.2 mL of 0.1 M 
NaOH to reach neutral pH value. Pepsin@GNP was separated from the sample by 
centrifugation (12,000 rpm for 10 minutes) resulting in a clear supernatant for UHPLC-
ESI-QTof-MS/MS analysis. 
Five aliquots of aforementioned CYC sample were digested using iteratively the same 
Pepsin@GNP bioconjugate which was recovered by spinning and washed before re-use. 
Two washing steps in between were performed with 20 mM sodium acetate pH 4.5 
(centrifugation at 12,000 rpm for 10 minutes). 
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Fig. S7: Recyclability testing. Score and sequence coverage of CYC sample digested by 
the same Pepsin@GNP material after its re-cycling and washing. 
 
As shown in Fig. S7 it was possible to identify CYC by Mascot search. The score value 
dropped in the first two cycles (from 242 to 110) but remained more or less constant 
thereafter (sore of around 50 in the 3rd to 5th re-use). Sequence coverage, on the other 
hand, remained essentially constant in the first three cycles of re-use (~70 %), dropped to 
51 % in the 4th cycle and to 26 in the 5th cycle of re-use. Thus, recyclability of 
Pepsin@GNP could be demonstrated by this experiment, but the digestion performance 
was starting to decrease after three cycles of re-use. 
 
Stability of the immobilized pepsin 
In this study digestion was performed with immobilized pepsin and pepsin in free solution. 
For the digestion protocol with free pepsin 0.2 mg ml-1 pepsin was used (0.25 mg mL-1 
final concentration in 1.2 mL total volume) and mixed with 0.8 mL pepsin in digestion 
buffer. The digestion was performed in 20 mM sodium acetate buffer pH 4.5 at 37 °C for 
4 hours digestion time and stopped by adding 0.2 mL of 0.1 M NaOH. The digestion with 
immobilized pepsin was performed as described in the previous subchapter. 
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99 µL aliquots of the CYC samples digested by Pepsin@GNP and pepsin in solution 
were taken and reacted with 1 µL trypsin (1 mg mL-1 stock solution in 20 mM Tris-HCl pH 
7.5) at 37 °C overnight, stopped by heat shock (95°C for 10 minutes) and analyzed by 
UHPLC-ESI-QTof-MS/MS. 
Protein identification was performed by Mascot search to identify (leached) pepsin. 
 
 
Fig. S8: Score and sequence coverage of the CYC samples digested by trypsin for the 
determination of (leached) pepsin. 
 
After the coupled digestion protocol of CYC (first digestion by Pepsin@GNP/pepsin in 
solution, second digestion by trypsin) it was possible to identify CYC by Mascot search 
for both samples (Fig. S8). After the tryptic digestion pepsin could also be identified for 
the sample with pepsin in solution but it was not possible to detect pepsin in the 
Pepsin@GNP sample. That means pepsin is immobilized on the gold nanoparticle and 
will not bleed off from the particles within the experiments and/or the washing procedure. 
 
Digestion of protein mix with GNP-conjugated pepsin 
Fig. S9a shows the TIC of a digest obtained from the protein mix (CYC, MYG, BSA) with 
pepsin-conjugated GNPs after 4h, and the 2D-plot in Fig. 9b reveals an overview of the 
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detected peptide precursor ions in dependence of the retention time. The numerous 
peptide peaks clearly confirm that the immobilized enzyme maintains its bioactivity. 
Exemplary an XIC of the peptide fragment VVSTQTALA, stemming from BSA, is shown 
in Fig. 9c and the +TOF MS-spectrum in Fig. 9d. Single and double charged peptide are 
found in the MS spectrum.  
The peak list from IDA scan was loaded into Mascot and database search performed with 
pepsin as enzyme (other parameters are specified in Experimental part of main 
document). A number of peptides were identified by Mascot from the peak list. From 
these signature peptides, the corresponding XICs were extracted for each protein and 
overlaid (Fig. S10) to document the success of digestion with the new heterogeneous 
nanobiocatalyst. Fig. S9 illustrates exemplarily the MS/MS spectrum of a characteristic 
peptide fragment of BSA. As can be seen there is good coverage of the sequence due to 
b-ions. 
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Fig. S9: Exemplary chromatogram of a peptide map obtained by digestion of the protein 
mix (CYC, MYG, BSA) with Pepsin@GNP conjugate and 4h digestion time (a), detected 
precursor ions in dependence of retention time (b), exemplary extracted ion 
chromatogram (XIC) of the peptide VVSTQTALA (c) and corresponding MS spectrum (d).   
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(a)
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Fig. S10: Overlay of XICs of specific peptides of (a) CYC, (b) MYG, and (c) BSA 
identified by Mascot search. Digestion with Pepsin@GNP for 4h. 
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Fig. S11: Model MS/MS spectrum of peptide VVSTQTALA. Determined b-/y-ions with 
PeakView of the peptide VVSTQTALA after digestion of the protein mix with 
Pepsin@GNP for 4 h (mass spectra shown in Fig. 8d of main document). Precursor (+1): 
889.4989 Da /(+2): 445.2531 Da. 
 
Peptide mapping for assessment of digestion performance and proteolytic 
specificity 
ExPasy Bioinformatics Resource Portal provides information on the proteolytic specificity 
of pepsin (http://web.expasy.org/peptide_cutter/peptidecutter_enzymes.html). It is stated 
that “Pepsin preferentially cleaves at Phe, Tyr, Trp and Leu in position P1 or P1'(Keil, 
1992). Negative effects on cleavage are excerted by Arg, Lys and His in position P3 and 
Arg in position P1. Pro has favourable effects when being located in position P4 and 
position P3, but unfavourable ones when found in positions P2 to P3'. Cleavage is more 
specific at pH 1.3. Then pepsin preferentially cleaves at Phe and Leu in position P1 with 
negligible cleavage for all other amino acids in this position. This specificity is lost at pH ≥ 
2“ 
  
 
Symbol
Res. 
Mass # (N) b b-17 b-18 y y-17 y-18 # (C)
V 99.06841 1 100.0757 83.04914 82.06513 889.4989 872.4724 871.4884 9
V 99.06841 2 199.1441 182.1176 181.1335 790.4305 773.404 772.4199 8
S 87.03203 3 286.1761 269.1496 268.1656 691.3621 674.3355 673.3515 7
T 101.0477 4 387.2238 370.1973 369.2132 604.3301 587.3035 586.3195 6
Q 128.0586 5 515.2824 498.2558 497.2718 503.2824 486.2558 485.2718 5
T 101.0477 6 616.3301 599.3035 598.3195 375.2238 358.1973 357.2132 4
A 71.03711 7 687.3672 670.3406 669.3566 274.1761 257.1496 256.1656 3
L 113.0841 8 800.4512 783.4247 782.4407 203.139 186.1125 185.1285 2
A 71.03711 9 871.4884 854.4618 853.4778 90.05496 73.02841 72.04439 1
(b)
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Table S2: Proteolytic specificities of pepsin according to PeptideCutter tool. 
Enzyme 
name 
P4 P3 P2 P1 P1' P2' 
Pepsin 
(pH1.3) 
- not H,K, or R not P not R F or L not P 
 - not H,K, or R not P F or L - not P 
Pepsin 
(pH>2) 
- not H,K or R not P not R F,L,W or Y not P 
 - not H,K or R not P F,L,W or Y - not P 
Table reprinted from PeptideCutter publicly available under ExPasy Bioinformatics Resource Portal 
“http://web.expasy.org/peptide_cutter/peptidecutter_enzymes.html” 
 
Fig. 7 of the main document showed already the peptide fragments generated by pepsin 
in free solution and the Pepsin@GNP conjugate for cytochrome C and myoglobin. Good 
sequence homology was observed when digestion in free solution and with 
heterogeneous nanobiocatalyst were compared. Corresponding results for BSA are 
illustrated in Fig. S10. The majority of peptide fragments generated by pepsin are found 
in digests of homogeneous and heterogeneous catalysis, while a few were only detected 
in one of the two approaches. Overall good homology can be found for this larger protein 
as well. 
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Fig. S12: Sequence of BSA with identified peptides found in digests with free pepsin in 
solution (solid arrows) and Pepsin@GNP (dashed arrows). Peptides were determined by 
Mascot search and compared with reference to the protein sequences. 
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Venn diagrams (Fig. S12) for identified peptides in protein mix (created with Venny 
2.1; http://bioinfogp.cnb.csic.es/tools/venny/index.html) 
In the control sample (0 hours) of the protein mixture (BSA, CYC and MYG) no peptides 
for BSA could be identified, neither for pepsin in solution nor for Pepsin@GNP. The 
number of identified peptides increase with increasing digestion times and were largely 
similar for homogeneous and heterogeneous catalysis. 
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Abstract 
Immobilized enzyme reactors based on nanoparticulate carriers are becoming 
increasingly popular. A toolbox of methods is usually utilized for their characterization in 
order to be capable of assessing their suitability for the intended purpose. In this work, as 
a model system pepsin was conjugated to gold nanoparticles (GNPs) by a 
straightforward adsorptive immobilization process. The success of the immobilization 
procedure was monitored by Vis spectroscopy via shifts of the localized surface plasmon 
resonance (LSPR) band, size characterization by dynamic light scattering (DLS), and ζ–
potential determinations by electrophoretic light scattering. DLS revealed a significantly 
different hydrodynamic diameter for unmodified GNPs and protein-coated GNPs. 
However, the hydrodynamic diameters of pepsin-coated GNPs obtained with various 
concentrations of pepsin in the coating solution were not significantly different. In 
contrast, Taylor dispersion analysis allowed measuring the slight differences in the 
hydrodynamic radius. It provided also information on the viscosity of GNP suspensions 
and diffusion coefficients for the various pepsin@GNP preparations. For the 
determination of the pepsin surface coverage on the GNPs results from indirect protein 
quantitation of non-immobilized pepsin by Lowry assay were compared to direct 
measurement of immobilized pepsin by resonant mass measurements. Reasonable 
agreement was found. Accurate information on enzyme coverage is of utmost importance 
for a representative comparison of the turnover numbers and catalytic efficiencies of 
nanoparticulate immobilized enzyme reactors, which is shown by the adsorptively 
immobilized pepsin@GNP as model system. 
 
 
 
Keywords 
Immobilized enzyme reactor, Taylor dispersion analysis, resonant mass measurement, 
nanoparticle, protein corona, heterogeneous biocatalyst 
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Introduction 
Immobilization of enzymes on nanostructured carriers is an emerging field in various 
industrial, biomedical and bioanalytical applications [1]. Such nanoparticulate immobilized 
enzyme reactors (nanoIMERs) promise important advantages as biocatalysts compared 
to free solution enzyme applications owing to their positive effect on enzyme stability, 
straightforward removal from the reaction product (e.g. by centrifugation in case of metal 
nanoparticles or magnetic separation in case of magnetic nanoparticles as carriers), and 
reusability. Also enhanced reaction rates have been reported for nanoparticle-based 
biocatalysts [2]. 
Size is one of the prime structural parameters of such nanobiocatalysts playing a decisive 
role for the functionality, bioactivity, and toxicity of these functional materials. Although a 
multitude of methods is available to measure nanoparticle size, it is still not a trivial task 
to provide accurate, representative values in many instances. Most common methods 
employed for nanoparticle sizing and size distribution analysis comprises microscopic 
techniques such as transmission electron microscopy (TEM), scanning electron 
microscopy (SEM) and atomic force microscopy (AFM) [3], scanning tunneling 
microscopy (STM) and scanning tunneling spectroscopy (STS) [4], dynamic light 
scattering (DLS) analysis [5, 6], nanoparticle tracking analysis (NTA) [7, 8], field flow 
fractionation [9-12], and differential mobility analysis (DMA) [13-18]. Depending on the 
method more or less deviating results may be obtained [19-21] which makes 
interpretation sometimes difficult. A particular problem is to have sufficient size resolution, 
in particular if the materials do not show unimodal distributions. Distinction between minor 
size variations is also challenging with many of those techniques and DMA appears to 
become one of the gold standards in this regard, however, has the disadvantage that it is 
a gas phase technique. 
Another challenge in the course of nanobiocatalyst characterization is accurate 
quantitation of the enzyme immobilized on the surface. Along this line, indirect 
photometric quantitation of unbound protein in the binding buffer by UV [22, 23] or use of 
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common protein quantitation assays, e.g. microbicinchonic acid protein assay for this 
purpose [24], are the most frequently utilized methods. Rarely direct methods have been 
proposed. Some few examples include the protein surface coverage determination by 
suspended microchannel resonator with which the amount of IgG coated on polystyrene 
beads (600 nm) has been measured [24]. Recently, targeted isotope dilution liquid 
chromatography-tandem mass spectrometry has been proposed for quantification of 
antibody coupled to magnetic nano- and microparticles involving on-bead tryptic digestion 
[25]. In another study, the average number of protein molecules bound to the surface of 
nanoparticles has been estimated by fluorescence correlation spectroscopy inferred from 
hydrodynamic radii [26, 27]. 
This report evaluates and compares some alternative techniques for size and surface 
coverage analysis of nanoparticulate IMERs. Pepsin adsorptively coated onto GNPs from 
incubation mixture with various pepsin concentrations thus yielding distinct thicknesses of 
the adsorbed layer has been employed as model system. Characterization of the 
resultant pepsin@GNP bioconjugates has been performed by Vis spectroscopy, DLS and 
ζ–potential measurements. Results of size determination by DLS of bioconjugates with 
different pepsin coating thicknesses are compared with the data from Taylor dispersion 
analysis. The potential of resonant mass measurement (RMM) as methodology for the 
direct analysis of the surface concentration of protein on the GNP is elucidated. Resultant 
data are compared with indirect surface coverage determination using the protein 
quantitation assay by Lowry of non-immobilized pepsin in the supernatant of the binding 
solution. The average number of immobilized pepsin was also estimated from the 
hydrodynamic radii measured by Tylor dispersion analysis using a previously reported 
model [26]. Finally, the bioactivity of the adsorptively bound pepsin@GNP is compared to 
free solution and covalently immobilized pepsin@GNP to rule out whether the adsorption 
process alters the bioactivity of the enzyme.  
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Materials and Methods 
 
Materials 
Pepsin (from hog stomach, E.C.3.4.23.1, 3651 U mg-1), gold (III) chloride trihydrate 
(HAuCl4·3H2O), cytochrome C, trisodium citrate, tris(hydroxymethyl)-aminomethane 
(Tris), ammonium acetate, MES, Na2CO3 anhydrous, Na-K-tartrate, CuSO4·5H2O, NaOH 
and Folin & Ciocalteu’s phenol reagent glycerol were obtained from Sigma-Aldrich. 
Ultrapure water was obtained by a PURELAB Ultra water purification system (ELGA 
LabWater, Ede, The Netherlands). 
 
Preparation of GNPs and adsorption of pepsin 
The preparation of GNPs was based on the reduction and simultaneous stabilization of 
gold (III) chloride trihydrate with trisodium citrate in accordance to the Turkevich-Frens 
method [28-31]. For the synthesis of 10 mL solution of GNPs, 5.05 mg HAuCl4 
(1.28 mmol in 11.25 mL double deionized water corresponding to a final concentration of 
1.14 mM) was used and heated up to the boiling point and kept under reflux under 
constant stirring. Afterwards 1.25 mL of 20.5 mM trisodium citrate solution (6.03 mg mL-1) 
was added (final concentration of 2.28 mM in a total volume of 11.25 mL) and heated for 
further 10 minutes, while the color turned red. The GNP solution was allowed to cool 
down and stirred at room temperature for another 60 minutes. The GNP solution was 
finally stored at + 4°C until usage. 
To obtain adsorptively bound pepsin, first 1 mL GNPs were centrifuged for 10 minutes at 
13,400 g. The supernatant was discarded. 1 mL Pepsin in 20 mM MES buffer pH 4.5 in 
different concentrations (0.0052, 0.052, 0.26, 0.52, 1.04, and 5.2 mg mL-1) was added to 
the centrifuged GNPs and stirred overnight at 4 °C. Afterwards the solution was 
centrifuged at 13,400 g and the pellet resuspended in 10 mM Tris buffer pH 7.5. This 
washing step was repeated twice. The supernatant of the first washing step was used for 
protein quantification by Lowry assay (see below; the protein concentration of the second 
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washing solution was below the detection limit) [30]. To disrupt aggregates the 
nanoparticles were treated in the ultrasonic bath for a few minutes. The resultant 
nanoparticles were washed twice and resuspended in double deionized water. They were 
then characterized by Vis spectroscopy, DLS and ζ-potential measurements. 
 
Characterization of nanoparticles 
The LSPR band was measured by Vis-spectroscopy before and after surface 
modification with pepsin acquiring spectra in the wavelength range between 350 and 
800 nm. All measurements were performed with a VWR UV-1600PC Spectrophotometer. 
The differently functionalized nanoparticles were further characterized by DLS and their 
ζ-potentials, derived from electrophoretic mobility of electrophoretic light scattering (ELS) 
measurements, before and after pepsin coating using a Zetasizer Nano ZS instrument 
(Malvern Instruments, Herrenberg, Germany). The Zetasizer was equipped with a He-Ne 
laser and detection was performed at 173° backscatter detection mode. Samples were 
diluted in double deionized water (1:5; v/v) and measured as triplicates. Each value was 
the mean of 15 sub-runs. 
A transmission electron microscopy (TEM) image of GNPs is shown in Supplemental 
Figure S1.  
 
Protein determination by Lowry Assay 
The amount of immobilized pepsin was determined by Lowry assay [32]. Briefly, the 
supernatant collected after the enzyme immobilization step was used for the 
quantification of non-immobilized pepsin. Applying the mass balance equation, the 
immobilized amount of enzyme could then be back calculated. A calibration function was 
set up with free pepsin in 20 mM MES buffer pH 4.5 in the range 0.05 to 1 mg mL-1. 
25 µL of the sample/standard/blank were mixed with 125 µL of Lowry A solution and 
reacted for 20 minutes. Afterwards 12.5 µL Folin & Ciocalteu’s phenol reagent (Lowry 
reagent B) was added and reacted for further 30 minutes before measurement. Lowry 
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reagent A was freshly prepared every day (2.45 mL 4% Na2CO3 anhydrous in ddH2O, 
2.45 mL 0.1 M NaOH, 0.1 mL 2% Na-K-tartrate in ddH2O and 0.05 mL CuSO4·5H2O in 
ddH2O). Folin & Ciocalteu’s phenol reagent was commercially available from Sigma-
Aldrich. 
For the photometric determinations, a Versa max microplate reader from Molecular 
Devices was used and the wavelength was set to 650 nm. All measurements were 
carried out at room temperature. 
 
Resonant mass measurements 
Resonant mass measurements (RMM) were performed with the Archimedes instrument 
(Malvern Instruments, Herrenberg, Germany). A sensor chip with a microchannel of the 
dimensions 8 x 8 µm2 was used for all experiments. It was initially mass calibrated with a 
polystyrene standard as specified by the instrument supplier. Afterwards, the sensor was 
rinsed with ultrapure water employing some sneezing steps to remove all particles from 
the microchannel. All the samples were diluted with ultrapure water (1:5; v/v) before each 
measurement. Then, the sample was loaded into the microchannel. The limit of detection 
was fixed to 0.030 Hz, which was well above the noise level and optimal for detection of 
the nanoparticles. The measurements were performed at ambient temperature and the 
number of measured particles was set to 2000 for the sake of adequate statistics. The 
buoyant mass of the particles was measured before and after coating of pepsin to the 
GNPs. For the calculation of the dry mass, a density of 19.320 g mL-1 was assumed for 
the GNPs and a density of 1 g mL-1 for the fluid. 
 
Taylor dispersion analysis 
Taylor dispersion analysis (TDA) was performed with the Viscosizer TD from Malvern 
Instruments (Herrenberg, Germany). The samples (40 nL) were injected into a looped 
fused silica capillary with 75 µm ID and 360 µm OD. The sample zone was transported in 
the capillary by applying a pressure of 140 mBar under a linear flow of ultrapure water 
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with a linear velocity of 2.4 mm/s. The capillary had a total length of 130 cm, and first and 
second window were located at a distance of 44 and 85 cm, respectively, from the inlet 
end. UV absorbance of the analyzed samples was recorded during their passage through 
the first and second detection window at 214 nm. All measurements were carried out at 
constant temperature of 20°C. 
The nanoparticle samples were concentrated by the factor of 10 for TDA. Thus, 1 mL of 
the nanoparticle sample was centrifuged at 13,400 g for ten minutes. 0.9 mL of the 
supernatant was discarded and the remaining 0.1 mL of the concentrated nanoparticle 
solution was used for analysis after re-suspension. 
 
Bioactivity test of adsorptively immobilized pepsin-conjugated GNPs 
Michaelis-Menten kinetics was studied for digestion of cytochrome C (CYC) with free 
pepsin in solution, adsorptively immobilzed pepsin@GNP and pepsin covalently bonded 
to GNPs via a bifunctional HS-PEG7-COOH spacer and amide coupling [33]. A 
concentration series of CYC was digested in 20 mM sodium acetate pH 4.5 for 
10 minutes at 37 °C. The digestion was stopped by adding 0.2 mL of 0.1 M NaOH to 
0.8 mL reaction mixture to achieve neutral pH. For the digestion with free pepsin, 100 µL 
enzyme solution (2.5 mg mL-1 stock solution, 0.25 mg mL-1 final concentration), 100 µL 
CYC solution in 600 µL of above buffer were used. For the approach with the immobilized 
pepsin 1 mL total volume of the nanoparticle solution was used and centrifuged at 
12,000 rpm for 10 minutes. The supernatant was removed and the nanoparticle pellet 
dissolved in reaction buffer as above. 100 µL CYC solution with different concentrations 
were added and digestion allowed to proceed as describe above. After stopping the 
digestion by adding 0.2 mL 0.1 M NaOH (total volume of the reaction mixture 1 mL) the 
nanoparticles were centrifuged and the supernatant was analyzed by LC-UV for 
quantification of undigested CYC. Michaelis-Menten parameters KM and Vmax were 
calculated according to Lineweaver-Burk diagrams [34].  
155 
 
Undigested CYC in the reaction mixture was quantified by HPLC analysis method using 
an Agilent 1100 series HPLC instrument with a binary gradient pump, vacuum degasser, 
autosampler, column oven and a variable wavelength detector. A monolithic poly(styrene-
co-divinylbenzene) ProswiftTM RP-1S (50 x 4.6 mm ID) from Dionex (Thermo Fisher 
Scientific) was employed as column. The mobile phase was composed of 50 mM 
ammonium formate pH 3.5 containing 5 % ACN in channel A and ACN + 5 % 50 mM 
ammonium formate pH 3.5 in channel B. The following gradient was programmed: 0-2 
minutes 20 % B, from 2 to 6 minutes linear gradient from 20 to 60 % B, 6.01-10 minutes 
20 % B (for test chromatogram see also Supplementary Material). The flow rate of the 
mobile phase was 1 mL/min and the column temperature was set to 40 °C. The injection 
volume was 5 µL and detection was performed at 280 nm. The method was validated in 
accordance to ICH guidelines. 
 
Results and Discussion 
Synthesis and characterization of pepsin-GNP bioconjugates 
The GNP carrier has been synthesized by the widely adopted Frens-Turkevich method 
[28, 29]. In this procedure, the HauCl4 is reduced by citrate which acts also as capping 
agent on the surface of the resultant GNPs giving them sufficient colloidal stability due to 
repulsive electrostatic interactions overcoming the strong van der Waals interactions 
between nanoparticles which drive aggregation. By adjusting a molar HauCl4-to-citrate 
ratio of 1:2 a GNP size of 30 nm has been targeted [20, 30, 35] (Supplemental Fig.S1). 
This larger particle diameter was found to be advantageous as compared to smaller sizes 
such as 10-20 nm for protein adsorption in a previous study due to higher protein 
coverage and bioactivity, respectively [30]. According to DLS measurements a 
hydrodynamic particle diameter of 44.1 ± 0.3 nm has resulted from the GNP synthesis 
and the ζ-potential of the citrate-capped GNPs was -34.1 ± 0.7 mV documenting that they 
are sufficiently stable colloids (Table 1). 
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Aliquots of this GNP batch have then been coated with pepsin using different 
concentrations in the reaction mixture covering a range between 5 µg/mL and 5 mg/mL. 
Pepsin is a gastric aspartic proteinase (mol. wt., 34,510 g mol-1) with a pI of about 3.2 
(Uniprot, Expasy). It needs acidic conditions for optimal bioactivity (pH between 1 and 2.5 
with activity up to 4.5) and is irreversibly denatured at pH > 8.5 [36, 37]. Adsorptive 
immobilization has been carried out at a pH close to the pI in order to minimize 
electrostatic repulsion between pepsin and the GNPs during the adsorption process 
which could compromise the immobilization efficiency. A recent paper has shown that 
pepsin has a ζ–potential of around 0 mV near pH 5 and therefore MES buffer pH 4.5 was 
deemed to be a good compromise in terms of mild conditions and attenuation of negative 
charge on GNPs [38]. 
The protein-coating success has been monitored by Vis spectroscopy, DLS and ELS 
(Figs. 1 and 2 as well as Table 1). Vis spectroscopy is a convenient, informative and 
straightforward method for a quick monitoring of the coating success of GNPs [20]. Such 
metallic NPs exhibit due to their plasmonic properties a LSPR band which can be excited 
in the Vis range and is highly sensitive to size, shape, interparticle distance (thus 
aggregation) as well as to changes in the refractive index of the proximate surrounding 
media (thus adsorption of e.g. proteins). It can therefore be used to monitor both 
adsorption of pepsin as well as aggregation of the resultant functionalized GNPs if the 
surface modification leads to unstable colloids. For the present non-modified citrate-
capped GNPs the LSPR band is observed at 525 nm. With increasing pepsin 
concentration in the incubation mixture, the LSPR band is slightly shifted to higher 
absorption maxima from 525 to 527 nm. The effect is significant but the shifts are 
relatively small. On the other hand, it can be seen that the pepsin-GNP bioconjugate 
prepared from the lowest pepsin concentration (5.2 µg mL-1) in the incubation mixture 
gets unstable and shows noticeable aggregation as can be derived from the additional 
absorption band (shoulder) at a wavelength of > 600 nm (Supplemental Fig. S1). 
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Next, ζ-potentials were determined at neutral pH for all particles. Although not active at 
pH 7, pepsin is sufficiently stable and does not irreversibly denature in the pH range of 6-
7 [36, 37]. At such pH, pepsin is above the pI and thus should generate a negative 
surface charge, like the citrate-capped GNPs. Indeed, probably due to this reason ζ‐
potentials are largely constants across all batches of (coated) GNPs (-32.5 ± 2.6 mV) 
(Fig. 2). This property is consequently not very informative in terms of effectiveness of 
pepsin immobilization. 
Thicker protein coatings are expected when the concentration of pepsin in the incubation 
mixture was elevated as indicated by the slight shift in LSPR band. DLS should be 
capable to display this effect as significant size increase. In fact, a significant increase of 
the hydrodynamic diameter of functionalized GNPs with adsorptively bound pepsin can 
be found in all pepsin-GNP bioconjugates as compared to non-modified citrate-capped 
GNPs (Fig. 2). A mean hydrodynamic diameter of 64 ± 2 nm was measured for the 
pepsin-coated GNPs regardless of the pepsin-concentration in the incubation mixture, 
except for the batch with 5 µg mL-1 pepsin (79.7 ± 5.7 nm) which represents an outlier 
(probably due to aggregation as indicated by the LSPR band). On the other hand, a 
diameter of only 44.1 ± 0.3 nm has been measured by DLS for the citrate-capped GNPs 
indicating pepsin-shell thicknesses of about 10 nm for the bioconjugates (Table 1). DLS 
was, however, not capable of resolving the size differences for the distinct pepsin-GNP 
bioconjugates batches prepared from distinct pepsin concentrations. Other methods for 
precise and accurate NP size classification are therefore required. 
 
Determination of surface coverage by Lowry assay and RMM 
The surface coverages of protein-modified solid carriers such as immobilized enzyme 
reactors are commonly determined indirectly by quantitation of non-immobilized protein in 
the supernatant of the reaction mixture. This procedure is also frequently adopted for 
protein immobilization of NPs [22, 24]. Micro-bicinchoninic acid (Micro-BCA) assay or 
Lowry assay are the most popular protein assays in NP bioconjugation reactions. Herein, 
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Lowry assay has been used and the protein concentration in the supernatant has been 
analyzed. Mass balance considerations have resulted in approximated values of 
immobilized pepsin (Table 1). Results from the Lowry assay suggest that indeed different 
pepsin coverages are present on the nanoparticles and hence some differences in the 
hydrodynamic diameters should be measurable. 
Besides this indirect method, a direct approach for the determination of adsorptively 
immobilized protein has been utilized as well. Resonant mass measurement has been 
recently proposed for such a purpose [24]. RMM uses micro-electromechanical systems 
(MEMS) technology with a sensor chip having a microfluidic channel (with a dimension of 
8×8 µm2) which harbors a resonant structure embedded inside. The nanoparticles are 
flushed through the microfluidic channel. When a particle passes the resonator a 
frequency shift (∆f) occurs which depends on the buoyant mass (MB) of that particle 
(eq.1) 
?  ∆ × *       (1) 
wherein S represents the microchannel resonator’s sensitivity (a parameter characteristic 
for the given chip which can be obtained by calibration). Thus, through initial mass 
calibration of the chip, RMM is able to detect and count particles as well as measure their 
mass and size. It has been reported that the resonant frequency of the sensor can be 
accurately measured [24]. Its mass limit of detection is in the sub-fg range (depending on 
the sample). From the buoyant mass the dry mass (M) can be calculated by eq. 2 if the 
particle is composed of a chemically homogenous material as in the case of unmodified 
GNPs. 
 	
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      (2) 
Wherein ρfluid and ρparticle are the densities of the transport fluid (here water) and the 
particle (here gold). Since we are interested in the surface coverage of pepsin on the 
GNPs, the drymass of protein coated on the GNP is the relevant figure. It has been 
calculated from the difference of buoyant masses after and before pepsin coating i.e. 
between the pepsin-coated GNPs and non-coated GNP (∆MB) in accordance to eq. 3 
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wherein M(pepsin coating) is the average mass of immobilized pepsin on a single GNP. The 
density of pepsin has been calculated to be ca. 1.42 g mL-1 from the exponential function 
reported by H. Fischer [39] (yielding negatively buoyant particles). 
If a sufficiently large number of particles is measured, a representative distribution of the 
buoyant masses of the citrate-capped and pepsin-coated GNPs can be obtained. Thus, 
RMM measurements have been performed with citrate-capped GNPs and pepsin-
conjugated GNPs obtained with 1 mg mL-1 pepsin in the incubation mixture (Fig. 3 and 
Supplemental Fig. S2). It becomes evident from Fig. 3 that a significant shift in buoyant 
mass can be observed upon coating of pepsin onto the GNP surface (Fig. 3). The 
measurements of the particle distributions by RMM were sufficiently repeatable as can be 
deduced from the overlap of the distribution curves of repetitive experiments (Fig. 
Supplemental Fig. S2). From Supplemental Fig. S2 it appears that there is a significant 
fraction of unmodified GNPs or GNPs with very low surface coverage of pepsin in the 
entire particle population. The determined dry mass of the pepsin coating is given in 
Table 1. According to eq. 3, 4.2 ± 0.2 fg pepsin per GNP are coated onto the surface 
according to RMM. This corresponds to 73,513 ± 3,327 pepsin molecules per GNP on 
average and is in the same order as determined by Lowry assay (Table 1). 
Hence, to conclude both Lowry assay and RMM document that pepsin has been 
successfully immobilized onto the GNPs by this simple adsorptive immobilization 
approach and Lowry assay indicates that there should be some differences in the 
hydrodynamic radius of the pepsin-coated GNPs prepared from distinct pepsin 
concentrations in the reaction mixture. 
 
Taylor dispersion analysis 
DLS, Lowry assay and RMM all indicated that pepsin is successfully coated onto GNPs. 
Unfortunately, DLS did not allow to accurately determine the size differences of the 
differently coated pepsin-GNP bioconjugates. Furthermore, hydrodynamic diameters 
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measured by DLS may be easily biased towards larger particles because the intensity of 
the scattered light is proportional to the sixth power of the radius, which makes the 
technique highly sensitive for larger particles and distorts particle distributions. Hence, 
Taylor dispersion analysis (TDA) was tested as alternative method.  
TDA became recently popular for the analysis of the hydrodynamic radius and the 
diffusion coefficient of biopharmaceuticals [40-42]. It has been shown that intra-assay 
and inter-assay variations were 1.2 % and 3.3 %, respectively, for a mouse IgG2a (100 
measurements) indicating its high precision and reliability for protein analysis [42]. In a 
few reports, TDA has also been used for the characterization of nanoparticles [43-48]. 
However, it was not considered before for measuring the protein coating thicknesses on 
GNPs. 
Due to the high precision and good accuracy shown in several publications (vide supra), 
TDA has therefore been applied to measure the hydrodynamic radius in dependence of 
different pepsin coating thicknesses and has been examined for its capability to resolve 
the size differences of those functionalized NPs. TDA using Viscosizer TD is suited for 
particles in the size range with a hydrodynamic radius (Rh) of 0.2 nm - 50 nm. It can also 
be utilized to determine the diffusion coefficients of molecules and nanoparticles. The 
method is based on the dispersion of a solute plug in a cylindrical tube under laminar 
Poiseuille flow driven by slight hydrodynamic pressure [40, 49, 50]). A sample plug is 
injected into the capillary and moved through the capillary by hydrodynamic pressure. A 
detector monitors the broadening of the sample zone by measuring the peak width at the 
two distinct positions of the capillary. The hydrodynamic radius (Rh) can then be derived 
from eq. 4 
( )
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ηπ
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      (4) 
wherein t1 and t2 are the peak center times at the first and second window, τ1 and τ2 are 
the corresponding standard deviations (band broadening), kB is the Boltzmann constant, 
T is the temperature, η is the viscosity, and r is the radius of the capillary. 
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Initially, the relative viscosity of the NP suspensions has been measured accurately with 
the Viscosizer TD based on the Poiseuille flow. The viscosity range which can be 
sufficiently accurately measured by the Viscosizer is between 0.9 cP and 50 cP 
(or mPa s). For this purpose, a rectangular sample plug (typically 6 µL) of citrate-capped 
GNPs has been pushed through the capillary and the absorbances have been monitored 
in the two windows (Supplemental Fig. S3). The edges of the sample plug are sharply 
detected at the two windows due to refractive index change, and the difference in times 
when the sample plug edges pass the windows can be readily determined (∆ts). The 
sample measurement is then referenced against the corresponding measurement for a 
solvent or buffer of known viscosity (e.g. water) (∆tr) enabling the calculation of the 
viscosity of the sample. This way, relative viscosities of 0.9771 (± 0.0055) cP have been 
determined for the citrate-capped GNP solutions (n=3). 
Next, the hydrodynamic radius and diffusion coefficient of pepsin has been measured, 
once under conditions as used for immobilization (pH 4.5; 20 mM sodium acetate) and 
once under optimal bioactivity pH (pH 1; 0.1 M HCl). It is striking that significantly broader 
peaks have been observed at pH 4.5 than pH 1 (Fig. 4a). Moreover, at pH 4.5 the UV 
trace reveals many spikes which indicate a tendency for aggregate formation of pepsin at 
this pH. Consequently, a hydrodynamic diameter as large as 4.4 ± 0.2 nm has been 
measured at pH 4.5 confirming protein aggregation. The corresponding diffusion 
coefficient has been calculated to be 48.8 ± 1.8 µm2 s-1. On the other hand, at pH 1 a 
nice peak shape can be seen without spikes in the UV trace. A hydrodynamic diameter of 
0.47 ± 0.03 nm has been determined and the corresponding diffusion coefficient has 
been calculated to be 459.1 ± 33.4 µm2 s-1. 
When the same experiment has been performed with citrate-capped GNPs, peaks 
corresponding to a bimodal distribution have been detected (Fig. 4b). A very sharp peak 
is sitting on top of a broad one which has been assigned as the peak corresponding to 
the GNPs. Since the GNPs have been stabilized by citrate, it has been argued that the 
superimposed sharp peak originates from citrate in the GNP suspension. Therefore, 
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citrate has been measured at 10 mg mL-1 and a hydrodynamic radius of 0.511 nm and a 
diffusion coefficient of 419.6 µm2 s-1 resulted. These values have been utilized to 
deconvolute the GNP peak with a bimodal distribution model [51]. As a result, a 
hydrodynamic radius of 17.8 ± 0.2 nm has been determined for citrate-capped GNPs and 
the diffusion coefficient corresponds to 12.1 ± 0.1 µm2 s-1. Similarly, the hydrodynamic 
radius of pepsin-coated GNPs has been analyzed and exemplary Taylorgrams are shown 
in Fig. 4c. The results are summarized in Table 1.  
It has been discussed that nanoparticles exposed to protein solutions build up a protein 
corona by monolayer formation in a stepwise manner [26]. When nanoparticles are 
exposed to protein solutions of varying concentrations, the protein nanoparticle 
interactions follows a typical sigmoidal binding behavior and the resultant average 
hydrodynamic radius Rh increases with the protein concentration in solution until the 
surface reaches saturation. This dependency of the hydrodynamic radius Rh(N) on the 
average number of protein molecules bound to the nanoparticle (N) can be described by 
eq. 5 [26, 27] 
( )3 1)0()( NcRNR hh ⋅+⋅=      (5) 
wherein Rh(0) is the hydrodynamic radius when no protein is bound and c is a scaling 
factor defining the volume ratio of protein to unmodified nanoparticle (c = VP/V0). The 
volumes of protein and nanoparticle can be calculated by Vi = (4π/3)(Rh(i))3 taking for 
Rh(i) the values measured for protein and unmodified nanoparticle by TDA.  
Looking at the TDA results it turns out that the NP radius Rh indeed slightly increases 
with pepsin concentration in the binding solution (Table 1). The outlier for the lowest 
pepsin concentration (5.2 µg mL-1) could be caused by particle aggregation as already 
indicated by LSPR (vide supra). Also, with the next two lowest pepsin concentrations 
(0.052 and 0.26 mg mL-1 pepsin in the reaction mixture, respectively) the particle radius 
did not grow significantly as compared to the citrate-capped GNPs. At higher pepsin 
concentrations, yet, a clear trend of larger radius can be seen (Fig. 5). In sharp contrast, 
DLS had problems to resolve these slight changes in hydrodynamic diameters, while the 
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Viscosizer can depict such small differences in the particle diameter and could be a 
valuable complementary technique for nanoparticle sizing. A pepsin shell thickness of ca. 
6-7 nm can be calculated for the pepsin-coated GNPs prepared from 5 mg mL-1 in the 
binding solution which is in reasonable agreement with DLS measurements (ca. 10 nm; 
vide supra). The effective dissociation constant derived from the binding isotherm is 
30.7 ± 4.1 µM. It shows that pepsin binds to the negatively charged citrate-capped GNPs 
with micromolar affinity. Using equation 4, the average number of bound pepsin 
molecules per GNP can be estimated (Table 1). It can be seen that for the pepsin-coated 
GNPs obtained from 1 mg mL-1 pepsin concentration in the binding buffer the determined 
values agree fairly well, i.e. they are in the same order of magnitude. On the other hand, 
Lowry assay seems to overestimate the pepsin coverage when close to saturation is 
achieved (5 mg mL-1) and possibly underestimates the coverage at low pepsin 
concentrations in binding buffer. 
 
Bioactivity 
Reactivity of immobilized enzymes may be compromised by several factors: i) linker and 
solid supporting particle, respectively, may hinder the access of the substrate to the 
active site, ii) they may influence the dynamic behavior of the enzyme (dynamic fit upon 
substrate binding), iii) enzyme adsorption may lead to conformational changes and thus 
alteration of activities [5, 23]. Hence, as a last question to be addressed the bioactivity of 
the present adsorptively immobilized pepsin-GNP bioconjugates have been evaluated in 
comparison to free pepsin and pepsin immobilized covalently on GNPs via a PEG spacer 
and amide coupling [33]. Cytochrome C has been employed as model substrate and the 
characteristic kinetic parameters in accordance to Michaelis-Menten formalism have 
been determined from the decrease in remaining substrate concentration after digestion 
(Table 2).  
It can be seen from Table 2 that KM is in the same order of magnitude for all three types 
of biocatalysts, i.e. free, covalently bound and adsorptively immobilized pepsin. In fact, 
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KM is slightly lower for the nanoparticulate biocatalysts as compared to pepsin in free 
solution, yet it is not significantly different between adsorptively bound and covalently 
linked pepsin@GNPs. It documents that access to the active site is not blocked by the 
nanoparticulate carrier. The adsorptively immobilized pepsin is also competitive what the 
maximal velocity is concerned. In fact, it was slightly larger than for the other two varieties 
of biocatalysts. The turnover number kcat is slightly higher for free pepsin. On the other 
hand, there is no significant difference between adsorptively bound pepsin and pepsin 
anchored via a long spacer, which has been deemed to guarantee access of substrate 
and dynamic flexibility of the biocatalyst. In terms of catalytic efficiency (kcat/KM), the three 
biocatalytic systems are largely equivalent. 
The data clearly document that the adsorptively bound pepsin is not much compromised 
in its catalytic activity due to the adsorption process and rules out significant steric 
hindrance of the active site as well as conformational protein alterations as negative 
influences on bioactivity. Thus, adsorptive pepsin immobilization appears to be a viable 
route to nanobiocatalytic materials. One has to assure, though, that the employed 
reaction conditions do not lead to desorption of the pepsin during reaction; low ionic 
strength in the incubation solution is therefore a requirement. Otherwise, the 
advantageous properties of the adsorptively bound nanobiocatalyst over free enzyme 
would be lost. Consequently, in terms of stability the covalently immobilized 
pepsin@GNP bioconjugate has certainly considerable advantages. 
 
Conclusions 
Immobilized enzyme reactors have become popular in many fields including analytical 
sample preparation. Enhanced enzyme stability and ease of removal from the reaction 
product are the most striking arguments to use such materials instead of free enzyme. 
For certain applications adsorptively bound enzymes on nanoparticles may be a viable 
route to produce such heterogeneous catalysts and may be attractive due to the 
simplicity of their preparation. Herein, we presented a set of tools for the characterization 
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of enzyme-nanoparticle conjugates. Vis spectroscopy, DLS, and ELS are well established 
methodologies to monitor the synthesis and enzyme coating success as well as colloidal 
stability. For the accurate size determination, DLS has the shortcoming of a bias in the 
NP size distributions towards larger particles as they are more sensitively detected. The 
slight changes due to different surface coverages of enzyme are difficult to detect. Taylor 
dispersion analysis with Viscosizer TD on the other hand can provide useful information 
even on the slight differences in hydrodynamic radius as consequence of different pepsin 
coating thicknesses. Resonant mass measurement with Archimedes is a valuable option 
to directly measure buoyant and dry masses of single particles in the fg range. Herein, 
we have determined the number of immobilized pepsin molecules which have been in 
rough agreement with indirect methods such as Lowry assay for protein quantification of 
non-immobilized enzyme in the supernatant and back calculation by mass balance 
considerations. Accurate measurement of the surface-bound enzyme on nanoparticulate 
IMERs is of importance for the determination of their turnover number and catalytic 
efficiency, and thus represents a basic requirement for unbiased comparison with free 
enzyme reactions. 
 
Acknowledgements 
We are grateful to Prof. Rolf Daniels for providing access to the Zetasizer Nano 
instrument for DLS and ζ-potential measurements. 
 
  
166 
 
References 
[1] M. Misson, H. Zhang, B. Jin, Nanobiocatalyst advancements and bioprocessing applications, Journal of 
The Royal Society Interface, 12 (2015). 
[2] B.J. Johnson, W. Russ Algar, A.P. Malanoski, M.G. Ancona, I.L. Medintz, Understanding enzymatic 
acceleration at nanoparticle interfaces: Approaches and challenges, Nano Today, 9 (2014) 102-131. 
[3] C. Kranz, B. Mizaikoff, Chapter 6 - Microscopic Techniques for the Characterization of Gold 
Nanoparticles, in: V. Miguel, I.L.-L. Ángela (Eds.) Comprehensive Analytical Chemistry, Elsevier 2014, pp. 
257-299. 
[4] S. Kano, T. Tada, Y. Majima, Nanoparticle characterization based on STM and STS, Chem. Soc. Rev., 44 
(2015) 970-987. 
[5] D.-H. Tsai, F.W. DelRio, A.M. Keene, K.M. Tyner, R.I. MacCuspie, T.J. Cho, M.R. Zachariah, V.A. 
Hackley, Adsorption and Conformation of Serum Albumin Protein on Gold Nanoparticles Investigated Using 
Dimensional Measurements and in Situ Spectroscopic Methods, Langmuir, 27 (2011) 2464-2477. 
[6] V.A. Hackley, J.D. Clogston, Measuring the Hydrodynamic Size of Nanoparticles in Aqueous Media Using 
Batch-Mode Dynamic Light Scattering, in: S.E. McNeil (Ed.) Characterization of Nanoparticles Intended for 
Drug Delivery, Humana Press, Totowa, NJ, 2011, pp. 35-52. 
[7] M. Wright, Nanoparticle Tracking Analysis for the Multiparameter Characterization and Counting of 
Nanoparticle Suspensions, in: M. Soloviev (Ed.) Nanoparticles in Biology and Medicine: Methods and 
Protocols, Humana Press, Totowa, NJ, 2012, pp. 511-524. 
[8] N.C. Bell, C. Minelli, A.G. Shard, Quantitation of IgG protein adsorption to gold nanoparticles using 
particle size measurement, Anal. Meth., 5 (2013) 4591-4601. 
[9] A. Zattoni, B. Roda, F. Borghi, V. Marassi, P. Reschiglian, Flow field-flow fractionation for the analysis of 
nanoparticles used in drug delivery, J. Pharm. Biomed. Anal., 87 (2014) 53-61. 
[10] J. Gigault, T.M. Nguyen, J.M. Pettibone, V.A. Hackley, Accurate determination of the size distribution for 
polydisperse, cationic metallic nanomaterials by asymmetric-flow field flow fractionation, J. Nanopart. Res., 
16 (2014) 2735. 
[11] S.T. Kim, Y.-J. Lee, Y.-S. Hwang, S. Lee, Study on aggregation behavior of Cytochrome C–conjugated 
silver nanoparticles using asymmetrical flow field-flow fractionation, Talanta, 132 (2015) 939-944. 
[12] A.-R. Jochem, G.N. Ankah, L.-A. Meyer, S. Elsenberg, C. Johann, T. Kraus, Colloidal Mechanisms of 
Gold Nanoparticle Loss in Asymmetric Flow Field-Flow Fractionation, Anal. Chem., 88 (2016) 10065-10073. 
[13] G. Allmaier, C. Laschober, W.W. Szymanski, Nano ES GEMMA and PDMA, new tools for the analysis of 
nanobioparticles—Protein complexes, lipoparticles, and viruses, J. Am. Soc. Mass Spectrom., 19 (2008) 
1062-1068. 
167 
 
[14] S. Guha, M. Li, M.J. Tarlov, M.R. Zachariah, Electrospray–differential mobility analysis of 
bionanoparticles, Trends Biotechnol., 30 (2012) 291-300. 
[15] P.T. Nilsson, A.C. Eriksson, L. Ludvigsson, M.E. Messing, E.Z. Nordin, A. Gudmundsson, B.O. Meuller, 
K. Deppert, E.C. Fortner, T.B. Onasch, J.H. Pagels, In-situ characterization of metal nanoparticles and their 
organic coatings using laser-vaporization aerosol mass spectrometry, Nano Res., 8 (2015) 3780-3795. 
[16] J. Parshintsev, J. Ruiz-Jimenez, T. Petäjä, K. Hartonen, M. Kulmala, M.-L. Riekkola, Comparison of 
quartz and Teflon filters for simultaneous collection of size-separated ultrafine aerosol particles and gas-
phase zero samples, Anal. Bioanal. Chem., 400 (2011) 3527-3535. 
[17] V.U. Weiss, L. Kerul, P. Kallinger, W.W. Szymanski, M. Marchetti-Deschmann, G. Allmaier, Liquid phase 
separation of proteins based on electrophoretic effects in an electrospray setup during sample introduction 
into a gas-phase electrophoretic mobility molecular analyzer (CE–GEMMA/CE–ES–DMA), Anal. Chim. Acta, 
841 (2014) 91-98. 
[18] V.U. Weiss, C. Urey, A. Gondikas, M. Golesne, G. Friedbacher, F. von der Kammer, T. Hofmann, R. 
Andersson, G. Marko-Varga, M. Marchetti-Deschmann, G. Allmaier, Nano electrospray gas-phase 
electrophoretic mobility molecular analysis (nES GEMMA) of liposomes: applicability of the technique for 
nano vesicle batch control, Analyst, 141 (2016) 6042-6050. 
[19] N.C. Bell, C. Minelli, J. Tompkins, M.M. Stevens, A.G. Shard, Emerging Techniques for Submicrometer 
Particle Sizing Applied to Stöber Silica, Langmuir, 28 (2012) 10860-10872. 
[20] H. Hinterwirth, S.K. Wiedmer, M. Moilanen, A. Lehner, G. Allmaier, T. Waitz, W. Lindner, M. 
Lämmerhofer, Comparative method evaluation for size and size-distribution analysis of gold nanoparticles, J. 
Sep. Sci., 36 (2013) 2952-2961. 
[21] A. Dudkiewicz, S. Wagner, A. Lehner, Q. Chaudhry, S. Pietravalle, K. Tiede, A.B.A. Boxall, G. Allmaier, 
D. Tiede, R. Grombe, F. von der Kammer, T. Hofmann, K. Molhave, A uniform measurement expression for 
cross method comparison of nanoparticle aggregate size distributions, Analyst, 140 (2015) 5257-5267. 
[22] J.E. Gagner, M.D. Lopez, J.S. Dordick, R.W. Siegel, Effect of gold nanoparticle morphology on adsorbed 
protein structure and function, Biomaterials, 32 (2011) 7241-7252. 
[23] P. Satzer, F. Svec, G. Sekot, A. Jungbauer, Protein adsorption onto nanoparticles induces 
conformational changes: Particle size dependency, kinetics, and mechanisms, Eng. Life Sci., 16 (2016) 238-
246. 
[24] M. Reza Nejadnik, W. Jiskoot, Measurement of the Average Mass of Proteins Adsorbed to a 
Nanoparticle by Using a Suspended Microchannel Resonator, J. Pharm. Sci., 104 (2015) 698-704. 
[25] N.A. Schneck, K.W. Phinney, S.B. Lee, M.S. Lowenthal, Quantification of antibody coupled to magnetic 
particles by targeted mass spectrometry, Anal. Bioanal. Chem., 408 (2016) 8325-8332. 
168 
 
[26] C. Röcker, M. Pötzl, F. Zhang, W.J. Parak, G.U. Nienhaus, A quantitative fluorescence study of protein 
monolayer formation on colloidal nanoparticles, Nat Nano, 4 (2009) 577-580. 
[27] M. Mahmoudi, A.M. Abdelmonem, S. Behzadi, J.H. Clement, S. Dutz, M.R. Ejtehadi, R. Hartmann, K. 
Kantner, U. Linne, P. Maffre, S. Metzler, M.K. Moghadam, C. Pfeiffer, M. Rezaei, P. Ruiz-Lozano, V. 
Serpooshan, M.A. Shokrgozar, G.U. Nienhaus, W.J. Parak, Temperature: The “Ignored” Factor at the 
NanoBio Interface, ACS Nano, 7 (2013) 6555-6562. 
[28] J. Turkevich, P.C. Stevenson, J. Hillier, The nucleation and growth processes in the synthesis of colloidal 
gold, Discuss. Faraday Soc., No. 11 (1951) 55-75. 
[29] G. Frens, Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions, 
Nature ., Phys. Sci., 241 (1973) 20-22. 
[30] H. Hinterwirth, W. Lindner, M. Laemmerhofer, Bioconjugation of trypsin onto gold nanoparticles: Effect of 
surface chemistry on bioactivity, Anal. Chim. Acta, 733 (2012) 90-97. 
[31] E. Haller, W. Lindner, M. Laemmerhofer, Gold nanoparticle-antibody conjugates for specific extraction 
and subsequent analysis by liquid chromatography-tandem mass spectrometry of malondialdehyde-modified 
low density lipoprotein as biomarker for cardiovascular risk, Anal. Chim. Acta, 857 (2015) 53-63. 
[32] O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, Protein measurement with the Folin phenol 
reagent, J. Biol. Chem., 193 (1951) 265-275. 
[33] M. Höldrich, A. Sievers-Engler, M. Lämmerhofer, Gold nanoparticle-conjugated pepsin for efficient 
solution-like heterogeneous biocatalysis in analytical sample preparation protocols, Anal. Bioanal. Chem., 
408 (2016) 5415-5427. 
[34] H. Lineweaver, D. Burk, Determination of enzyme dissociation constants, J. Am. Chem. Soc., 56 (1934) 
658-666. 
[35] H. Hinterwirth, S. Kappel, T. Waitz, T. Prohaska, W. Lindner, M. Lämmerhofer, Quantifying Thiol Ligand 
Density of Self-Assembled Monolayers on Gold Nanoparticles by Inductively Coupled Plasma–Mass 
Spectrometry, ACS Nano, 7 (2013) 1129-1136. 
[36] T.G. Rajagopalan, S. Moore, W.H. Stein, Pepsin from Pepsinogen: PREPARATION AND PROPERTIES, 
J. Biol. Chem., 241 (1966) 4940-4950. 
[37] A.P. Ryle, The Porcine Pepsins and Pepsinogens,  Methods Enzymol.1970, pp. 316-336. 
[38] I. Dewald, O. Isakin, J. Schubert, T. Kraus, M. Chanana, Protein Identity and Environmental Parameters 
Determine the Final Physicochemical Properties of Protein-Coated Metal Nanoparticles, J. Phys. Chem. C, 
119  25482-25492. 
[39] H. Fischer, I. Polikarpov, A.F. Craievich, Average protein density is a molecular-weight-dependent 
function, Protein Sci., 13 (2004) 2825-2828. 
169 
 
[40] A. Hawe, W.L. Hulse, W. Jiskoot, R.T. Forbes, Taylor Dispersion Analysis Compared to Dynamic Light 
Scattering for the Size Analysis of Therapeutic Peptides and Proteins and Their Aggregates, Pharmaceut. 
Res., 28 (2011) 2302-2310. 
[41] A. Hawe, S. Zölls, A. Freitag, J.F. Carpenter, S.A. Berkowitz, Chapter 10 - Subvisible and Visible Particle 
Analysis in Biopharmaceutical Research and Development A2 - Houde, Damian J,  Biophysical 
Characterization of Proteins in Developing Biopharmaceuticals, Elsevier, Amsterdam, 2015, pp. 261-286. 
[42] A. Lavoisier, J.-M. Schlaeppi, Early developability screen of therapeutic antibody candidates using Taylor 
dispersion analysis and UV area imaging detection, mAbs, 7 (2015) 77-83. 
[43] F. d’Orlyé, A. Varenne, P. Gareil, Determination of nanoparticle diffusion coefficients by Taylor 
dispersion analysis using a capillary electrophoresis instrument, J. Chromatogr. A, 1204 (2008) 226-232. 
[44] L. Cipelletti, J.-P. Biron, M. Martin, H. Cottet, Polydispersity Analysis of Taylor Dispersion Data: The 
Cumulant Method, Anal. Chem., 86 (2014) 6471-6478. 
[45] U. Pyell, A.H. Jalil, C. Pfeiffer, B. Pelaz, W.J. Parak, Characterization of gold nanoparticles with different 
hydrophilic coatings via capillary electrophoresis and Taylor dispersion analysis. Part I: Determination of the 
zeta potential employing a modified analytic approximation, J.Colloid Interf. Sci., 450 (2015) 288-300. 
[46] U. Pyell, A.H. Jalil, D.A. Urban, C. Pfeiffer, B. Pelaz, W.J. Parak, Characterization of hydrophilic coated 
gold nanoparticles via capillary electrophoresis and Taylor dispersion analysis. Part II: Determination of the 
hydrodynamic radius distribution – Comparison with asymmetric flow field-flow fractionation, J. Colloid Interf. 
Sci., 457 (2015) 131-140. 
[47] L. Cipelletti, J.-P. Biron, M. Martin, H. Cottet, Measuring Arbitrary Diffusion Coefficient Distributions of 
Nano-Objects by Taylor Dispersion Analysis, Anal. Chem., 87 (2015) 8489-8496. 
[48] F. Oukacine, A. Morel, I. Desvignes, H. Cottet, Size-based characterization of nanoparticle mixtures by 
the inline coupling of capillary electrophoresis to Taylor dispersion analysis, J. Chromatogr. A, 1426 (2015) 
220-225. 
[49] G. Taylor, Dispersion of Soluble Matter in Solvent Flowing Slowly through a Tube, P. Roy. Soc. Lond.A. 
Mat., 219 (1953) 186-203. 
[50] R. Aris, On the Dispersion of a Solute in a Fluid Flowing through a Tube, P. Roy. Soc. Lond. A Mat., 235 
(1956) 67-77. 
[51] H. Cottet, J.-P. Biron, M. Martin, Taylor Dispersion Analysis of Mixtures, Anal. Chem., 79 (2007) 9066-
9073. 
 
  
170 
 
Tables: 
 
 
Table 1 Characteristics of functionalized nanoparticles (n=3). 
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Table 2 Comparison of kinetic data for digestion of cytochrome C as model protein by 
adsorptively bound pepsin@GNP, covalently-linked pepsin@GNP, and free pepsin. 
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Figures and Figure Captions: 
 
 
Fig. 1 Vis spectra of citrate capped GNPs and pepsin-conjugated GNPs. 
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Fig. 2 Hydrodynamic diameters (nm) as determined by DLS and ζ–potentials (mV) as 
measured by ELS of citrate-capped GNPs as well as pepsin-coated GNPs. 
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Fig. 3 Histograms of buoyant mass measurement by RMM of citrate-capped GNPs and 
pepsin-coated GNPs (obtained from 1.04 mg mL-1 pepsin in reaction mixture). Samples 
were diluted 1:5 (v/v) with ultrapure water before measurement. 
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Fig. 4 Taylorgrams as measured for (a) pepsin at two distinct pH values, (b) citrate and 
citrate-capped GNPs, and (c) pepsin-coated GNPs prepared from 5 µg mL-1 in binding 
buffer (comparison with 5 mg mL-1 in binding buffer can be found in supplemental 
Fig. S4). 
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Fig. 5 Hydrodynamic radius in dependence on pepsin-concentration in binding buffer as 
measured by Taylor dispersion analysis with Viscosizer TD. 
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Supplementary Material 
 
Characterization of nanoparticles 
Transmission electron microscopy (TEM) images were acquired by Philips CM200 
(acceleration voltage 200 kV, equipped with a CompuStage goniometer, a CCD Camera 
System (Gatan Orius SC600) and a carbon free vacuum system. For this purpose, GNPs 
were deposited on standard support films of amorphous carbon spanning Cu grids. The 
grids were immersed in the GNP suspension and withdrawn. The solution was 
evaporated leaving back a high number density of GNPs (typically >100 GNPs per µm2). 
The Cu grids were the transferred to the microscope using a single tilt holder. 
 
 
Figure S1: TEM image of citrate-stabilized GNPs (average particle size dTEM ∼30 nm, 
dDLS ∼ 40 nm). 
 
178 
 
 
Figure S2 Mass shift of buoyant mass measurement by RMM of citrate-capped GNPs 
and pepsin-coated GNPs (obtained from 1.04 mg mL-1 pepsin in reaction mixture). 
Samples were diluted 1:5 (v/v) with ultrapure water before measurement. 
 
 
Figure S3 Viscosity measurement of citrate-stabilized GNPs with Viscosizer TD from 
straylight corrected signal shifts in window 1 and 2 as well as reference to a sample with 
known viscosity.  
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Figure S4 Exemplary Taylorgrams of pepsin-coated GNPs prepared from (a) 5 µg mL-1 
and (b) 5 mg mL-1 in binding buffer). 
 
180 
 
 
Figure S5 Exemplary test chromatogram of cytochrome C digestion. 
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Abstract 
Surface-modified gold nanoparticles (GNPs) were synthesized via layer-by-layer process 
with alternating cationic polyallylamine and anionic poly(acrylic acid) polyelectrolyte 
layers leading to a highly hydrophilic biocompatible shell supporting colloidal stability. 
Afterwards, papain was covalently immobilized on the modified GNPs via amide coupling 
between the amino groups on papain and the terminal carboxylic groups of the modified 
GNPs by using N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide and N-
hydroxysulfosuccinimide sodium as coupling agents. The resultant papain-functionalized 
gold nanoparticles were characterized by surface plasmon resonance, dynamic light 
scattering and zeta potential measurements. The new technology resonant mass 
measurement was applied for determining the average number of papain molecules 
immobilized per GNP by measurement of the single nanoparticle buoyant mass in the 
range of femtograms. The activity of the immobilized enzyme was estimated by 
determination of the kinetic parameters (Km, Vmax and kcat) with the standard chromogenic 
substrate Nα-benzoyl-DL-arginine-4-nitroanilide hydrochloride. It was found that Km of 
immobilized and free enzyme are in the same order of magnitude. On contrary, turnover 
numbers kcat were significantly higher for GNP-conjugated papain. Further, the gold 
nanobiocatalyst was applied for digestion of polyclonal human immunoglobulin G to yield 
protein fragments. The resultant fragment mixture was further analyzed by high-
performance liquid chromatography-microelectrospray ionization-quadrupole-time-of-
flight mass spectrometry, which demonstrated the applicability of the bioreactor based on 
papain functionalized GNPs. The immobilized papain not only has higher catalytic activity 
and better stability, but also can be easily isolated from the reaction medium by 
straightforward centrifugation steps for reuse. 
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Introduction 
Enzymes with a number of excellent properties (high activity, selectivity and specificity) 
are extensively used to catalyze a wide range of commercially important processes [1]. 
However, some limitations exist for the applications of enzymes, such as low stability and 
high sensitivity to the employed conditions. Therefore, immobilization techniques of 
enzymes (leading to immobilized enzyme reactors, IMERs) emerged as a powerful 
strategy to overcome some of these limitations [2-9, 10 ]. They received particular 
interest due to some advanced properties such as high catalytic efficiency, improved 
stability, elimination of self-digestion, flexible control of the reaction, easy removal after 
reaction, no contamination of the product with enzyme and repetitive usage [4, 11-14]. 
Enzymes immobilized on nanomaterials possess considerable prospect in various fields, 
because the catalytic properties of enzymes can be flexibly combined with the unique 
features of nanomaterial structures [12, 15-19].  
Silica nanoparticles [20], polystyrene [4] and magnetic nanoparticles [21] have been 
frequently utilized for the enzyme immobilization by covalent binding, entrapment, 
adsorption, ionic binding, affinity binding and so on [22-24]. A growing number of studies 
suggested that immobilizing enzyme on nanomaterials can enhance reaction rates while 
improving enzyme stability [25-28]. Amongst the nanomaterials, gold nanoparticles 
(GNPs) have received great attention in biology, biochemistry and biomedical research 
areas due to controlled geometrical, excellent optical and flexible surface chemical 
properties [29]. GNPs can be synthesized in a straightforward and low-cost method by 
reduction of gold(III) chloride. Due to the chemical inertness of gold they possess 
excellent chemical stability and due to charged capping groups on their surface also a 
high colloidal stability. They can be easily further functionalized with appropriate organic 
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or biological ligands which form the basis for their extremely broad applications. Like for 
other metal nanoparticles, a surface plasmon resonance (SPR) band can be observed in 
the visible spectrum which is the result of the collective oscillation of electrons in the 
conduction band of gold nanoparticles in resonance with a specific wavelength of incident 
light [30]. For gold nanoparticles it results in a strong absorbance band in the visible 
region (around 525 nm). The exact wavelength maximum as well as width of the 
absorption band depends on the nanoparticle size and shape, size distribution, and 
morphological uniformity of GNPs [31, 32]. SPR measurement is therefore a 
straightforward and useful tool to characterize GNPs and monitor the success of surface 
modification as well as to evaluate the aggregation status of GNP suspensions. If a 
second peak can be observed in the red-shifted region of the UV-VIS spectrum, it implies 
that aggregation of GNPs occurred. The large surface-to-volume ratio of GNPs provides 
considerable promise for the bioconjugation with various receptor molecules (e.g. 
proteins, DNAs, aptamers, antibodies, or lectins) [33]. The bioconjugation chemistries 
used for the immobilization are generally derived from the protein labeling chemistries by 
using various commercial crosslinkers based on maleimides, succinimidyl esters and so 
on. In addition, carboxylic and amino groups of proteins are widely used as the reactive 
sites for conjugation through amide bond formation [34]. 
Papain, a cysteine protease with broad specificity present in the latex of Carica papaya, 
catalyzes the hydrolysis of peptide, ester and amide bonds. Therefore, it is extensively 
employed in food, pharmaceutical, biology and biomedical researches [35-40]. In recent 
years, preparing Fab fragments with papain via specific digestion above the hinge region 
(the site of the disulfide bonds which connect the two heavy chains) of the whole antibody 
attracted some attention. The Fab fragment is a monovalent antibody structure harboring 
the CDR (complementarity-determining region) without Fc portion. It can still specifically 
recognize and bind to antigens. In biopharmaceuticals research and quality control, Fab 
fragments are prepared to characterize the protein on an intermediate level instead of the 
whole intact immunoglobulin (middle up and middle down). Middle-up refers to the 
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analysis of an antibody after its cleavage into large fragments, e.g. by reduction or limited 
proteolytic cleavage. Proteins of such smaller size are easier to analyze than larger 
proteins like intact antibody and can be detected with better sensitivity. Middle-down 
refers to the mass measurement of the gas phase fragmentation of antibody fragments, 
in analogy to the mass measurement of the gas phase fragmentation of intact protein in 
top-down analysis [41]. An antibody digested by papain generates two Fab fragments 
(about 50 kDa) and one Fc fragment (also about 50 kDa). Pure Fab fragment can be 
obtained after purification of digests by affinity chromatography (with protein A to remove 
the Fc part), ion exchange, and size exclusion chromatography [39, 40]. 
The main goal of this study was to prepare stable immobilized papain on GNPs for use in 
sample preparation protocols of antibody analytics. For this purpose, it is necessary that 
the obtained immobilized papain nanobiocatalyst has sufficient colloidal stability and 
satisfactory bioactivity to yield useful Fab fragments for analytical characterization by 
mass spectrometry via enzyme digestion. In this research, surface-modified GNPs with 
highly hydrophilic and biocompatible shell were first prepared from oppositely charged 
polyelectrolytes via their alternating deposition by a layer-by-layer process (LBL) onto 
citrate stabilized GNPs [42-44]. The immobilization process was carried out by using 
cross-linker agents to link the carboxylic group on the surface of carboxy-modified GNPs 
with the amino group on papain [42-44]. The covalent (instead of adsorptive) bonding 
was selected for irreversible immobilization to avoid enzyme leaching from the support 
surface [45]. The number of immobilized papain molecules on GNPs is an important 
figure for the determination of the immobilization efficiency. Resonant mass 
measurement (RMM) was applied herein to measure the mass increase of the 
nanoparticles upon immobilization of papain and determine the surface coverage [46]. It 
is well-known that papain, like other proteases, is prone to auto-digestion. The resultant 
peptides will cause the contamination of the protein digestion products. Therefore, 
immobilization of proteases like papain on a solid support is a good solution to eliminate 
this kind of contamination produced by auto-digestion [47]. In addition, the papain-
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functionalized GNPs can be easily removed from the reaction solution by a simple 
centrifugation process, which also terminates the digestion. Therefore, using immobilized 
papain makes it easy to control the reaction time without using any stop reagents which 
normally introduce contamination to the product solution. 
 
 
Experimental 
 
Materials 
Papain (EC 3.4.22.2) was purchased from Acros Organics (Geel, Belgium). Human 
immunoglobulin G (Gammanorm) (h-IgG) was obtained from Octapharma (Heidelberg, 
Germany). The lot employed in this study was already expired. Gold(III) chloride 
trihydrate (HAuCl4·3H2O), trisodium citrate, poly(acrylic acid, sodium salt) solution (PAA, 
Mw. ~ 15,000, 35% in H2O), poly(allylamine hydrochloride) (PAH, Mw.~17,500), N-(3-
dimethylaminopropyl)-N'-ethylcarbodiimide (EDC), N-hydroxysulfosuccinimide sodium 
(sulfo-NHS), sodium phosphate monobasic dihydrate, sodium carbonate anhydrous, 
sodium hydroxide, K-Na-tartrate (potassium sodium tartrate), N-benzoyl-DL-arginine-4-
nitroanilide hydrochloride (BNpNA) and p-nitroaniline, copper(II) sulfate, Folin & 
Ciocalteu’s phenol reagent glycerol, 2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris 
base), acrylamide/bis-acrylamide (30% solution), glycerol, and a ProteoSilver TM silver 
staining kit were obtained from Sigma-Aldrich (Munich, Germany). Ammonium persulfate 
was from AppliChem (Darmstadt, Germany). HPLC-grade acetonitrile was purchased 
from JT Baker Chemical Co. (Deventer, The Netherlands). Double deionized water 
(produced by Elga Purelab Ultra ELGA, System LabWater, Celle, Germany) was used 
throughout synthesis of functionalized GNPs and analytical procedures including LC-MS. 
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Preparation of papain-functionalized GNPs 
Gold nanoparticles were prepared according to the Turkevich-Frens method with some 
modifications [48]. In brief, 25.25 mg HAuCl4 was dissolved in 50 mL water (with a final 
concentration of 1.14 mM) and then heated at 170˚C under reflux and constant stirring for 
10 min. Afterwards 6.25 mL trisodium citrate (2.28 mM) was added and heated for 
another 10 min under reflux and constant stirring. Then the colloidal solution was kept 
stirring without heating for an additional 60 min to cool down to room temperature. The 
obtained citrate-GNP solution was stored at 4 ˚C for further usage. 
The surface modification of GNPs was realized via the layer-by-layer process (LDL) 
reported by Schneider and Decher [49]. In brief, citrate-stabilized GNP suspensions were 
first centrifuged (12000 rpm, 10 min), the supernatant discarded and the pellet washed 
with water to remove citrate from the supernatant. Afterwards 10 mL citrate-GNP 
suspension was added dropwise to the same volume of PAH solution (20 mg mL-1, 
10 mL) under continuous vigorous stirring, and then kept gently stirring for 30 min at 
room temperature in the dark. To remove excess PAH, the reaction mixture was 
centrifuged (12000 rpm, 15 min), the supernatant discarded and the pellet washed twice 
with 10 mL water. The second layer coating process was performed according to the first 
coating step but PAH was replaced by PAA (20 mg mL-1). After removal of the 
supernatant and two washing steps performed as above, the modified GNPs 
(GNP/PAH/PAA) were resuspended in 20 mM phosphate buffer (pH 6.8). Subsequently, 
20 µL EDC (12 mM) and 20 µL sulfo-NHS (60 mM) solutions in water were added into 
760 µL GNP/PAH/PAA suspension to yield activated carboxylic groups in the form of 
sulfo-NHS esters which were further coupled with amino groups on the surface of papain. 
For this purpose, 800 mL activated GNP/PAH/PAA suspension was added dropwise into 
200 µL papain solution with four different concentrations (1 mg mL-1, 2 mg mL-1,  
5 mg mL-1, 10 mg mL-1) under continuous vigorous stirring. The reaction mixture was 
then stirred gently for 2 h, and allowed to stand for 12 h at room temperature. To remove 
excess papain, the obtained papain-GNP suspension was centrifuged (12000 rpm, 
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15 min), the supernatant discarded and the pellet washed with water. The wash 
procedure was repeated two times and finally the pellet was resuspended in 20 mM 
phosphate buffer (pH 6.8). The papain-GNP solution was stored at 4 ˚C prior to use. 
 
Characterization 
After each step of surface modification, SPR bands of GNPs were measured in the 
wavelength range between 300 nm and 800 nm with a UV-1600PC spectrophotometer 
(from VWR, Darmstadt, Germany) to determine the size changes as well as nanoparticle 
dispersion and aggregation status. Size and size distribution of GNPs were studied by 
dynamic light scattering (DLS) based on the Brownian motion of the particles using a 
Zetasizer Nano ZS from Malvern Instruments (Herrenberg, Germany). The stability of the 
GNP dispersions was determined by zeta potential (ζ-potential) measurements before 
and after each modification step with the Zetasizer Nano ZS. The Zetasizer Nano ZS was 
equipped with a He–Ne laser and each measurement was performed at 173 ˚C 
backscatter detection mode. Each sample was diluted with water (1:5; v/v) before 
detection and measured in triplicate. Each reported value represents the mean of at least 
15 subruns. 
 
Quantitative determination of the immobilized papain 
RMM using the Archimedes instrumentation from Malvern Instruments was employed to 
determine the amount of immobilized papain on nanoparticles. All the samples were 
diluted with water (1:5; v/v) before each measurement. Before measurements, (mass) 
calibration of the microchip was performed with 1 µm latex standard and a sample of 
deuterium. The microchannel was then flushed with purified water before analysis, and 
the impurities in the system were subsequently removed by sneezing steps. The limit of 
detection was set to 0.030 Hz, which was well above the noise level and optimal for 
detection of nanoparticles. Each measurement was carried out at room temperature, and 
the determination numbers of particles were set to 2000 to ensure satisfactory statistics 
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of the nanoparticle distributions. The density of gold was 19.320 g mL-1, and the density 
of fluid was 1g mL-1. With these conditions, the average buoyant masses of particles 
before and after immobilization of papain were measured. The average real masses 
(drymass) of papain-GNPs were obtained from the conversion of buoyant mass. 
 
Assays of papain activity 
In order to determine the activity of both free papain and immobilized papain, N-benzoyl-
DL-arginine-4-nitroanilide hydrochloride (BApNA) was selected as a substrate for the 
kinetic assays. In principle, BApNA was cleaved by papain to produce p-nitroaniline 
which was measured with the Versa max microplate reader (from Molecular Devices 
LLC, Biberach, Germany) at an absorbance of 410 nm. A concentration series of BApNA 
was digested with papain (free papain and immobilized papain, respectively) in 20 mM 
phosphate buffer (pH 6.8) at 37 ˚C. For the digestion with papain, different volume of 
BNpNA stock solutions in phosphate buffer (2 mM) and 50 µL enzyme solution  
(2 mg mL-1, and 1 mg mL-1 in final solution) were added to the 96 wells, and different 
volumes of phosphate buffer were filled to obtain the final volume of 100 µL. Digestion 
was performed at 37 ˚C controlled by the microplate reader, and the absorbance of all the 
samples were recorded every two minutes with kinetics scan mode. For the digestion 
with papain-GNP, 50 µL papain-GNP solution in 20mM phosphate buffer (pH 6.8) were 
added and digestion was performed as described above for 10 min. After stopping the 
digestion by immediate centrifugation, the supernatant was analyzed with microplate 
reader in endpoint mode. The Michaelis-Menten plot and Lineweaver-Burk plot were built 
based on the calculated initial velocity. Finally, the kinetic parameters (Km, Vmax and kcat) 
were calculated by using the Lineweaver-Burk equation. All experiments were performed 
in triplicate. 
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Antibody digestion with papain-functionalized GNPs 
For the antibody digestion, immunoglobulin G solutions were first digested with papain-
functionalized GNPs. For digestion, 10 mg mL-1 IgG solution was diluted with water to 
0.5 mg mL-1 and used as stock solution. Subsequently, 100 µL of above solution of 
immobilized papain on GNPs was mixed with 100 µL IgG solution (0.5 mg mL-1), and 
incubated at 50 ˚C with gentle shaking at 450 rpm with a Thermoshaker (Peqlab, 
Erlangen, Germany) for 4h, 8h and 24h, respectively. After digestion, the GNP-based 
nanobiocatalyst was easily separated from the crude digest by a centrifugation step 
(12000 rpm, 10 min). Finally, the clear digestion solution (supernatant) was analyzed by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and high-
performance liquid chromatography-microelectrospray ionization-quadrupole-time-of-
flight mass spectrometry (HPLC-µESI-QTOF-MS) in intact protein mode (vide infra). 
 
SDS-PAGE 
A Mini-PROTEAN 3Cell with Mini-PROTEAN 3 PowerPac 300 system (200/240V) 
obtained from Bio-Rad Laboratories (Munich, Germany) was applied for the SDS-PAGE. 
The Precision plus protein mix (from Bio-Rad Laboratories) was used as the standard 
protein marker. A tn percent Tris-HCl gel with a thickness of 0.75 mm and 10 sample 
wells was prepared according to the product technical information from Bio-Rad 
Laboratories. All the samples were mixed with non-reducing sample buffer in a ratio of 
1:1 (v/v) before application of 7.5 µL into each well. 2 µL of the protein standard were 
applied. After development of the gel, the protein bands were stained with a Proteosilver 
Plus Silver Stain Kit from Sigma-Aldrich (Munich, Germany) according to the product 
technical information. 
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HPLC-µESI-QTOF-MS method for determination of IgG masses before and after 
digestion 
An Agilent Technologies (Waldbronn, Germany) 1290 Series UHPLC and a PAL-xts 
(CTC, Zwingen, Switzerland) autosampler were used for chromatographic separation and 
injection, respectively. A ProSwift RP-4H monolithic capillary column (500 µm ID × 10 
cm) from Thermo Scientific (Waltham, Massachusetts, USA) was applied for protein 
separation. The LC gradient is shown in Table 1. Solvent A consisted of ultrapure water 
(from Elga Purelab Ultra ELGA) with 0.1 % (v/v) formic acid, and solvent B consisted of 
acetonitrile with 0.1 % (v/v) formic acid. The flow rate was set to 50 µL/min and injection 
volume was 3 µl. 
Detection was carried out with a Triple TOF 5600+ quadrupole time-of-flight mass 
spectrometer from AB Sciex (Concord, Ontario, Canada) equipped with a DuoSpray 
source operated in positive mode using a 50 µm ID microelectrospray ionization (µESI) 
needle (from Sciex). The source temperature was set to 400 °C and the ionspray voltage 
floating was 5100 V. Nebulizer gas (GS1) was set to 50 psi, drying gas (GS2) to 40 psi, 
and curtain gas to 30 psi. Finally, the declustering potential (DP) was set to 230 V, and 
the collision energy (CE) to 30 V. TOF-MS scan ranged from 500 to 4000 Da. For intact 
protein detection Sciex’s Intact-Protein script was activated, Q1 transmission was set to 
100 % at 1250 m/z, and sensitivity was increased by summing 60 time bins. PeakView 
from Sciex containing the Bio Tool Kit software package was used for data processing 
and identification of the proteins by a deconvolution procedure.  
 
 
Result and discussion 
 
Preparation of papain functionalized GNPs 
For analytical and bioapplications, the GNPs should support the property of colloidal 
stabilization in physiological medium as well as provide a large surface for a high 
192 
 
bioconjugation capacity with receptor molecules or, in present case, enzymes [50]. To 
cope with this goal a LBL activation of the GNP surface was employed before 
bioconjugation of the enzyme. The schematic presentation for the preparation process of 
the functionalized GNPs is shown in Figure 1. First, citrate stabilized GNPs were 
prepared according to the Turkevich-Frens method [48]. In this reaction, citrate played 
the role as both reducing and stabilizing reagent. Capping citrate anions on the GNP 
surface provide them with negative charges and give them colloidal stability due to 
electrostatic repulsion of the particles precluding their van der Waals driven aggregation. 
Modification with charged polymer reagents (i.e. polyelectrolytes) was supposed to 
further increase the colloidal stability of GNPs by formation of soft shells on the GNP 
surface based on electrostatic repulsion and steric hindrance. Moreover, the coated 
polyelectrolytes provide sufficient anchor groups for covalent bonding of protein. This 
biocompatible and highly hydrophilic shell was obtained by an alternating deposition of 
oppositely charged polyelectrolytes on the nanoparticle surface. For the first layer, PAH 
with multiple positive charges was adsorbed onto the surface of negatively charged 
GNPs based on electrostatic interactions. Afterwards, addition of the positively charged 
PAH/GNPs to the negatively charged PAA solutions caused the formation of a second 
stabilized layer on the surface of GNPs with negative charge. After each modification 
step, two washing steps were performed to remove unbound polyelectrolyte as well as 
coexisting particles formed by the nanoaggregation of PAH with PAA [51]. Immobilization 
of papain on the LBL-modified GNPs was performed by using EDC and sulfo-NHS as 
activation reagents for amide coupling between carboxylic groups on the surface of the 
LBL-modified GNPs and amino groups of papain. Immobilization of papain on the first 
cationic PAH polyelectrolyte layer failed, because the single-layered and positively 
charged PAH/GNPs were easily aggregated in phosphate buffer (20 mM, pH 6.8) which 
was commonly used for the immobilization and digestion with papain. 
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Characterization of functionalized GNPs 
In order to monitor the quality of the modified GNPs, various physicochemical 
characterizations were performed after each surface modification step with analytical 
techniques such as visible spectroscopy measuring the absorbance maximum (λmax) of 
the SPR band, DLS for measuring particle size distributions (i.e. hydrodynamic 
diameters) and electrophoretic light scattering for ζ-potential determinations [52]. 
The characterization results of the various synthesized nanoparticles with regard to their 
SPR band are shown in Figure 2. It becomes evident that λmax of the SPR band of 
citrate-stabilized GNPs (527 nm) and the LBL-modified GNP/PAH/PAAs are essentially 
identical while it has obviously shifted for the papain-functionalized GNPs (papain-GNPs) 
towards longer wavelength (543 nm). Furthermore, the broader peak width of papain-
GNPs in comparison to GNP/PAH/PAAs and citrate-GNPs reveals that papain has been 
successfully immobilized. Due to absence of a strong red shifted absorption band at λ > 
600 nm, it can be concluded that no significant aggregation of papain-GNPs occurs. 
During the functionalization process, four different concentrations of papain (0.2, 0.4, 1, 
and 2 mg mL-1, respectively) in the reaction mixture were used to prepare four batches of 
papain-GNPs with different sizes and protein-coating thicknesses. Even though a longer 
wavelength and broader peak shape has been found after immobilization of papain from 
0.2 mg mL-1 papain reaction solution, it can be interestingly seen from Figure 2b that 
negligible SPR band shifts result among the four batches of papain-GNP solutions 
prepared from differently concentrated papain solutions. Therefore, these results imply 
that SPR is not sensitive enough for detecting these further size and size distribution 
changes. Therefore, another characterization method, DLS, has been used to reveal the 
size differences between the four batches of papain-GNPs. 
Hydrodynamic diameters (dh) and ζ-potentials of the different stages of modification are 
shown separately in Figure 3a and 3b. The citrate-capped GNPs were first prepared with 
mean diameter of 36.4 ± 0.3 nm and a ζ-potential value of -35.7 ± 0.3 mV. After first layer 
modification, the size greatly increased to 127.6 ± 5.7 nm with the ζ-potential changing 
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from the negative value of -35.7 ± 0.3 mV to the positive value of 69.6 ± 3.6 mV. The 
results confirmed successful modification with PAH. After second layer modification with 
PAA, the ζ-potential of the nanoparticles changed to a negative value of -44.4 ±1.0 mV 
with an average size of 126.3 ± 6.3 nm according to DLS measurements. It is striking that 
the size does not change significantly although effective deposition of the anionic 
polyelectrolyte PAA is evident from the ζ–potential. The internal repulsive electrostatic 
interactions between PAH polymer chains which lead to an increase of the shell 
thickness after first layer deposition appear to be effectively attenuated when the 
oppositely charged PAA polyelectrolyte is applied on the surface. This might lead to a 
condensation of the shell thickness so that there is actually not much difference in dh 
compared to the stage before. After functionalization with four different concentrations of 
papain (0.2, 0.4, 1, and 2 mg mL-1, respectively), the hydrodynamic radius dh grew 
significantly from 176.2 ± 5.2 nm (for 0.2 mg mL-1) to 1315 ± 136 nm (for 2 mg mL-1). 
Since severe aggregation was not found in the visible spectra (Fig. 2b), the increase in 
the hydrodynamic diameters with more papain in the reaction mixture was (largely) 
attributed to the increased amount of papain on the GNPs.  
The ζ-potentials of all these four batches of papain-GNPs still remained highly negatively 
charged, which indicated that a good colloidal stability persisted. Moreover, it is worth 
noting that absolute values of the ζ-potential decreased with increasing amounts of 
immobilized papain. Papain (pI ~ 8.75) which carries a net positive charge in the 
employed phosphate buffer (pH 6.8) partly compensates negative charges of the 2-step 
LBL-modified GNPs which might compromise their colloidal stability.  
In conclusion, DLS measurements confirm the successful immobilization of papain and 
that the amount of papain covalently bonded on the GNPs can be readily increased by 
higher concentrations of papain used during protein coupling reaction. ELS 
measurements, on the other hand, reveal that ζ-potentials of these nanobioconjugates 
are large enough to support their colloidal stability. 
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Loading amount of immobilized papain 
RMM was recently introduced as an innovative technology for accurately measuring the 
mass of nano- and microparticles with detection limits in the range of femtograms to 
attograms [46, 53-55]. It allows convenient particle classification in the size range of 50 
nm to 5 µm if a sufficient number of particles is counted. Therefore, RMM was envisaged 
as a useful tool in our study for the determination of the average number of papain 
molecules immobilized on GNPs by using an Archimedes instrument. This instrument 
accommodates a sensor chip with a microfluidic channel (having a dimension of 8×8 
µm2) in which a resonant structure is embedded inside. When a nanoparticle passes 
through this microchannel, a shift of the resonant frequency occurs because the resonant 
structure senses the density difference between the particle (ρparticle) and the transport 
fluid (ρfluid). Information on the buoyant mass of the nanoparticles can be derived from the 
resonant frequency shift [46]. 
The number of particles measured was set to 2000. The average buoyant mass (MB [fg]) 
of this nanoparticle population was calculated by conversion from the resonant frequency 
shift (∆f [s-1]) according to Eq. 1. 
?  ∆ × *       (1) 
wherein S [fg s] represents the microchannel resonator’s sensitivity. It is a fixed value for 
each resonator, which reflects a simple linear relationship over the entire range of 
measurable particles, and has to be determined by a simple calibration procedure. From 
the buoyant mass the dry mass M [fg] can be calculated for a defined chemically 
homogeneous particle according to Eq. 2 [46, 56]. 
 	
5B
!CDEFGHIJ/ELMNOIPGQ$
      (2) 
However, in the present case we are dealing with a composite material i.e. a shell particle 
in which gold core and protein shell have distinct densities which needs to be considered 
in the calculations. Hence, a modified version of Eq. 2 has been utilized. By comparing 
the average buoyant mass changes of GNPs before and after functionalization (∆MB), the 
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average mass of immobilized papain on a single GNP (M(papain shell)) can be approximated 
by Eq. 3 
!R6R6TU	7ZS[[$ 	
∆5B
!CDEFGHIJ/EW\QGG$
    (3) 
wherein ρshell is the density of the papain shell. The density of the fluid (water) used was 
1g mL-1 in all calculations, and the density of the papain shell on the GNP surface was 
calculated to be 1.43 g cm-3 from the exponential function reported by H. Fischer [57]. 
Hence, the average mass of immobilized papain was obtained. More importantly, with the 
calculated average mass of a papain molecule from the known molecular weight of 
papain (23,406 Da), the average number of papain molecules immobilized on each 
nanoparticle was finally obtained [46]. The particle buoyant mass distributions of LBL-
modified GNPs (GNP/PAH/PAA) and papain-GNPs (0.2 mg mL-1 and 1 mg mL-1) are 
shown in Figure 4. The graph in Figure 4a shows a relatively narrow buoyant mass 
distribution of GNP/PAH/PAA nanoparticles. Surface functionalization with 0.2 mg mL-1 
papain yielded a slight, but insignificant shift of the average buoyant mass from 
3.14 ± 0.06 to 3.42 ± 0.31 fg (Figure 4b and Table 2). On the other hand, for GNPs 
functionalized with 1 mg mL-1 papain solution, a significant shift of the distribution towards 
a larger average buoyant mass (27.30 ± 2.25 fg) with a broader width indicative for 
increased polydispersity can be observed (Figure 4c and Table 2). 
Therefore, with this technology the average mass of papain per GNP, the concentration 
of nanoparticles, the concentration of immobilized papain and the number of papain 
molecules per GNP can be calculated (shown in Table 2). Such knowledge is of 
importance for the calculation of the turnover numbers (kcat) of the immobilized enzyme 
nanobioreactors. It can be seen that the average mass increase due to papain 
immobilization (with 0.2 mg mL-1) on GNP/PAH/PAA corresponds to the mass of 
2.39 ± 2.14 × 104 papain molecules per single GNP. By using the same calculation for the 
papain-GNPs (from 1 mg mL-1), the average mass increase corresponds to 
2.06 ± 0.19 × 106 molecules of papain immobilized per GNP. The factor 100 increase in 
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surface coverage upon a factor 5 increase of the papain concentration in the reaction 
mixture is unexpected. However, it is confirmed by the more than proportional size 
increase as measured by DLS and may have to do with the specific conformational 
arrangement and morphology, respectively, of the polyelectrolyte coating. Calculations 
based on the approximately available surface area of GNP/PAH/PAA with a diameter of 
126 nm for papain adsorption and the hydrodynamic diameter of papain as estimated by 
DLS leads to the conclusion that the papain shell is formed by a multilayer bonding on 
the GNPs. One could imagine bonding of multiple papain molecules on loosely adsorbed 
loops of the outer PAA polymer chains yielding elevated protein surface coverage. 
Furthermore, it can be clearly seen from Table 2 that the nanoparticle concentrations in 
the suspension continuously decline. The GNP/PAH/PAA solution showed the highest 
concentration of 1.06 × 10-11 mol L-1, but the concentration decreased after 
functionalization with papain, which is due to the loss of nanoparticles during reaction. In 
conclusion, the RMM technology is an effective tool for measuring the average mass of 
immobilized protein on each nanoparticle. 
 
Determination of kinetic parameters of immobilized and free papain 
The enzyme activity of free papain and of the four distinct papain-GNP bioconjugates 
was evaluated at 37 ˚C and pH 6.8 by investigating the hydrolysis of BApNA as the 
substrate [48]. In principle, BApNA is cleaved in the presence of papain to produce 
chromogenic p-nitroaniline (pNA) which exhibits strong absorbance at the wavelength of 
410 nm (Suppl. Fig. S1). Thus, the activity of papain can be conveniently measured by 
the released pNA with a photometric assay. To obtain the Michaelis-Menten parameters 
(Km, Vmax, kcat; see also Suppl. Material), the activities of free and immobilized papain for 
various concentrations of BApNA were measured and the obtained data were plotted in 
the form of Lineweaver-Burk plots, as shown in Figure 5a. These plots document a good 
linear relationship between 1/[S] and 1/v0 for both free and immobilized papain. Km and 
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Vmax values of free and immobilized papain were calculated from the intercepts on x- and 
y-axes, respectively, and the results are summarized in Table 3. 
The Michaelis constant Km is the substrate concentration at which half of the maximal 
reaction rate (Vmax/2) can be achieved. In free solution, it is independent of the enzyme 
concentration. Upon immobilization, the enzyme conformation might change, thus 
negatively (or even positively) influencing enzyme-substrate complex formation. 
Furthermore, the access of the substrate to the active site might be altered upon 
immobilization. Both of these properties might change in dependence of the surface 
coverage. For instance, at low surface concentrations the active site might be better 
accessible than at high coverage for which sterically hindered and limited access to the 
enzyme’s catalytic site might compromise the rate constant for association and thus 
affect or alter Km. The data in Table 3, however, reveal that Michaelis constants Km 
remain in the same order of magnitude when different concentrations of papain are 
immobilized on GNPs, ranging between 1.4 and 2.6 mM (mean = 2.0 ± 0.6 mM; the slight 
fluctuations represent experimental uncertainties which are in a similar order as for the 
repetitive experiments with free papain) (see also Suppl. Fig. S2). A comparison of this 
mean with Km of free solution reaction reveals that there is no statistically significant 
difference in Km. Hence, binding affinity is not compromised upon immobilization of 
papain [58]. 
Vmax of enzyme reactions reflects how fast the biocatalyst can catalyze the 
biotransformation. Vmax rises linearly with the enzyme concentration in free solution 
reactions. This is also observed for the papain-GNP conjugates varying in papain surface 
concentrations (Fig. 5b). Vmax values of immobilized papain range from 6.00 ± 0.27 ×    
10-5 mM s-1 (0.2 mg mL-1 papain in reaction mixture) to 7.12 ± 0.17× 10-4 mM s-1 
(2.0 mg mL-1) (Table 3). The corresponding reaction with free papain reached a Vmax of 
2.03 ± 0.57 × 10-4 mM s-1, respectively. A faster reaction with immobilized enzyme is 
clearly evident. This, in turn, has also the advantage that less enzyme could be used to 
reach the same maximum reaction rate if it is immobilized to the GNP carrier. This is 
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highly relevant in biocatalytic industrial applications with precious enzymes and those of 
limited availability.  For instance, the same Vmax as with 1 mg mL-1 papain in free solution 
can be achieved with papain-GNP conjugated biocatalyst prepared from only 
0.54 mg mL-1 in the reaction mixture (equivalent concentration Ceq) (Fig. 2b). Thus, a 
factor of almost 2 less enzyme would be consumed if the supernatant after reaction is 
discarded and disposed. Actually, since only a small fraction of the enzyme is bonded to 
the GNPs, the unbound enzyme can be easily recycled from the reaction mixture after 
centrifugation. For instance, in the reaction with papain-GNP conjugate prepared from 
1 mg mL-1 the acutally papain concentration in the digestion is only 21.3 µg mL-1 
(2.9 µg mL-1 in the digestion with bioconjugate prepared from 0.2 mg mL-1) Thus, the 
savings of enzyme are even more pronounced (about factor 100), making this approach 
with nanoparticulate heterogeneous biocatalysts most attractive for precious enzymes.  
A better figure to define and compare the reaction rate of a series of biocatalysts is the 
turnover number kcat. It is the number of substrate molecules converted to product per 
enzyme molecule per second. By using the known concentrations of free papain and 
immobilized papain calculated from RMM, the kcat values were finally calculated to be 
4.75 ± 1.33×10-3 s-1 (free), 0.20 ± 0.02 s-1 (conjugated from 1 mg mL-1) and 0.65 ± 0.03 s-1 
(conjugated from 0.2 mg mL-1), respectively. It becomes striking that the reaction is 
accelerated by a factor of 137 when free solution enzyme reaction and heterogeneous 
nanobiocatalysis with papain-GNP conjugate prepared from 1 mg mL-1 are compared. 
Local accumulation of substrate on the surface of the nanobiocatalyst or close to it, thus 
forming a concentration gradient to the adjacent solution (like in a double layer model) 
might be invoked as an explanation for this increased reaction rates. Furthermore, the 
ratio kcat/Km, a characteristic parameter, was calculated to describe the catalytic efficiency 
of the immobilized papain in comparison to free papain. It was found that immobilized 
papain had a much higher ratio kcat/Km compared to the free papain, which means that 
the immobilized papain exhibited significantly higher catalytic efficiency. Therefore, from 
above results it can be concluded that the immobilized enzyme with many additional 
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advantages provides the higher catalytic efficiency compared to the free papain. Besides 
acceleration of reaction rates, immobilization on nanoparticulate carriers might be a 
viable strategy to safe precious enzymes in industrial applications. 
 
SDS-PAGE for monitoring antibody digestion 
The primarily intended application of the papain-modified nanoparticles is fragmentation 
of IgG into smaller fragments which facilitate their MS analysis (middle-down and middle-
up) [41]. In the present case, a therapeutic protein, human IgG, was utilized to verify the 
bioactivity and digestion performance of papain-functionalized GNPs (prepared from 
0.2 mg mL-1 papain in the reaction mixture) in comparison to in-solution digestion 
(1 mg mL-1 papain). By taking advantage of the heterogeneous biocatalyst, the papain-
GNPs can be readily removed after digestion, avoiding the contamination of enzyme into 
the fragment products. IgG digests obtained from GNP-conjugated and free papain were 
characterized by SDS-PAGE under non-reducing conditions using silver staining for 
detection (providing detection limits around 0.25 - 0.5 ng of protein). The resultant gel is 
shown in Figure 6. It is evident that new bands (at around 50 kDa) appeared in the 
samples (lanes B,C,D and F,G,H) after digestion. The molecular weight of these protein 
bands corresponds to the expected IgG fragments. Papain cleaves the intact IgG above 
the Hinge region to yield three fragments of similar size, two Fab fragments (around 
50 kDa each) and one Fc fragment (around 50 kDa as well). In addition, bands around 
100 kDa and 25 kDa were also found in the digested samples. It seems that the 
employed papain does not have enough specificity for the cleavage of IgG just above the 
Hinge region, but also the F(ab’)2 and Fc/2 fragments are obtained. In sharp contrast, in 
the non-digested IgG solution (lane A), only intact IgG (around 150 kDa) and aggregated 
forms (ca. 300 kDa) rather than the fragments were found (the large quantities of 
aggregates can be explained by the fact that the h-IgG used in this study was already 
expired for a long time). These results clearly indicate that IgG was efficiently digested 
with papain-functionalized GNPs. 
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To test for possible bleeding of papain from the nanoparticulate carrier, a suspension of 
papain-functionalized GNPs was allowed to stand in 10 mM phosphate buffer pH 6.8 
overnight. Afterwards the suspension was spinned down and the supernatant was also 
applied as sample to the gel (lane E). It can be clearly seen that there is no band (E) at 
the position where papain is expected (ca. 23 kDa region). This implies that, after their 
removal by centrifugation, papain-GNP conjugates do not cause any background 
interferences in the gel and that papain is not bleeding from the nanoparticulate carrier 
due to covalent attachment. From these results it can be derived that the new 
nanobioreactor is suitable for practical applications. 
 
HPLC-µESI-QTOF-MS method for characterization of lgG fragments after digestion 
The generated fragments of human IgG were finally analyzed by HPLC-µESI-QTOF-MS 
to document the practical applicability of the nanoparticulate enzyme reactor. High 
resolution-MS using a QTOF equipped with a µESI sprayer and a ProSwift column for 
separation of proteins were used for the characterization of intact IgG and the fragments 
digested with papain-GNPs. Detection limits for smaller proteins like IgG fragments are 
around 500 fg on-column with this µESI setup. Figure 7a shows the total ion 
chromatogram of the intact IgG before digestion, and Figure 7b shows the deconvoluted 
mass spectrum of the peak with tR 14.66 min corresponding to IgG with a mass of around 
150 kDa (note, this is not a monoclonal antibody but human IgG isolated from plasma). 
After digestion, the deconvoluted mass of IgG (150 kDa) disappeared, and meanwhile 
the fragments (Fab and Fc), eluting at ca. 9.6 min could be detected (Figure 7c). The 
deconvoluted TOF-MS spectrum in Figure 7d for the peak at 9.6 min shows several peak 
groups in the range of 50 kDa to 55 kDa corresponding to Fab and Fc, respectively. It 
can be explained by the fact that human IgG is a collection of immunoglobulin molecules, 
and therefore a mixture of similar fragments with slightly different masses can be 
expected for the digested IgG as well.  
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The TIC chromatogram in Fig. 7c, like the gel, shows some additional peaks. The first 
two peaks (between tR 7.7 and 8.5 min) could not be assigned to a reasonable mass. 
However, the deconvoluted peak (tR between 8.8 to 9.5 min) showed fragment masses of 
around 25 kDa, which correspond to the Fc/2 fragments (Fig. 7e). In addition, a peak at tR 
of 14.63 min was detected in the digest and it was initially assumed that this peak 
corresponds to intact human IgG due to incomplete digestion. However, the 
deconvoluted TOF-MS spectrum of the peak at 14.63 min actually corresponds to a 
100 kDa F(ab’)2 fragment of human IgG (Fig. 7f) while the intact IgG (150 kDa) was not 
detected at all. This finding clearly confirms the successful and complete digestion. It 
seems that the employed papain does not have enough specificity for cleaving the IgG 
just above the Hinge region, but produces also a F(ab’)2 fragment in significant amounts 
besides Fab. Overall, the LC-MS results clearly document that the new nanoparticulate 
enzyme reactor has adequate bioactivity and catalytic efficiency for enzymatic IgG 
fragmentation. The limited specificity of papain both in free and immobilized forms, 
however, explains why nowadays IdeS (immunoglobulin G-degrading enzyme of 
Streptococcus pyogenes, a bacterial cysteine protease which specifically cleaves IgGs 
under their hinge region [41]) is mainly used for middle-down characterization of IgGs by 
LC-MS. It is obvious that this highly specific enzyme should be immobilized in the same 
way to afford a highly specific, highly efficient immobilized enzyme reactor which can be 
easily removed and reused for IgG fragmentation. 
 
 
Conclusion 
In the present study, GNPs were functionalized with papain by a layer-by-layer strategy 
producing an efficient heterogeneous biocatalyst. Characterization with SPR, DLS and ζ-
potential measurements revealed the successful immobilization of papain. The higher 
amount of papain used in the reaction mixture for immobilization has led to bigger particle 
sizes than expected. With the RMM technology, the concentration and average buoyant 
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mass of the GNP biocatalyst was obtained, and the number of papain molecules 
immobilized on one GNP was calculated.  The results implied that GNPs activated with 
polyelectrolyte layers provided a high loading capacity for papain due to its large surface 
to volume ratio and the specific surface modification with polyelectrolyte chains. In 
comparison with free papain, the immobilized papain provides the higher catalytic 
efficiency with the advantages of easy removal and flexible control of reaction. SDS-
PAGE and HPLC-µESI-QTOF-MS characterization proved the successful digestion of 
IgG with papain-modified GNPs as heterogeneous biocatalyst which indeed shows great 
potential in bioanalysis. The limited specificity of papain could be overcome by use of 
IdeS as an enzyme for immobilization.  
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Figures and Figure captions: 
 
 
Fig. 1. Schematic presentation of the GNP functionalization process with papain. The 
surface modification of the GNPs was performed by a layer-by-layer (LBL) polyelectrolyte 
deposition strategy, and finally carboxylic acid moieties stemming from PAA were 
functionalized with papain by activation of carboxylic acid groups of the LBL-modified 
GNPs with EDC and sulfo-NHS as coupling agents and subsequent amide coupling with 
amino groups of papain. (PAH+, polyallylamine hydrochloride; PAA-, polyacrylic acid 
sodium) 
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Fig. 2. Characterization of nanoparticles via surface plasmon resonance band. (a) Vis 
spectra of GNPs after each step of synthesis and surface functionalization. (b) Vis 
spectra of GNPs after functionalization with four different concentrations of papain in the 
reaction mixture (0.2, 0.4, 1 and 2 mg mL-1, respectively) 
  
0,0
0,2
0,4
0,6
0,8
1,0
1,2
1,4
350 400 450 500 550 600 650 700 750 800
Papain-GNP (2 mg/mL)
Papain-GNP (1 mg/mL)
Papain-GNP (0.4 mg/mL)
Papain-GNP (0.2 mg/mL)
546 nm
544 nm
543 nm
A
b
s
o
rp
ti
o
n
544 nm
Wavelength (nm)
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
350 400 450 500 550 600 650 700 750 800
 Citrate-GNP
 GNP/PAH/PAA
 Papain-GNP (0.2 mg/mL)
A
b
s
o
rp
ti
o
n
Wavelength (nm)
527 nm
543 nm
527 nm(a)
(b)
210 
 
 
Fig. 3. Characterization of nanoparticles after each step of modification by (a) DLS and 
(b) ζ-potential measurement (n=3) (note, the indicated concentrations refer to the final 
papain concentrations in the reaction mixture). 
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Fig. 4.  Distribution of the buoyant mass of particles in 20 mM phosphate buffer (pH 6.8) 
of LBL-modified GNPs (GNP/PAH/PAA) (a), GNPs functionalized with papain 
(0.2 mg mL-1) (b) and (1 mg mL-1) (c) (note, the indicated concentrations refer to the final 
papain concentrations in the reaction mixture ). 
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Fig. 5. a) Lineweaver-Burk diagrams for BApNA hydrolysis at pH 6.8 catalyzed by 
papain-GNP bioconjugates obtained from reaction mixtures with different papain 
concentrations, and for comparison by free (1 mg mL-1) papain, and (b) effect of different 
surface coverages (as obtained from different papain concentrations in the reaction 
buffer) on maximal reaction rates Vmax (indicated values are mean values of three 
experiments, n=3, and error bars represent the standard deviations; note, the indicated 
concentrations refer to the final papain concentrations in the reaction mixture; Ceq 
represents the equivalent papain concentration needed in the reaction buffer for 
immobilization to obtain GNP-conjugated papain with the same Vmax as a 1 mg mL-1 free 
papain solution). 
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Fig. 6. SDS-PAGE (gel: 10%-Tris-HCl) for non-reduced human IgG digestion samples 
with silver staining for protein visualization. (M) protein marker; (A) IgG in PB (10 mM, pH 
6.8); (B-D) IgG digested with papain-GNPs for 4h (B); for 8h (C); for 24h (D); (E) 
suspension of papain-GNPs after centrifugation; (F-H) IgG digested with free papain for 
4h (F); for 8h (G); for 24h (H); (I) free papain in PB (10 mM, pH 6.8) (note, usually     
0.25 - 0.5 ng of protein are considered as limit of detection for silver staining). 
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Fig. 7. HPLC-µESI-TOF-MS analysis of human IgG digested with papain-GNP 
bioconjugate. (a) TIC chromatogram of the IgG before digestion; (b) the deconvoluted 
TOF-MS spectrum of the peak with tR 14.66 showing the intact IgG (ca. 150 kDa); (c) TIC 
chromatogram of human IgG after digestion with papain-GNPs; (d) the deconvoluted 
TOF-MS spectrum of the peak with tR 9.62 showing the IgG fragments (Fab and Fc, ca. 
50 kDa); (e) the deconvoluted TOF-MS spectrum of Fc/2 fragments (ca. 25 kDa) of the 
peak at tR between 8.8 to 9.5 min; (f) the deconvoluted TOF-MS spectrum of the 100 kDa 
F(ab’)2 IgG fragment of the peak at tR 14.63 min. 
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Tables: 
 
Step Total Time (min) Flow Rate (µL/min) %A %B 
0 0.0 50 80.0 20.0 
1 2.0 50 80.0 20.0 
2 12.0 50 65.0 35.0 
3 13.0 50 5.0 95.0 
4 17.0 50 5.0 95.0 
5 17.5 50 80.0 20.0 
6 20.0 50 80.0 20.0 
 
Table 1. The LC gradient profile for HPLC-µESI-TOF-MS. Solvent A consisted of ddwater 
with 0.1 % (v/v) formic acid, and solvent B consisted of acetonitrile with 0.1 % (v/v) formic 
acid. 
 
Nanobeads 
Mean 
buoyant mass 
[fg]  
Concentration 
of nanobeads 
[mol L-1] 
Mean mass of 
papain per 
GNP [fg] 
Concentration of 
immobilized 
papain [mol L-1] 
Mean number 
of papain per 
GNP 
GNP/PAH/PAA 3.14±0.06 1.06×10-11 - - - 
Papain-GNPs [0.2 mg mL-1] 3.42±0.31 7.74×10-12 0.93±0.83 1.85±1.65×10-7 2.39±2.14×104 
Papain-GNPs [1 mg mL-1] 27.30±2.25 1.43×10-12 80.2±7.3 2.95±0.27×10-6 2.06±0.19×106 
 
Table 2. Summary of the experimental results from RMM measurements comprising 
mean buoyant mass, concentration of nanobeads, mean mass of papain per GNP, 
concentration of immobilized papain and mean number of papain molecules per GNP 
(n=3). 
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Parameter 
Papain-GNP 
(0.2  mg mL-1)a 
Papain-GNP 
(0.4 mg mL-1)a 
Papain-GNP 
(1mg mL-1)a 
Papain-GNP 
(2 mg mL-1) a 
Free papain 
(1 mg mL-1)b 
Km [mM] 1.41±0.05 2.32±0.04 1.61±0.03 2.62±0.15 2.71±0.98 
Vmax [mM s-1] 6.00±0.27×10-5 2.28±0.06×10-4 2.91±0.03×10-4 7.12±0.17×10-4 2.03±0.57×10-4 
kcat [s-1] 0.65±0.03 n.d. 0.20±0.02 n.d. 4.75±1.33×10-3 
kcat/ Km [mM-1 s-1] 0.46±0.01 n.d. 0.12±0.03 n.d. 1.8±0.2×10-3 
Regression 
equation 
Y=23499X + 
16693 
Y=10155X + 
4382.1 
Y=5530.9X + 
3432.9 
Y=3671.5X + 
1404.7 
Y=13096X + 
5248.1 
R2 0.9988 0.9997 0.9667 0.9980 0.9998 
a The concentrations  refer to the papain concentration used for the immobilization, the final 
concentration in the digestion solution are 9.25×10-8 mol L-1 and 1.48×10-6 mol L-1 for papain-GNP 
(0.2 mg mL-1 and 1 mg mL-1), respectively (see Table 2). 
b The concentration refers to the final papain concentration in the digestion solution. 
 
Table 3. Summary of the kinetic parameters (Km, Vmax, kcat) calculated by Lineweaver-
Burk plots for both free papain and immobilized papain (0.2 mg mL-1 and 1 mg mL-1, 
respectively ) (Values represent mean ± standard deviation of 3 replicate experiments; 
n.d., not determined). 
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Supplementary Material 
 
Determination of kinetic parameters of immobilized and free papain 
The enzyme activity of free and immobilized papain was evaluated at 37 ˚C at pH 6.8 by 
investigating the hydrolysis of BApNA as the substrate (Figure S1). To determine the 
kinetic parameters (Km, Vmax, kcat) the reaction was carried out at variable substrate 
concentrations with free papain and immobilized papain-GNP conjugates obtained from 
different concentrations of papain in the reaction mixture. The kinetic parameters were 
derived from the Lineweaver Burk plots and the results are given in Figure 5 and Table 3 
of the main document along with corresponding data of a reaction with 1 mg mL-1 free 
papain. 
 
 
Figure S1: Reaction scheme for the hydrolysis of the substrate BApNA by papain. The 
activity of papain can be measured by the released p-nitroaniline (pNA) at an absorbance 
wavelength of 410 nm. 
 
This single-substrate enzyme reaction can be described by the following equation (eq. S1 
  (S1) 
 
Wherein E, S, ES, P and EP represent the enzyme, substrate, enzyme-substrate 
complex, product and enzyme-product complex concentrations, k1 and k-1 are the rate 
constants for enzyme-substrate association and dissociation, respectively, and kcat is the 
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rate constant for product formation (also termed turnover number). The kinetics of this 
reaction is usually investigated by measuring the initial velocities v0 in dependence of the 
substrate concentration. The results are then evaluated in terms of the Michaelis-Menten 
equation (eq. S2) 
 
1
1 k
kkK ƆƄƗ
Ɛ += −        (S3) 
 
wherein Vmax is the maximal reaction rate achieved when all enzyme is saturated with 
substrate ([ES] = [E]t; with [E]t being the total enzyme concentration in the reaction i.e. 
[E] + [ES]). Km is the Michaelis constant which is defined by (eq. S3) 
 
1
1 k
kkK ƆƄƗ
Ɛ += −        (S3) 
 
As mentioned above, the data have been evaluated in the linearized form, i.e. the 
Lineweaver-Burk plot (eq. S4) 
 
[ ] maxmax
VSV
K
ƙ Ɛ 11
0
+
⋅
=       (S4) 
 
In a reaction with free enzyme Km does not change with enzyme concentration in the 
reaction mixture. Upon immobilization of enzyme, Km might change with enzyme 
concentration immobilized on the carrier because the conformation of the enzyme and 
steric access of the binding site might be altered in dependence of the enzyme’s surface 
concentration. For instance, at low surface concentrations the active site might be better 
accessible than at high coverage for which limited access to the enzyme’s catalytic site 
might compromise the rate constant for association. 
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Figure S2 shows a plot of Km values in dependence of distinct papain concentrations in 
the reaction mixture during bioconjugation. It becomes evident that Km is in the same 
order of magnitude for all 4 bioreactors (Figure S2). Hence, it can be concluded that 
access to active sites is not compromised at higher papain surface concentrations. 
 
 
Figure S2: Michaelis-Menten constant versus papain concentration in the reaction 
mixture in the course of preparation of papain-GNP bioconjugate. 
 
In sharp contrast, Vmax changes linearly with the enzyme concentration in accordance to 
eq. S5 
 
ƗƆƄƗ
EkV ][
max ⋅=  (S5) 
 
In sharp contrast, Vmax changes linearly with the enzyme concentration in accordance to 
eq. S5 
 
ƗƆƄƗ
EkV ][
max ⋅=        (S5) 
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Figure S3: Vmax in dependence of the papain concentration in the reaction mixture in the 
course of preparation of papain-GNP bioconjugate (Standard Error of Est. = 0.0000734; 
P-value intercept = 0.7548; P-value slope = 0.0237). 
 
This is also found for a series of enzyme reactions performed with the bioreactors having 
distinct papain coverages (Figure S3). Higher enzyme concentrations in the incubation 
mixture due to use of papain-GNP conjugates with higher surface coverages (which 
result from higher papain concentrations in the reaction mixtures during protein coupling 
step) accelerate the conversion. 
Eq. S5 can be used to calculate kcat, the turnover number, which is a better figure to 
define the reaction rate. In this work kcat has been calculated for free papain and two 
bioconjugates with distinct surface coverage of papain (see Table 3 of main document). 
Finally, the ratio of kcat/Km, termed specificity constant or catalytic efficiency, is a measure 
of how efficiently an enzyme converts substrates into products and is given in Table 3 of 
the main document as well. 
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Abstract 
The ability to accurately quantify the protein coverage on nanoparticles is critical for 
assessing the quality of the surface chemistry and the success of the functionalization 
process of protein-nanoparticle conjugates. Surface coverage determination is therefore 
an integral part in the quality control of protein-modified nanoparticles in industrial 
nanotechnology. In this work, a novel and conventional method was established for direct 
quantification of the protein surface coverage on metallic nanoparticles. Different 
concentrations of pepsin were conjugated to gold nanoparticles (GNPs) by a 
straightforward adsorptive immobilization process as a model system, and a protein 
quantitation methodology based on the amino acid analysis of the hydrolysate of the 
protein-GNP conjugates was established. For this purpose, pepsin functionalized GNPs 
(pepsin-GNP bioconjugates) were processed via in situ hydrolysis with 6N HCl and 
subsequent derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC 
reagent). Direct quantitative amino acid analysis was performed based on measuring the 
intensity of AQC-glycine derivative by High-performance liquid chromatography with 
fluorescence detection (HPLC-FLD). The method allows for detection of surface 
coverages as low as 0.1 µg mL-1 pepsin (corresponding to 2.89 × 10-9 mol L-1) in the 
colloidal solution. Method imprecision for replicated surface coverage determinations was 
< 5 % RSD and accuracies, as determined by % recoveries, were always in the            
98-118 % range. This method allows precise and accurate quantification of protein 
coverages, even when less than 1 % of the protein in the reaction mixture is immobilized. 
It was found that the degree of surface coverage of adsorptively bound pepsin on GNPs 
correlated with the pepsin concentrations in the conjugation reaction mixtures. Washing 
with phosphate buffer removed weakly bound proteins, i.e. the soft protein corona. The 
adsorption behavior could be described by a Freundlich isotherm model. This direct and 
reliable method promises great potential for the accurate quantification of protein 
coverages of various protein-nanoparticle bioconjugates. 
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Introduction 
Nowadays, nanoparticles are being extensively used in biomedical and biotechnological 
research. For instance, nanoparticle-antibody conjugates have been employed as affinity 
carriers to extract specific biomarkers for mass spectrometric analysis from complex 
biological samples [1-5]. Due to their controlled geometrical and flexible surface chemical 
properties, nanomaterials have also acted as excellent solid supports for enzyme 
immobilization [6]. For all these applications, the assay performance of protein-
nanoparticle bioconjugates depends mainly on the interactions between the nanoparticle 
and protein, including the protein surface coverage and orientation on the nanoparticle 
surface [7-10]. Therefore, in order to control assay quality and optimize the surface 
chemistry, it is critical to develop a method for the accurate quantitation of the surface 
coverage on nanoparticles in order to evaluate the success and reproducibility of 
nanoparticle-protein conjugation reactions. In addition, accurate quantification of the 
protein concentration on nanoparticles is a key requirement for the valid assessment of 
the kinetic performance of enzyme-nanoparticle conjugates, and also for their quality 
control to make it possible that the enzyme-nanoparticle bioconjugate can be 
successfully and reproducibly applied as heterogeneous catalyst in industrial processes.  
The accurate determination of the protein surface coverage on protein-nanoparticle 
conjugates is still challenging. To date, only a few studies directed some attention 
towards the determination of the protein concentration on nanomaterials [11-18]. 
However, compared to the vast number of scientific articles on nanoparticle synthesis, 
modification and enzyme immobilization methods, research on protein surface coverages 
and methods for this purpose are highly underrepresented in nanoscience. Typically, total 
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protein quantification assays (Lowry assay, Bradford assay and bicinchoninic acid BCA 
assay) are employed which allow detection of non-immobilized proteins in the 
supernatant of the binding/reaction mixture with low concentrations [12, 13, 19, 20]. The 
immobilized protein content can be calculated by mass balance considerations. Thus, 
these approaches are therefore so-called indirect assays. A validation of these assays is 
rarely carried out in the context of protein surface coverage determination of such 
bioconjugates. It is assumed that accuracies may suffer with these indirect protein 
quantitation assays. For example, the protein content is usually determined in the 
reaction mixture after removal of the nanoparticles. However, during the following 
washing steps protein loosely adsorbed to the surface might be desorbed and the protein 
coverage will hence be altered. Loss of protein, e.g., due to adsorption on other surfaces 
during the sample preparation might lead to erroneous results as well [7]. Furthermore, 
these protein quantification assays have limited precision, which may cause problems, if 
only a small percentage of the protein in the reaction mixture is bound to the nanoparticle 
surface. For instance, if the imprecision of the assay is 10 % (RSD) and only 1 % of the 
protein in the reaction mixture gets immobilized, it can rarely be imagined that the protein 
coverage can be determined with high accuracy by these indirect assays. Besides, these 
assays are prone to interferences from various chemicals. Therefore, the direct analysis 
of bound protein is considered highly advantageous in terms of assay accuracy. ELISA 
assays have been used for the determination of bound proteins (e.g. antibodies) on gold 
nanoparticles [1, 21]. If such ELISA assays are directly used to detect immobilized 
proteins, the effect of the matrix (nanoparticle carrier) on the determined protein 
concentration will remain unclear. Furthermore, ELISA kits are expensive. Fluorescence 
methods have also been proposed to directly analyze protein concentrations on 
nanoparticle surfaces [7]. This method involves fluorescence labeling of the protein in 
order to achieve sufficient sensitivity. Other techniques such as dynamic light scattering 
(DLS) and nanoparticle tracking analysis (NTA) measure the increase in hydrodynamic 
diameter after adsorption in order to derive information on surface coverages [14-18, 22, 
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23]. However, the thickness of the bound protein layer does not directly provide accurate 
information on bound proteins per nanoparticles. Yet, models have been derived which 
allow to correlate the average number of protein molecules bound to the nanoparticle to 
the hydrodynamic radius [24, 25]. Such a model has also been exploited to convert 
hydrodynamic radii measured by Taylor dispersion analysis (TDA) into protein surface 
coverages [26]. Recently a technique called resonant mass measurement (RMM) has 
been proposed to determine the protein mass on single nanoparticles [14, 27-29]. It 
actually measures the buoyant mass of nanoparticles in a microfluidic channel by 
frequency shifts of a resonator when a nanoparticle passes by. The buoyant mass can be 
converted to dry mass, which allows then to calculate the number of proteins per 
nanoparticle due to knowledge of the numbers of particles, which are counted as well. 
Another sophisticated method uses an electrospray-differential mobility analyzer (ES-
DMA) for the separation of NP and protein-NP conjugates which are coupled to an 
aerosol particle mass analyzer (APM) that determines mass by a balance of electrical 
and centrifugal forces. The differential analysis of unmodified carrier and protein-modified 
NPs allows the quantification of ligand densities [30]. Very recently, a targeted mass 
spectrometry-based method has been developed to directly measure the amount of 
antibody covalently bound to magnetic particles [11]. This method involves an on-bead 
digestion and analysis of a few characteristic tryptic peptides by isotope-dilution liquid 
chromatography-tandem MS, using selected reaction monitoring acquisition. 
Unfortunately, all these latter techniques require equipment, which is not widely available 
in analytical laboratories. 
 
Hence, the aim of this study was to establish a novel and generally applicable strategy for 
directly quantifying protein coverages on gold nanoparticles based on the reliable method 
of amino acid analysis following acidic hydrolysis of the protein. In this work, pepsin was 
employed as the model protein, and different concentrations of protein-GNP 
bioconjugates coated with different concentrations of pepsin were prepared by a 
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straightforward adsorptive immobilization process with subsequent washing steps to 
remove unbound and loosely bound proteins. protein-GNP bioconjugates were 
chemically digested in situ with 6N HCl to generate free amino acids and GNPs mixtures. 
After GNP removal and amino acid derivatization, direct quantitative analysis was 
performed based on measuring the intensity of the AQC-glycine derivative by using 
HPLC-FLD (Figure 1). An in situ digestion procedure of the bioconjugates was adopted 
without prior protein elution and isolation steps from nanoparticles, which extended the 
application ranges to protein-nanoparticle conjugations with different bonding 
chemistries. This direct, accurate and reliable method with excellent reproducibility shows 
great potential for quantification of any other proteins on nanoparticles. 
 
 
Experimental 
 
Materials 
Pepsin (from porcine gastric mucosa, E.C.3.4.23.1, 3200-4500 units/mg protein), 
gold(III)chloride trihydrate (HAuCl4·3H2O), trisodium citrate, 2-(N-morpholino)ethane 
sulfonic acid (MES) monohydrate, ammonium acetate (NH4Ac), sodium tetraborate 
decahydrate, boric acid, 2-amino-2-(hydroxymethyl)-propan-1,3-diol (Tris) base, sodium 
hydroxide, hydrochloric acid, sodium phosphate monobasic dihydrate and sodium 
phosphate dibasic dihydrate were purchased from Sigma Aldrich (Germany). 6-
Aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) was purchased from Synchem 
(Altenburg, Germany). HPLC-grade acetonitrile was purchased from JT Baker Chemical 
(Deventer, The Netherlands), and HPLC-grade methanol was bought from Sigma Aldrich. 
Double deionized water (produced by Elga Purelab Ultra ELGA, System LabWater, Celle, 
Germany) was used throughout synthesis of GNPs and analytical procedures including 
HPLC-FLD. Phosphate buffer (PB) (10 mM, pH 7.5) was prepared with sodium 
phosphate monobasic dihydrate and sodium phosphate dibasic dihydrate.  
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Preparation of pepsin-GNP bioconjugates 
Gold nanoparticles were prepared according to the Turkevich-Frens method with some 
modifications [1, 20]. In brief, 25.25 mg HAuCl4 were dissolved in 50 mL double 
deionized water (with a final concentration of 1.14 mM) and then heated at 170˚C under 
reflux and constant stirring for 10 min. Afterwards, 6.25 mL trisodium citrate (2.28 mM) 
were added and heated for another 10 min under reflux and constant stirring. The colloid 
solution was then allowed to cool down to room temperature under continuous stirring for 
an additional 60 min. The obtained citrate-GNP solution was stored at 4 ˚C for further 
usage [31]. For the preparation of pepsin-GNP bioconjugates, 1 mL of the above GNP 
solution was centrifuged and the supernatant removed. To these centrifuged 
nanoparticles, 1 mL of pepsin solutions with different enzyme concentrations in the range 
of 0.0052 to 5.2 mg mL-1 in 20 mM MES buffer pH 4.5 was added. These reaction 
mixtures were incubated at 4°C overnight. Afterwards, the pepsin-GNP bioconjugates 
were washed with 10 mM Tris-HCl (pH 7.5) and 10 mM PB (pH 7.5), respectively. 
Washing steps with Tris-HCl buffer were performed twice and with PB buffer thrice 
(centrifugation at 12000 rpm for 15 min, removal of supernatant and resuspension in 
respective buffer). 
 
Digestion of samples and calibrants 
Pepsin solutions with concentrations in the range of 0.001 to 5 mg mL-1 were applied as 
standard calibrants (calibration set 1). To match the same matrix of samples, the same 
concentration range of pepsin (0.001 to 5 mg mL-1) mixed with GNPs were prepared as a 
second set of calibrants (calibration set 2, matrix-matched calibration). A third more 
generic calibration based on amino acid standards was also tested. In this case, the 
protein concentration was calculated from the determined amino acid concentration, the 
molecular weight of the protein and the number of the respective amino acid residue in 
the protein. For this purpose, a calibration series of an amino acid standard mixture (in 
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the range of 0.0025 to 0.5 mM) was prepared in 0.2 M borate buffer (pH 8.5) (calibration 
set 3) and was directly used for AQC derivatization (vide infra).  
Before protein digestion, 1 mL pepsin-GNP bioconjugates samples were concentrated to 
100 µL. For the digestion, one hundred microliter of sample solutions (pepsin, pepsin 
mixed with GNPs, pepsin-GNP bioconjugates) were first evaporated to dryness in a 
Thermo Savant ISS110 SpeedVac at 43 ˚C for 2 h. Next, the dried samples were 
hydrolyzed with 100 µL 6N HCl at 110°C for 24h. Afterwards, the hydrochloric acid in the 
samples was removed by evaporation in the SpeedVac at 43 °C for 5 h. Finally, 100 µL 
of 0.2 M borate buffer (pH 8.5) were added to re-dissolve the hydrolysis product by 
rinsing the inner surface of the vials on a vortex mixer. These protein hydrolysates, 
redissolved in derivatization buffer, were centrifuged twice (12000 rpm, 15 min) to 
remove the nanoparticles. The obtained solutions (supernatants) were stored at -20 ˚C 
for further AQC derivatization.  
 
AQC derivatization 
AQC derivatization reagent (3 mg mL-1) was prepared by dissolving purified 3 mg AQC in 
1 mL anhydrous acetonitrile. Ten microliter of each obtained hydrolysis product solution 
(from pepsin, pepsin mixed with GNPs, and pepsin-GNP bioconjugates, respectively) 
were added to 70 µL of 0.2 M borate buffer (pH 8.5). Afterwards, to each solution 20 µL 
of AQC solution (3 mg mL-1 in acetonitrile) were added. The reaction was allowed to 
proceed at 55 °C under continuously shaking at 800 rpm for 10 min. The obtained 
samples containing AQC derivatives of amino acids were directly analysed by HPLC-
FLD. 
 
HPLC-FLD analysis 
HPLC-FLD analysis was performed on an Agilent 1100 HPLC instrument consisting of a 
binary pump, autosampler, column compartment and fluorescence detector. Agilent 
Zorbax Eclipse XDB C18 column (4.6 x 150 mm, 5 µm) was used for the 
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chromatographic separation. Mobile phase A consisted of 2.5 mM ammonium acetate in 
water, and mobile phase B consisted of 3.8 mM aqueous NH4Ac/ACN (30:70; v/v). Amino 
acid separation was performed at 25°C with gradient elution (0-12 min 1-8 % B, 12-
25 min 8-11 % B, 25-27 min 11 % B, 27-29 min 11-20 % B, 29-39 min 20 % B, 39-40 min 
20-25 % B, 40-40.1 min 25-100 % B, 40.1-43.1 min 100 % B, 43.4-48 min, 100-1 % B). 
The flow rate was set to 1 mL min-1, and injection volume was 5 µL. Detection was 
carried out by fluorescence detection with excitation at 254 nm and emission at 395 nm. 
 
 
Result and discussion 
 
Development of protein quantification method 
The accurate unbiased characterization of protein concentrations on protein-nanoparticle 
bioconjugates is of prime importance in many fields. Still it represents a major not fully 
solved challenge. Many of the methods applied for this purpose are biased due to indirect 
measurements, assumptions in the calculations (e.g. volume dimensions of the 
immobilized proteins), insufficient precision, bias from complicated sample preparation 
and other problems. Therefore, we have been looking for a method which circumvents 
these shortcomings, viz. a method that i) is based on the direct analysis of the purified 
bioconjugate and not indirectly via free (unbound) proteins, ii) directly measures the 
protein content without assumptions in calculations, and iii) exhibits high precision. A 
method that is based on direct hydrolysis of the protein-NP conjugate and classical amino 
acid analysis of the generated hydrolysate has appeared attractive as it turns out to be 
the most reliable and precise methodology. In this study, the direct quantification method 
of protein on nanoparticles was established with adsorptively bound pepsin on GNPs 
(pepsin-GNP bioconjugates) as a model system. The strategy for directly quantifying 
adsorbed pepsin on GNPs is depicted in Figure 1a. In general, the samples are first 
digested with 6 N HCl, evaporated to dryness, redissolved in derivatization buffer, GNPs 
230 
 
removed by centrifugation and the resultant amino acid hydrolysate in derivatization 
buffer subjected to derivatization with AQC reagent followed by HPLC-FLD analysis.  
 
In the first step, pepsin-GNP bioconjugates have been prepared by straightforward 
adsorption of pepsin in different concentrations onto GNPs. After conjugation, unbound or 
loosely bound pepsin has been removed by washing steps (centrifugation and re-
dissolution) with 10 mM Tris-HCl (pH 7.5) and 10 mM PB buffer (pH 7.5), respectively. 
After removal of the supernatants and evaporation to dryness, the pepsin-GNP 
bioconjugates have been subsequently digested with 6 N HCl. During the digestion 
process, pepsin bound on GNPs has been completely hydrolyzed to amino acids. This 
classical method of peptide and protein hydrolysis is well established and has proven to 
be highly reproducibile. The GNP carrier, on the other side, is chemically stable against 
HCl, which allows straightforward removal of the GNPs from the hydrolysate by simple 
centrifugation on a minispin. In order to be able to detect even small quantities of 
immobilized protein, a concentration step by a factor of 10 has been implemented in the 
course of the hydrolysis procedure. The obtained hydrolysate solutions containing amino 
acid and nanoparticles (which aggregated after hydrolysis) have been evaporated to 
dryness to completely remove HCl and subsequently have been re-dissolved in 0.2 M 
borate buffer (pH 8.5). Two centrifugation steps have been carried out to remove the 
GNP pellets from the solutions and the remaining supernatant containing the generated 
amino acids have been used for derivatization with AQC. The reaction scheme for the 
derivatization is shown in Figure 1b. AQC is an excellent derivatization reagent for amino 
acid analysis [32]. It reacts fast with both primary as well as secondary amino acids to 
form stable AQC-amino acid derivatives, which can be sensitively detected by 
fluorescence detection with excitation at 250 nm and emission at 395 nm [33, 34]. For the 
derivatization, 0.2 M borate buffer (pH 8.5) has been selected as the reaction buffer 
because it provides the highest derivatization yields [33]. Finally, the AQC-amino acid 
derivatives have been analyzed by HPLC-FLD using a C18 column and gradient elution. 
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Figure 2a shows a representative chromatogram of a mixture containing the 20 standard 
amino acids derivatized with AQC. Each peak has been identified by comparing the 
retention times with single amino acid standard injections. Under optimized conditions, a 
successful separation of each amino acid has been achieved except for valine and 
tyrosine (peak 13). Under given conditions they have similar lipophilicity. Arg is 
accompanied by a second peak, which originates from the derivatizing agent, which is 
not fully baseline resolved. Since none of these three amino acids was considered to be 
used for the quantitative analysis herein, no further attempts have been made to separate 
them because longer gradients would have been necessary at expense of analysis times. 
For the quantitative analysis of the pepsin concentration the peak of AQC-glycine 
derivative at retention time 13.67 (± 0.05) min has been selected due to the reason that 
glycine accounts for 10.7 % related to all amino acids in pepsin (serine for 13.5 %). 
Consequently, a good sensitivity of the fluorescence signal can be obtained for these two 
amino acids [35]. However, during the hydrolysis process with 6 N HCl serine can 
decompose to some degree due to water cleavage (5-15 % destruction) has been 
reported, which might easily result in inaccurate quantification results. In contrast, a high 
recovery of over 95 % has been reported for glycine in common protein hydrolysis 
reactions [32, 36-38]. Whatsoever, also other well resolved amino acids such as Ala, Ile, 
Leu or Phe can be selected for quantitation e.g. if another protein has to be determined 
which shows higher contents of these amino acids or for validation purposes. 
 
Calibration and method validation 
Calibration can be based either on the protein to be determined, here pepsin, or on the 
amino acid selected for quantitation, here glycine. The former approach is more 
straightforward and is preferred if a sufficient amount of the protein is available. The 
second approach will be selected, if the protein is precious and only limited amounts are 
amenable. A main requirement in this case is the overall knowledge of the amino acid 
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sequence and the number of the selected amino acid residue in the protein. Herein, we 
will compare these two approaches. 
First, pepsin has been used for calibration. Two sets of standard solutions, pepsin 
(calibration set 1) and pepsin mixed with GNPs (matrix-matched) (calibration set 2), have 
been employed for calibration in order to examine whether the matrix (i.e. the GNPs) 
represent a problem during digestion and influence hydrolysis yields or decompose 
amino acids. After acidic hydrolysis and derivatization, the AQC-amino acid derivatives 
from the hydrolyzed pepsin have been analyzed by HPLC-FLD under optimized 
conditions. The chromatograms of hydrolyzed pepsin in the concentration range between 
0.001 to 2 mg mL-1 from calibration set 2 in the presence of GNPs are shown in Figure 
2b. It can be seen that the peak intensity of AQC-glycine increases significantly with 
higher concentration of pepsin used as calibrant, as expected. Calibration curves for 
these two sets of standards (calibration set 1 and 2) have been obtained by plotting the 
integrated peak areas of AQC-glycine against pepsin concentrations (see Figure 3a). It is 
worthwhile noting that these two calibration curves are almost perfectly overlapping with 
each other. Thus, very similar linear regression equations are obtained for these two 
calibration curves (shown in Table 1). Both calibration curves show a linear range from 
0.001 to 2 mg mL-1 with excellent linearity (R2 value of 0.9998 and 0.99994, 
respectively). Moreover, the limit of detection (LOD; S/N = 3) and the limit of 
quantification (LOQ; S/N = 10) are identical for the two calibration sets (pepsin, pepsin 
with GNPs). They have been determined to be 0.0001 and 0.0003 mg mL-1. These 
results clearly demonstrate the negligible influence of the matrix (gold nanoparticles) on 
the protein quantification process.  
Furthermore, the method using matrix-matched calibration (calibration set 2) has been 
validated in accordance with the ICH guideline. Thus, intra- and inter-day precision and 
accuracy have been validated at three concentration levels for quality control (QC) 
samples (pepsin mixed with GNPs) in three replicates, and all these validation 
characteristics have been evaluated under the same experimental conditions. The 
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obtained results are summarized in Table 2 [39]. It can be seen that excellent intra- and 
inter-day assay precision (< 5 % RSD) and accuracy (98-118 % recovery) can be 
achieved, which indicates the absence of a significant bias and proves the high reliability 
of this established method. Overall, all these results demonstrate that the established 
method can be used for detection and quantification of pepsin on the surface of GNP 
over a wide concentration range. 
Next it has been tested, whether consistent results can be obtained, when amino acid 
mixtures instead of pepsin are used as calibrants. Thus, a standard amino acid mixture 
(containing all amino acids in the range of 0.0025 to 0.5 mM) has been prepared as the 
third set of calibrants (calibration set 3) and injected to the HPLC-FLD. The calibration 
data are summarized in Table 1. The amino acid sequence of pepsin is well known. It 
contains 35 glycine residues. With this information in hand, the corresponding protein 
concentrations can be readily calculated from the determined amino acid (glycine) 
concentrations. The resultant calibration function is shown in Fig. 3b and compared with 
the calibration of set 2 (pepsin mixed with GNPs) (Fig. 3b insert). 
Similar linearity relationships and calibration functions (slopes and intercepts) of these 
two curves clearly show the consistency between the amino acid-based calibration and 
the pepsin-based calibration. The result demonstrates that calibration can be carried out 
with amino acid calibrants instead of the emanating protein. With the amino acid mixtures 
for calibration, the novel, yet simple and universal method can be extended to a wide 
range of proteins showing a great potential for quantification of protein surface coverages 
on nanoparticles. 
 
Quantification of pepsin on GNPs 
To verify the capability of this novel method for the quantification of immobilized proteins, 
two series of adsorptively bound pepsin-GNP bioconjugates have been synthesized and 
the protein coverage on the nanoparticles has been quantified by the established 
method. The bioconjugates have been prepared by adsorption of pepsin onto GNPs 
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using different concentrations of protein (5.2 µg mL-1 to 5.2 mg mL-1) in the reaction 
mixture. During adsorption, a hard protein corona is gradually formed from the initially 
loosely bound protein shell through adsorption, desorption and rearrangement processes 
of the proteins onto the GNPs [40]. After conjugation, purification of pepsin-GNP 
bioconjugates has to be performed in order to remove the unbound as well as loosely 
bound proteins. For purification, 10 mM (pH 7.5) Tris buffer (2x washed) has been used 
for one set of pepsin-GNP bioconjugates, while 10 mM PB buffer (pH 7.5) (3x washed) 
has been used for the second set. Due to their distinct ionic strengths and different 
number of washing steps different protein surface coverages might result from their 
different strength and efficiencies in disruption of electrostatic interactions between 
protein and gold surface as well as between protein molecules. 
For the quantitative analysis of the protein coverage, all pepsin-GNP bioconjugate 
samples have been analyzed in triplicates using the same hydrolysis and derivatization 
procedures as described for the pepsin standard solutions. All the measurements of the 
derivatized amino acid solutions have been performed by HPLC-FLD. The total amount 
of adsorbed pepsin has been calculated using two distinct calibration curves (matrix-
matched pepsin i.e. calibration set 2 as well as amino acid mixtures i.e. calibration set 3). 
For comparison, the supernatants after protein immobilization were analyzed as well by 
the same method and used for back-calculation of the adsorbed protein concentration by 
mass balance considerations (indirect determination) (see Supplementary Material). The 
results of the indirect method clearly document that this assay format is not reliable (see 
Supplementary Material). Furthermore, the binding efficiency (%) has been calculated 
according to Eq. (1) 
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To obtain the exact number of immobilized pepsin molecules per GNP, the measured 
protein concentration has to be divided by the GNP concentration, which has been 
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determined by resonant mass measurement and has been found to be               
1 25 × 10-11 mol L-1 [26]. All the results are summarized in Table 3 and the corresponding 
equilibrium isotherms are shown in Fig. 4a. The results in Table 3 show clearly that 
pepsin adsorption, i.e. the number of pepsin molecules per GNP, increases significantly 
with the pepsin concentration in the reaction mixture. With the highest pepsin 
concentration (5.2 mg mL-1) in the reaction mixture, ca. 25,000 pepsin molecules per 
GNP have remained adsorbed, after washing with Tris buffer. After washing with PB 
buffer, a surface coverage of only ca. 7,000 pepsin molecules per GNP has been found. 
On the contrary, the binding efficiency has significantly dropped with increasing pepsin 
concentration in the reaction mixture. While about 20-30 % of the pepsin in the reaction 
mixture has been immobilized from the lowest concentration, the percentage of pepsin 
immobilized has decreased to about 0.2 % at the highest concentration for the 
bioconjugates washed with Tris buffer. Again, the corresponding numbers have been 
lower for pepsin-GNP bioconjugates washed with PB. This indicates that the PB washing 
procedure more efficiently replaces loosely bound protein molecules from the adsorbent 
surface, either due to the additional washing step (2 times with Tris buffer and 3 times 
with PB buffer) or due to a more efficient replacement of loosely adsorbed protein 
molecules on the outer layers. 
Various isotherm models have then been fitted to the binding data in Figure 4a. The 
Langmuir isotherm has shown a poor quality of fit. Thus, a Freundlich model has been 
tested and has provided a good fit for the adsorption behaviors. The Freundlich sorption 
isotherm equation is given by Eq. (2), 
 
qe = Kf Ce
(1/n)           (2) 
 
wherein qe is the number of pepsin molecules per GNP and Ce is the equilibrium pepsin 
concentration (mg mL-1). Kf is the Freundlich constant related to the binding capacity of 
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GNPs for pepsin, and 1/n is the exponent of non-linearity providing information on the 
affinity change of GNPs to pepsin with pepsin concentration [41]. 
The Freundlich parameters Kf and 1/n can be determined by the nonlinear regression and 
are summarized in Table 4. This sorption behavior can be explained by a gradual 
decrease of the binding affinity with increasing equilibrium concentration and gives a non-
linear isotherm with a negative curvature. The exponent of the Freundlich isotherm is a 
measure of the deviation from an infinite perfectly homogenous surface. Here it can be 
assumed that at low concentration the pepsin strongly adsorbs at the gold surface 
forming a hard protein corona. Once the high affinity sorption sites are mostly occupied, 
affinity declines for steric reasons. Upon further protein binding, pepsin molecules bind to 
the protein covered nanoparticles forming a soft protein shell (soft corona). Affinity may 
be significantly lower for these binding sites explaining the negative curvature. It should 
be mentioned that a fractal Langmuir isotherm [42, 43] also reasonably well explained the 
sorption process with the same general interpretation of the sorption process. 
Furthermore, the data in Table 3 and 4 provide clear evidence that the surface coverage 
of pepsin on the GNPs strongly depends on the type of wash buffer. Much higher pepsin 
concentrations on GNPs can be obtained with Tris buffer (washing twice) compared to 
PB buffer (washing three times). These results are very similar regardless of which of the 
two different calibration curves (matrix-matched calibration with pepsin, calibration with 
amino acid mixtures) have been used for calculation of the surface coverage. At lower 
coverages, there is a complete overlap as observed for the two adsorption curves in PB 
buffer. 
The same adsorption experiments (pepsin onto GNPs at the same concentrations in the 
reaction buffer and washing with 10 mM Tris buffer) have been carried out previously in 
our work and the resultant particles have been characterized by Taylor dispersion 
analysis (TDA) [26]. It is evident by Figure 4b that the pepsin adsorption curve measured 
herein follows the same general pattern as the one from the earlier work and is 
characterized by hydrodynamic diameters (from TDA). This can be regarded as a further 
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indication of the validity of the novel established method for quantification of protein 
coverages on GNPs.  
It was further of interest to assess whether the determined pepsin concentrations 
correspond to a protein monolayer on the GNP surface or whether multilayer adsorption 
results from excessive protein in the reaction mixture. Since the Langmuir model has not 
been suitable to describe the adsorption process adequately, the latter adsorption 
characteristic, i.e. multilayer adsorption, has therefore been expected to apply. According 
to a recent publication, the monolayer adsorption capacity (Nmono) at 100 % coverage can 
be estimated using simple geometric considerations assuming that proteins remain 
globular on the GNP surface [14, 44]. For its rough theoretical estimation, the surface 
area of the particles at half a protein diameter above the particle was calculated and 
divided by the protein cross-sectional area to achieve the theoretical numbers at 100 % 
coverage [44], as given by eq. 3, 
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wherein RGNP and Rprotein are the radius of the GNPs and the protein, respectively. For 
the GNPs used herein a hydrodynamic diameter of 44.1 ± 0.3 nm has been measured by 
DLS and a dry state diameter of ca. 30 nm by TEM. A hydrodynamic radius of pepsin of 
0.47 ± 0.03 nm has been determined recently by TDA [26]. Based on the dry state radius 
of GNPs by TEM and the hydrodynamic radius of pepsin by TDA, a monolayer capacity 
of around 4200 pepsin molecules per GNP can be estimated. Using the DLS radius 
instead, this number would be around 9000 pepsin molecules per GNP. Considering that 
the radius determined by DLS is typically overestimated to some extent, the former value 
appears more plausible. Looking at the values in Table 3, it can be noticed that with Tris 
buffer the monolayer capacity is already reached at the lowest concentration of pepsin in 
the reaction mixture (0.0052 mg mL-1). At higher pepsin concentrations in the reaction 
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mixture, the GNPs adsorb further proteins and most probably build up multilayers. A 
coverage with 9200 pepsin molecules per GNP correspond to a bilayer coating, 15000, 
21000, and 27000 molecules per GNP to triple, quadruple, and quintuple layer coatings, 
respectively (calculations based on TEM radius and hydrodynamic radius of pepsin from 
TDA). In contrast, with PB buffer protein coverages largely corresponding to monolayer 
coatings are formed over a wide concentration range of pepsin in the reaction buffer and 
only at the highest pepsin concentration (5.2 mg mL-1) a second pepsin layer is attached 
on the surface. It seems that the additional washing step (3x instead of 2x with Tris) or 
PB more efficiently desorbs loosely bound proteins (soft protein corona) and only the 
strongly adsorbed protein molecules (hard protein corona) remain adsorbed on the 
surface after repetitive PB wash. Thus, pepsin-coated GNPs synthesized by this way are 
supposed to be more stable. 
While documented herein with adsorptively bound protein-GNP conjugates, the approach 
can also be used for covalently linked protein-GNP bioconjugates, as documented in the 
supplementary material by protein functionalized GNPs obtained by coupling of pepsin to 
carboxy-PEGylated GNPs (see Supplementary Material). 
 
 
Conclusion 
Protein-nanoparticle conjugates have become very popular in many fields of 
nanoscience, including immobilized enzyme reactors, nanoparticle-based biosensors and 
protein-enabled nanomaterials for biomarker enrichment. Therefore, understanding and 
assessing the surface coverage is of utmost importance for producing protein-
nanoparticle conjugates with excellent reproducibility. The determination of the protein 
coverage on the NP surface constitutes therefore an essential step in quality control. The 
majority of methods are indirectly analyzing the surface coverage via free protein 
quantitation in the supernatant of the reaction. Other methods make assumptions during 
calculation of the protein surface concentration from measured physicochemical 
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properties. The herein newly established method for protein coverage determination by 
contrast is directly analyzing the protein concentration on the protein-GNP bioconjugates. 
It is based on the classical and reliable amino acid analysis of peptides and proteins. The 
AQC-amino acid derivatives, obtained after in situ digestion of protein-GNP 
bioconjugates and subsequent derivatization process with AQC reagent, are analyzed by 
HPLC-FLD, which ensures high sensitivity (0.1 µg mL-1 for pepsin, corresponding to 
2.89 × 10-9 mol L-1) and allows determination of even the smallest surface concentrations. 
The calibration curves showed good linearity and high correlation coefficients. Validation 
experiments demonstrated excellent intra-and inter-day assay precision and accuracy of 
this method for pepsin quantification. The method is supposed to be valuable for the 
study of adsorption phenomena of proteins onto nanoparticles in which even minor 
alterations can be monitored. In order to increase the sample throughput, this method 
could be transferred to UHPLC with sub-2µm or core-shell particle columns, which 
provides fast separation with much reduced run times at equal resolutions. This generic 
approach based on the amino acid analysis strategy turns out to be an accurate method 
for the determination of protein coverage and shows great potential for quantification of 
any other protein with easy operation and low cost. It is, however, not applicable to 
mixtures of proteins. In this case, the analysis based on signature peptides by targeted 
HPLC-MS/MS analysis seems to be more appropriate. 
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Figure captions: 
 
 
Fig. 1. (a) Schematic illustration of the workflow based on the amino acid analysis 
performed by HPLC-FLD for the direct quantication of the pepsin amount bound onto 
gold nanoparticles (GNPs); (b) The reaction scheme of amino acid derivatization with 
AQC reagent. 
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Fig. 2. (a) Optimized chromatographic separation of an amino acid standard mixture (0.1 
mg mL-1), which was derivatized with AQC reagent; (b) The chromatograms of calibrants 
(pepsin mixed with GNP) with different concentrations, after the process of hydrolyzation 
and derivatization. 
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Fig. 3. (a) Calibration curves for the two sets of calibrants, pepsin (calibration set 1) and 
pepsin mixed with GNPs (calibration set 2), obtained by plotting the integrated peak 
areas of AQC-glycine against pepsin concentrations (set 1 and 2 are completely 
overlapped indicating absence of matrix effects); (b) Comparison of the two calibration 
curves for the set 2 and set 3 (pepsin mixed with GNPs, amino acid mixture as the 
calibrants), by plotting the integrated peak areas of AQC-glycine against pepsin 
concentrations. For the amino acid mixture as the calibrant, the pepsin concentrations (x-
axis) were obtained from the conversion of the glycine concentrations (35 glycine 
residues per pepsin molecule). 
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Fig. 4. (a) Adsorption isotherms of pepsin binding onto GNPs. The solid curves are the 
best fits of the Freundlich adsorption isotherm model to the experimental data. The error 
bars represent standard deviations; (b) The curves of an increase in hydrodynamic 
diameter measured by TDA and the increase in pepsin surface coverage measured with 
the established method (Pepsin concentration on the x-axis refers to the pepsin 
concentration used for the conjugation reaction). 
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Tables: 
 
Calibrants 
Pepsin 
(Calibration set 1) 
Pepsin and GNP 
mixture 
(Calibration set 2) 
Amino acid mixtures 
(glycine)a 
(Calibration set 3) 
Amino acid mixtures 
(pepsin)b 
(Calibration set 3) 
Linear range 0.001 to 2 mg mL-1 0.001 to 2 mg mL-1 0.0025 to 0.5 mM   0.00247 to 0.495 mg mL-1 
Regression 
equation 
y = 3576.8x - 18.638 y = 3585.0x - 18.182 y = 2886.5x + 0.1502 y = 2918.2x + 0.1502 
R2 0.9998 0.99994 0.99992 0.99992 
LODc   0.0001 mg mL-1 0.0001 mg mL-1 0.00008 mM   0.000079 mg mL-1 
LOQd   0.0003 mg mL-1 0.0003 mg mL-1 0.00025 mM   0.000247 mg mL-1 
a The amino acid mixtures were used as the standards, and the calibration curve was obtained 
with integrated peak areas of AQC-glycine (y-axis) versus glycine concentrations (x-axis). 
b The amino acid mixtures were used as the standards, and the calibration curve was obtained 
with integrated peak areas of AQC-glycine (y-axis) versus pepsin concentrations (x-axis) 
calculated from glycine concentrations (35 glycine residues per pepsin molecule). 
cLOD, the limit of detection was obtained from the signal to noise ratio 3: 1 
dLOQ, the limit of quantification was obtained from the signal to noise ratio 10: 1 
 
Table 1. Summary of calibration curves with different standard solutions as the calibrants 
employing pepsin (calibration set 1), pepsin mixed with GNPs (matrix-matched; 
calibration set 2), and amino acid mixtures (calibration set 3; results for calibration set 3 
are given in two distinct units, once in mM and once in mg mL-1 to allow for better 
comparison). 
 
Concentration  
 of pepsin mixed 
with GNPs  
 [mg mL-1]  
Intra-day (n=3) 
  
Inter-day  (n=3) 
Calculated 
Concentration  
[mg mL-1] 
Accuracy 
(%) 
Precision  
R.S.D (%) 
  
Calculated 
Concentration 
[mg mL-1] 
Accuracy 
(%) 
Precision  
R.S.D (%) 
0.01 0.0118±0.0002 117.76% 2.24%  0.0118±0.0003 118.15% 1.97% 
0.75 0.75±0.021 100.46% 2.84%  0.78±0.039 103.92% 4.95% 
1.5 1.48±0.043 98.70% 2.89%   1.52±0.063 101.53% 4.11% 
 
Table 2. Accuracy and precision of the amino acid-based HPLC-FLD method for the 
quantification of pepsin surface coverages on GNPs. 
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Samples 
  In Tris-HCl buffer   In PB buffer 
 
Results calculated with pepsin 
(mixed with GNPs) calibration 
curve 
Results calculated with glycine 
calibration curve 
 
Results calculated with 
pepsin (mixed with GNPs) 
calibration curve 
Results calculated with 
glycine calibration curve 
Concentration 
[mg mL-1] 
 Binding 
efficiency (%) 
Pepsin 
molecules 
per GNP 
Binding 
efficiency 
(%) 
Pepsin 
molecules per 
GNP 
 Binding 
efficiency (%) 
Pepsin 
molecules 
per GNP 
Binding 
efficiency 
(%) 
Pepsin 
molecules 
per GNP 
0.0052  30.60±0.31% 3677 ± 37  25.79±0.28% 3100 ± 46  22.56±0.16% 2710 ±20  15.8±0.20% 1899 ±24 
0.052  7.81±0.26% 9382 ± 316  8.48±0.33% 10184 ± 392  3.09±0.67% 3714 ±803  2.62±0.83% 3145 ±997 
0.26  1.91±0.05% 11496 ± 317  2.13±0.07% 12810 ±393   0.65±0.01% 3903 ±32  0.56±0.01% 3380 ±40 
0.52  1.11±0.01% 13281 ± 159  1.25±0.02% 15028 ±197   0.37±0.03% 4472 ±315  0.34±0.03% 4087 ±391 
1.04  0.60±0.05% 14326 ± 1246  0.68±0.06% 16325 ± 1548   0.21±0.01% 4936 ±353  0.19±0.02% 4663 ±438 
5.2   0.20±0.01% 23573 ± 1781 0.23±0.02% 27810 ± 2212   0.06±0.00% 7031 ±95  0.06±0.00% 7265 ±118 
 
Table 3. Summarized results of the pepsin binding efficiency and surface coverage 
(molecules) on GNPs. 
 
Samples 
Freundlich parameters 
R2 Kf(-) 1/n (-) 
Pepsin-GNP 
resuspended in Tris-
HCl buffer 
Calculated with the Pepsin 
calibration curve 0.97 15675 ± 548 0.23 ± 0.022 
Calculated with the Glycine 
calibration curve 0.97 17849 ± 690 0.26 ± 0.025 
Pepsin-GNP 
resuspended in PB 
buffer 
Calculated with the Pepsin 
calibration curve 0.92 5220 ± 197 0.14 ± 0.021 
Calculated with the Glycine 
calibration curve 0.95 4945 ± 192 0.21 ± 0.024 
 
Table 4. Summary of Freundlich isotherm parameters for pepsin adsorption onto GNPs 
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Supplementary material 
 
Quantification of adsorbed pepsin on GNPs with indirect method 
For comparison and to illustrate the problems of indirect determination of the surface 
coverage, the samples analyzed in Table 3 of the main document were also analyzed by 
using an indirect assay for pepsin surface coverage quantification. 
 
Experimental 
Quantification of pepsin in the supernatant (indirect method) 
After the immobilization reaction at 4°C overnight, the reaction mixtures were centrifuged. 
The supernatant was collected for the indirect quantification of bonded pepsin, and also 
the Pepsin@GNP pellets were washed for the direct quantification. The washed 
Pepsin@GNP pellets were further treated as described in the main document. The 
combined supernatant and washing solutions containing non-immobilized (free) pepsin 
were evaporated to dryness in a Thermo Savant ISS110 SpeedVac at 43 ˚C for 2 h. 
Next, the dried samples were hydrolyzed with 100 µL 6N HCl at 110°C for 24h. 
Afterwards, the hydrochloric acid in the samples was removed by evaporation in the 
SpeedVac at 43 °C for 5 h. Finally, 100 µL of 0.2 M borate buffer (pH 8.5) were added to 
redissolve the hydrolysis product by rinsing the inner surface of the vials on a vortex 
mixer. The obtained solutions were stored at -20 ˚C for further AQC derivatization and 
RPLC analysis as described in the main document. The bonded pepsin concentration 
(Cbound) on the GNPs was calculated by mass balance considerations from the total 
pepsin concentration before immobilization (Ctot) and the free pepsin concentration in the 
supernatant after immobilization (Cfree) by eq. S1. 
 
ƉrƈƈƗƒƗƅƒƘƑƇ
CCC
−=          (S1) 
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Fig. S1a shows the quantification results of the supernatant (indirect assay), and in 
comparison, Fig.S1b presents the quantification results of the Pepsin@GNP pellets 
(direct assay). Both assay results were calculated with the calibration curve of pepsin 
mixed with GNPs (calibration set 2). The comparison of these two methods was 
performed only with the pepsin concentration in reaction solutions from 0.0052 to 
1.04 mg mL-1 due to the linearity limit (0.001 to 2 mg mL-1) of the calibration curve 
(5 mg mL-1 was outside of the linearity range). 
 
Results and Discussion 
The indirect method for pepsin surface coverage determination has been realized based 
on the quantification of non-immobilized pepsin in the supernatant which has been 
collected after the pepsin immobilization step. The amount of immobilized enzyme has 
then been back calculated by applying the mass balance equation (eq. S1). With the 
indirect method, inaccurate results and even negative values of bonded pepsin 
concentration have been obtained (Fig. S1a). This can be due to the reason that during 
the immobilization only a tiny amount of pepsin gets adsorbed onto the GNPs, and 
therefore caused an insignificant decrease of the pepsin concentration in the 
supernatant. Negligible changes of the pepsin concentration in the supernatant compared 
to the initial concentration of pepsin in the reaction mixture (in the order of the 
experimental error of the method) may therefore translate into large standard deviations, 
significant bias (i.e. inaccuracy of the method) and even negative results. For example, 
negative values for surface coverage have resulted at two concentrations (0.0052 and 
0.52 mg mL-1) (Fig. S1a). Large standard deviations have been found at two levels (0.26 
and 0.52 mg mL-1). Furthermore, besides the negative values also the highest 
concentration (1.04 mg mL-1) showed a significant bias, e.g. about factor 2 higher 
concentrations (Fig. S1a). 
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Figure S1. Bonded pepsin concentrations (mg pepsin per mL GNP suspension) 
quantified with indirect method (a), and the bonded pepsin concentrations obtained with 
direct method (b). 
 
Quantification of pepsin covalently immobilized on GNPs via a chemical spacer 
To document that the method can also be used to covalently immobilized protein-GNP 
conjugates, pepsin was immobilized on carboxy-pegylated GNPs by amide coupling. The 
surface coverage was then determined by the direct assay described in the main 
document for the adsorptively bound pepsin-GNP conjugates. 
 
Experimental 
Immobilization of pepsin on GNP via PEG spacer 
First, the surface of citrate-capped GNPs was modified with O-(2-carboxyethyl)-O′-(2-
mercaptoethyl) heptaethylene glycol (HS-PEG7-GOOH). One microliter of HS-PEG7-
GOOH solution was added to 1mL citrate-capped GNP solution, and the modification 
reaction was performed overnight under constant stirring at room temperature. After 
modification, the obtained solution was washed twice by centrifugation at 12,000 rpm and 
re-suspension in 20 mM MES buffer pH 4.5. Afterwards, carboxylic acids on the GNP 
surface were activated with 20 µL N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC, 
12 mM) and 20 µL N-hydroxysulfosuccinimide sodium (sulfo-NHS, 60 mM) for 30 min. 
After centrifugation, 500 µL pepsin solutions with different concentrations (0.05, 0.25, 0.5, 
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1, 5 mg mL-1) in 20 mM MES buffer pH 4.5 were added to these centrifuged GNP pellets 
(from 500 µL HOOC-PEG7-GNP solutions). The reaction mixture was incubated at 20˚C 
for 2h. The obtained immobilized pepsin-GNP solutions were washed in triplicate with 10 
% isopropanol in 20 mM PB buffer pH 7.5. 
 
Digestion and derivatization 
500 µL of obtained immobilized pepsin-GNP solution was centrifuged and the pellets 
were digested with 100 µL HCl for 24h. After digestion, the digests were dissolved in 
100 µL 0.2M borate buffer pH 8.5. Ten microliters of each obtained hydrolysate solution 
were added into 70 µL 0.2 M borate buffer (pH 8.5), respectively. Afterwards in each 
solution, 20 µL of AQC solution (3 mg/mL in acetonitrile) was added and reacted at 55 °C 
under continuously shaking at 800 rpm for 10 min. The obtained amino acid derivative 
samples have been directly used for the analysis with HPLC-FLD. 
 
Results and Discussion 
After the immobilization of pepsin on HOOC-PEG7-GNPs via amide coupling, the 
obtained Pepsin-PEG7-GNPs have been carefully washed with 10% isopropanol in 
20 mM PB buffer pH 7.5 to remove the physically adsorbed pepsin from the 
nanoparticles. After derivatization with AQC, the obtained solutions have been analyzed 
with HPLC-FLD. Fig.S2 shows the bonded pepsin concentrations on PEG7-GNPs against 
the equilibrium pepsin concentrations.  It can be clearly seen that the method is 
applicable to covalently immobilized protein as well. With higher pepsin concentrations in 
the reaction mixture for amide coupling, the surface coverage increased in accordance to 
a Langmuir isotherm. At high pepsin concentrations in the reaction buffer (5 mg mL-1), the 
saturation capacity seems to be reached. 
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Figure S2. Binding isotherm of covalently immobilized pepsin on HOOC-PEG7-GNPs 
(mg pepsin per mL functionalized GNP suspension), and the error bars represent 
standard deviations. 
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Protein analytics by LC-MS often involves protein digestion to peptides (e.g. tryptic 
digests) or to smaller protein fragments (e.g. antibodies to antibody fragments). 
Immobilized enzyme reactors based on nanoparticulate supports are getting 
popular in this field. Gold nanoparticles turned out to be attractive nanocarriers for 
enzyme immobilization due to ease of preparation, flexible enzyme conjugation, 
straightforward sample processing steps, and in particular accelerated digestion 
kinetics. 
 
Immobilization of enzymes on solid supports (leading to immobilized enzyme reactors, 
IMERs) emerged as a powerful strategy to overcome some of the limitations of free 
enzymes in industrial processes and analytical sample preparation procedures, such as 
low stability, self-digestion, product contamination with enzyme and no repetitive usage of 
precious enzymes. While immobilization can improve or overcome such shortcomings of 
homogenous catalysis, concomitant reduction in activity has been frequently reported 
upon immobilization on microparticulate carriers. Such activity loss can be ascribed to 
steric hindrance of active sites of enzymes in immobilized state due to unfavorable 
enzyme orientation, changes in tertiary structure of enzyme upon bonding to a support, 
and slower diffusion of microparticulate enzyme carriers. Since active enzyme is mostly 
buried inside the mesoporous channels in microparticulate heterogeneous biocatalysts, 
fast digestion is limited by mass transfer resistances of substrates which must migrate by 
diffusion into the mesoporous channels to reach the enzyme on the inner surface. 
Through optimization of enzyme immobilization, it is however generally possible to 
maintain enzyme activity and immobilization of enzymes on nanoparticulate carriers 
turned out to be a successful strategy to enhance enzyme performances. Large surface 
areas that allow a higher enzyme loading and reduced mass transfer resistance for 
substrates (enzymes are readily accessible by substrates on the surface of nonporous 
materials eliminating intraparticulate mass transfer resistances which exist in 
microparticulate enzyme carriers) promote acceleration of enzyme activity at nanoparticle 
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interfaces [1]. A wide variety of nanocarriers have been propagated for enzyme 
immobilization [2]. Magnetic nanoparticles are probably the most popular ones. We use 
gold nanoparticles (GNPs) as carriers for enzyme conjugation due to its inertness, 
straightforward size-controlled synthesis, convenient and flexible surface modification by 
self-assembled monolayer formation, good colloidal stability which allows their handling 
(pipetting) like solutions similar to homogenous catalysis, and their high density which 
enables straightforward separation of the nanoparticles from reaction mixtures by simple 
centrifugation on a minispin. 
 
Synthesis and characterization of protein-conjugated gold nanoparticles 
GNPs can be synthesized by the Turkevich-Frens method from HAuCl4 and trisodium 
citrate [3]. In this reaction, citrate plays the double role as a Au(III) reducing agent and 
colloidal GNP stabilizing reagent due to capping citrate anions which are attached on the 
GNP surface and avoid aggregation by electrostatic repulsion. The synthesis follows a 
nucleation and growth mechanism and thus the size of the GNPs can be conveniently 
controlled by the HAuCl4 to trisodium citrate ratio. GNPs synthesized by this method 
range between 10 and 40 nm depending on the HAuCl4 to citrate ratio [4]. 
Size and size-distribution analysis is an important parameter for the characterization of 
GNPs and functionalized GNPs. Different methods exist and are utilized for this purpose. 
However, accurately measuring the size and size distribution is still a challenging task 
because distinct methods may provide slightly different results [4]. Transmission electron 
microscopy (TEM) provides information on the average size, size distribution, and shape 
of nanoparticles, however, lacks information about solution properties such as 
aggregation which is relevant for assessing the suitability of GNPs in many applications 
(Fig. 1a). On the contrary, dynamic light scattering (DLS) measures the nanoparticles 
with their solvation shell. If aggregation occurs in colloidal solutions, size distributions are 
significantly shifted. If particle distributions are multimodal, the size distributions 
measured by DLS unfortunately are biased because light scattering intensity increases 
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with the sixth power of the particle diameter which leads to distortions in favor of large 
particles. If asymmetric flow field flow fractionation (AsFlFFF, AF4) is employed for sizing, 
one has to make sure that particle adsorption on the membrane of the channel, which 
serves as an accumulation wall for larger particles does not distort the size distributions. 
Last but not least, differential mobility analyzers (DMA), such as nanoelectrospray gas-
phase electrophoretic mobility molecular analyzer (nES-GEMMA), have become popular 
recently for nanoparticle size analysis. nES-GEMMA allows the electrophoretic 
separation of singly charged particles in an orthogonal applied electric field at high 
laminar gas flow at atmospheric pressure and from such experiments, the particle 
diameter can be calculated. Multiply charged ions are generated using an electrospray 
process and then singly charged particles and neutrals are produced from the multiply 
charged particles by charge reduction with a Polonium-210 source which are then 
electrophoretically separated in the gas phase. nES-GEMMA has shown good size 
resolution, but represents dry state particle diameters. Fig. 1b-1e shows a comparison of 
size distributions of two distinct batches of GNPs with different average diameters as 
measured with different techniques. Many other techniques also exist [5]. 
Enzymes can be immobilized by a variety of methods such as covalent binding, 
entrapment in adsorbed polyelectrolyte layers, adsorption, ionic binding, affinity binding. 
However, covalent attachment is preferred in order to avoid bleeding of enzyme from the 
surface into the reaction mixture. For GNPs this requires the attachment of linkers and a 
number of bifunctional linkers with reactive group, e.g. carboxylic acid group, for protein 
coupling on one end as well as thiol group on the other end which enables their 
immobilization by self-assembled monolayer (SAM) formation have been used (Fig. 1f). It 
has been found that the surface coverage of those linkers depends on their length 
ranging from about 6 ligands per nm2 for a C2 spaced linker to about 4 ligands per nm2 
for a PEG7 spaced bifunctional linker (Fig. 1g) [6]. Shorter ligands obviously pack more 
densely on the surface of GNPs, however, the longer PEG7 spacer has turned out to be 
favorable. It greatly supported the colloidal stability, eliminated to large extent non-
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specific binding to the nanoparticle surface and assured a sufficient enzyme 
immobilization density and improved bioactivity [3]. Larger GNPs e.g. 33 nm were 
favorable as nanocarriers over smaller ones e.g. 18 nm [3]. 
An alternative concept for GNP functionalization with enzymes represents a layer-by-
layer adsorption of polyelectrolytes and subsequent protein bonding by amide coupling 
reaction [7]. For instance, coating of poly(allylamine) and subsequently with poly(acrylic 
acid) yields biocompatible and highly hydrophilic carboxy-terminated nanoparticles for 
enzyme coupling by EDC/sulfoNHS chemistry.  
The success of such surface functionalization can be controlled after each step by simple 
methods such as visible (VIS) spectroscopy, DLS and electrophoretic light scattering 
(ELS) (Fig. 2). VIS spectroscopy allows to measure the absorbance maximum (λmax) of 
the surface plasmon resonance (SPR) band (at around 525 nm for GNPs). It depends on 
the nanoparticle size and shape, size distribution, and morphological uniformity of GNPs, 
and consequently allows to monitor whether shifts of the SPR band occurred due to 
immobilization of ligands on the GNP surface, and most importantly whether aggregation 
occurred, as indicated by a band observed in the red-shifted region of the VIS spectrum. 
DLS documents the size increase due to immobilization of ligand and enzyme, 
respectively, and ELS indicates whether ζ-potentials are large enough to support colloidal 
stability by electrostatic repulsion between modified GNPs. Examples for enzyme 
conjugated GNPs described hereafter are given in Fig. 2. 
 
Trypsin-conjugated gold nanoparticles 
Trypsin is probably the most important enzyme in protein analytics and frequently used in 
bottom up protein analysis, e.g. in proteomics. Drawbacks are long digestion times (up to 
24 h), auto-digestion sub-products and poor enzyme-to-substrate ratio limiting high-
throughput protein identification. It was immobilized on GNPs using a bonding chemistry 
as outlined in Fig. 3a with variable spacers comprising 3-mercaptopropionic acid (MPA), 
11-mercaptoundecanoic acid (MUA), 16-mercaptohexadecanoic acid (MHA), HS-PEG4-
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COOH (PEG4) and HS-PEG7-COOH (PEG7) [3]. The effect of the spacer length on 
trypsin activity was investigated with the standard chromogenic substrate N-benzoyl-DL-
arginine-4-nitroanilide hydrochloride (BApNA). With longer spacer length the amount of 
trypsin bound onto GNPs could be increased significantly and PEG7 spacer turned out to 
be advantageous for this and other reasons, namely stabilization of the colloids as well 
as biocompatibility. Digestions with a protein test mixture revealed that the sequence 
coverage can be improved with trypsin-GNP bioconjugate having i) a PEG7 spacer 
instead of a MHA spacer and ii) when the GNP carrier was 33 nm instead of 18 nm in 
diameter [3]. BSA digestions further showed higher sequence coverage with GNP-PEG7-
Trypsin compared to Trypsin in free solution digestion. Good sequence coverages could 
be observed after 1-2 h digestion with GNP-PEG7-Trypsin. While digestion efficiencies 
were better with the GNP-PEG7-Trypsin conjugate as compared to free solution 
digestion, self-digestion was only observed in the reaction batches with free trypsin. 
 
Pepsin-conjugated gold nanoparticles 
Pepsin is another enzyme of significant utility in protein analytics. It is commonly 
employed in monoclonal antibody digestion near the hinge region to produce specifically 
F(ab')2 (with a molecular mass of about 100 kDa) and Fc fragment (ca. 50 kDa). Such 
antibody fragments are particularly useful for middle-up mass measurement for 
characterization of therapeutic antibodies by high-resolution MS. 
Pepsin was conjugated to GNPs by essential the same surface chemistry described 
above for GNP-PEG7-Trypsin [8]. However, pepsin is irreversible denatured under the 
conditions used for trypsin coupling and therefore the reaction buffer had to be adjusted 
(20 mM MES pH 4.5 instead of 50 mM bicarbonate buffer, pH 8.5 as for trypsin 
immobilization). With such conditions, the coupling efficiency of pepsin on GNP-PEG7-
COOH was good and about 0.25±0.03 mg mL−1 could be conjugated onto GNPs [8]. Due 
to bonding of bifunctional linker the nanoparticle diameter increased from ca. 30 nm for 
citrate-capped GNPs to ca. 50 nm, and further to ca. 100 nm after pepsin conjugation 
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(Fig. 2b). A ζ-potential of around -30 mV ensured a sufficient colloidal stability which is 
important because aggregated GNPs precipitate and lose their digestion efficiency. 
A monoclonal anti-HSA antibody was digested with such GNP-PEG7-Pepsin conjugate to 
document the biofunctionality of this bionanocatalyst [8]. The reaction product was 
characterized by HR-MS using a QTOF equipped with a µESI sprayer and a C18 online 
trap column for desalting of the protein sample.  Non-digested anti-HSA antibody was 
analyzed as well. The deconvoluted TOF-MS spectrum of the intact monoclonal antibody 
is illustrated in Fig. 4c [8]. It shows the characteristic mass of about 149 kDa with a 
number of isoforms. After digestion with pepsin-GNP conjugate a single peak with a 
deconvoluted mass of 97,619.4 Da for F(ab')2 was detected. These results clearly 
document the functionality of the immobilized pepsin nanobiocatalyst and evidence its 
practical utility for therapeutic protein characterization. 
 
Papain-conjugated gold nanoparticles 
Papain is another enzyme that can be used for antibody digestion. It is a cysteine 
protease which cleaves the antibody above the hinge region (the site of the disulfide 
bonds which connect the two heavy chains) yielding two Fab fragments and one Fc 
fragment (each ca. 50 kDa). Fab fragments are prepared to characterize the protein on 
an intermediate level instead of the whole intact immunoglobulin (middle up and middle 
down). 
Papain-GNP conjugates were synthesized by a layer-by-layer (LBL) polyelectrolyte 
coating approach with alternative deposition of first polyallylamine followed by polyacrylic 
acid and subsequent enzyme coupling to terminal carboxylates (Fig. 5a) [7]. ζ-Potentials 
of the modified GNPs indicated the successful coating as they changed from negative to 
positive upon polyallylamine coating, back to negative after polyacrylic acid deposition 
(Fig. 2d). DLS meaurement also indicated the successful coating by a significant size 
increase. It seems that a highly hydrated shell resulted from this LBL activation approach 
which supported colloidal stability and biocompatibility. It can be further seen in Fig. 2c 
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that the sizes of the papain-GNP conjugates significantly increased with more papain in 
the reaction mixtures during amide coupling. Resonant mass measurement (RMM), 
which measures the buoyant masses of single particles in a microfluidic channel that 
senses the density differences of the particle and the transport fluid via frequency shifts 
when the particle passes the sensor, was used to determine the amount of papain per 
GNP [5, 7]. It was found that the papain-GNP conjugate prepared from 1 mg/mL papain 
in the reaction mixture had an enzyme coverage of 2.06±0.19 × 106 papain molecules 
per GNP. Measurements of the enzyme kinetics with the model substrate BApNA 
showed that the Michaelis constant Km is not compromised by immobilization and that 
reaction rate is by a factor of 100 faster with the immobilized papain compared to papain 
in free solution [7]. This makes it possible to achieve the same reaction rates with much 
less enzyme which could be of interest for precious enzymes. 
The papain-GNP conjugate was then used to digest human IgG (Fig. 5b) and the 
resultant fragments were analyzed by HPLC-µESI-QTOF-MS (Fig. 5c) [7]. The 
deconvoluted mass spectrum of the hIgG before digestion showed a group of peaks 
around 150 kDa (note, this sample is not a monoclonal antibody but human IgG isolated 
from plasma).  After digestion, the deconvoluted mass of hIgG (ca. 150 kDa) disappeared 
and deconvoluted masses corresponding to fragments (Fab and Fc) in the range of 50–
55 kDa emerged. It clearly documents the functionality of the papain-GNP conjugate 
which may have great utility for antibody analysis. 
 
Conclusions 
Enzyme-GNP conjugates can be useful heterogeneous catalysts in protein analytics 
combining favorable properties of homogeneous and heterogeneous catalysis. Enzyme 
activity can be maintained by appropriate immobilization schemes. Reaction rates can be 
significantly enhanced. Enzyme stability is improved and self-digestion eliminated. Such 
colloidal bionanocatalysts can be conveniently pipetted and enzyme-GNP conjugates can 
be easily removed after reaction by simple short centrifugation on a tabletop minispin. As 
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a consequence, they turn out to be useful tools in bioanalysis and biopharmaceuticals 
analysis. 
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Figures and Figure captions 
 
 
Figure 1. Size determination of GNPs and surface coverage of different bifunctional 
ligands bonded by self-assembled monolayer (SAM) formation. TEM image of citrate-
stabilized GNPs (average particle size dTEM ∼30 nm, dDLS ∼ 40 nm) (a) [6]. Size 
distribution of GNPs prepared from two distinct HAuCl4 (H) to trisodium citrate (C) ratios 
by TEM (b), DLS (c), AsFlFFF (AF4) (d), nES-GEMMA (e) [4]. Scheme for GNPs with 
different bifunctional ligands assembled on the gold surface via dative thiol-gold bond (f), 
and their surface coverages as determined by ICP-MS (g) [6] (Abbreviations: MPA,3-
mercaptopropionic acid; MUA, 11-mercaptoundecanoic acid; MHA, 16-
mercaptohexadecanoic acid; PEG4, HS-PEG4-COOH; PEG7, HS-PEG7-COOH). 
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Figure 2. Characterization of enzyme-GNP conjugates. VIS spectroscopy measuring 
shifts in the surface plasmon resonance band, exemplified by pepsin-PEG7-GNP 
conjugate [8] (a). DLS (hydrodynamic particle diameters) and ELS (ζ-potentials) at 
distinct stages of surface modification as measured for pepsin-PEG7-GNP conjugate [8] 
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(b) and papain-GNP conjugate [7] (c and d) (abbreviations: PAH, polyallylamine 
hydrochloride; PAA, polyacrylic acid). 
 
 
Figure 3. Trypsin-conjugated GNPs. Synthesis of GNPs by Turkevich-Frens method, 
subsequent modification by SAM formation and immobilization of trypsin by amide 
coupling (a). Tryptic digestion of a model protein mix followed by HPLC-ESI-MS/MS 
analysis of the digest (b) [3]. 
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Figure 4. Pepsin-conjugated GNPs. Synthesis scheme (a), monoclonal antibody 
digestion scheme (b) and deconvoluted ESI-TOF-MS spectra before and after digestion 
of monoclonal anti-HSA antibody by Pepsin-conjugated GNPs [8]. 
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Figure 5. Papain-conjugated GNPs. Synthesis scheme by layer-by-layer approach and 
subsequent protein coupling (a), human IgG digestion scheme (b) and deconvoluted ESI-
TOF-MS spectra before and after digestion of human IgG by Papain-conjugated GNPs 
[7]. 
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4. Final Conclusions 
This dissertation deals with the complete synthesis and characterization of heterogeneous 
nano biocatalysts based on gold nanoparticles for sample preparation of biopharmaceuticals, 
such as proteins and antibodies before analysis using high-resolution mass spectroscopy. 
The aim was to check basic parameters such as functionality and stability of the platform 
also with regard to the development of a corresponding sample processing tool. Various 
characterization methods for the different GNP synthesis steps, such as Vis-spectroscopy, 
DLS, zeta potential, Taylor dispersion analysis, resonant mass measurement and protein 
assays have been used and compared. The determination of protein functionality was 
studied by Michaelis-Menten kinetics. For this purpose, a HPLC method was developed and 
validated according to ICH guideline. Model proteins such as BSA, cytochrome C and 
myoglobin were analyzed by liquid chromatography coupled with a high-resolution mass 
spectrometer. With an in-silico protein tool the sample proteins could be deduced due to the 
peptide pattern. 
 
Basically, the new and advanced method is aimed at quality control of bioprocesses in the 
biopharmaceutical industry. Due to the complete investigation of the developed 
nanobiocatalysts, this requirement seems to be fundamentally possible. 
 
The results of the synthesis of the heterogeneous nano biocatalysts show comparable 
results with the corresponding literature. In a one-month stability study unvaried results could 
be determined by Vis-spectroscopy, DLS and zeta potential analysis. The results of these 
characterization techniques could be compared and completed with those of TDA and RMM 
in order to generate a more versatile toolbox for nanoparticle determination. 
 
In addition, it was possible to conclude that the immobilized pepsin does not bleed from the 
nanoparticle or undergo auto digestion. This could be determined by using a coupled 
digestion protocol, on the one hand to confirm the functionality of the immobilized pepsin and 
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on the other hand to investigate the possible presence of pepsin related peptides in the 
analytical sample. Therefore, a defined protein mixture was digested with the nano 
biocatalysts. Afterwards the sample was separated from the nano particles and re-digested 
with trypsin in order to determine possible characteristic peptides from pepsin by UHPLC-
ESI-QTof-MS/MS analysis. 
 
Another functional parameter was the investigation of enzyme activity by Michaelis-Menten 
kinetics. For this purpose, an analytical HPLC method was developed and validated for the 
determination of the enzymatic degradation of cytochrome C. The comparison of the enzyme 
activity of non-immobilized (free) pepsin and immobilized pepsin showed comparable results. 
The enzyme activity is therefore not adversely affected by the immobilization.  
 
A final comparison of defined protein mix samples was performed by LC-MS/MS for 
confirming the presence of characteristic peptides related to pepsin digestion. As a 
biopharmaceutical sample a monoclonal antibody was specifically digested with the newly 
synthesized heterogeneous nanobiocatalysts and analyzed using the proprietary on-line SPE 
high-resolution mass spectrometry method. The method was also used for the intact mass 
determination of the human growth hormone genotropin. This confirmed the practical 
application of the new nano catalysts and ensured the versatility of the on-line SPE method. 
 
Advantages, such as the handling of the colloidal suspension as a classic liquid (transfer by 
means of pipettes, etc.), the possibility of a complete separation of the sample solution by 
bench top centrifuge and the reusability of the catalysts, greatly facilitated the daily research 
work and made it accessible for the reverse analysis and characterization strategies. 
 
The goal of the present work, namely the development and characterization of new 
heterogeneous nano biocatalysts for the sample preparation of protein samples and 
biopharmaceuticals such as monoclonal antibodies, has been fully achieved. The particles 
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were fully analyzed in terms of size, functionality, stability and practical application. They 
represent a new and well-established quality control tool of bioprocesses in 
biopharmaceutical production. 
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